data_1qr5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1qr5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptp . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.641 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 2.4 mm-40 -95.3 165.34 12.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.703 0.287 . . . . 0.0 110.812 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.697 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 2.2 pt20 -163.65 156.38 18.12 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -163.15 118.95 1.76 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.032 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 p -89.31 152.34 21.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.918 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 59.4 m-85 -142.96 -179.89 6.63 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.899 0.857 . . . . 0.0 112.877 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.413 ' O ' HG21 ' A' ' 7' ' ' THR . 9.7 t -152.88 96.47 2.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.022 -1.444 . . . . 0.0 107.976 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 mt -96.29 -168.97 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.043 -176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.614 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 2.7 pp -145.86 15.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 122.314 0.246 . . . . 0.0 111.612 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -75.86 80.98 2.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.625 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -52.4 -22.39 4.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.478 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -37.98 23.21 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.11 -166.25 19.97 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.757 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.5 mt -69.42 81.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.006 0.432 . . . . 0.0 110.815 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.517 ' CE1' ' HB3' ' A' ' 17' ' ' ARG . 14.3 p80 -70.78 -162.16 0.06 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.261 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.51 -28.72 67.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.562 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 31.1 ttp180 -74.94 -62.0 0.95 Allowed Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 36.0 Cg_endo -64.49 -33.34 57.44 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.306 2.004 . . . . 0.0 112.888 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.9 -63.21 1.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.883 -0.144 . . . . 0.0 111.062 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.1 m -54.29 -31.85 54.89 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.698 0.285 . . . . 0.0 110.719 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.548 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -64.27 -54.57 31.18 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.596 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 mt -58.74 -35.7 73.14 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 27' ' ' SER . 62.6 t -54.45 -62.24 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.92 -51.51 61.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.747 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 97.0 m -52.73 -61.37 2.33 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.105 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.31 -47.75 84.67 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.102 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 50.2 p -59.82 -29.02 67.96 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 25' ' ' THR . 3.7 mtpm? -63.43 -54.28 39.02 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.662 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 28.3 m-85 -65.65 -37.68 87.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.125 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 84.07 -20.26 0.32 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.533 -1.667 . . . . 0.0 112.275 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 81.6 p -67.73 143.19 56.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.475 0.655 . . . . 0.0 112.399 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.34 114.84 18.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.521 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.674 HG23 ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -100.89 114.28 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.851 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.688 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 14.9 pm0 -90.3 107.19 18.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 122.089 0.947 . . . . 0.0 109.318 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.576 ' CB ' ' HB3' ' A' ' 44' ' ' LEU . 4.5 tt -97.09 114.09 25.72 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.777 -1.556 . . . . 0.0 108.831 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.771 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -92.96 174.77 7.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 125.936 2.022 . . . . 0.0 111.641 -179.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 28.9 t80 -133.22 165.05 25.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.714 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.487 ' HB3' ' CG ' ' A' ' 60' ' ' GLU . 1.2 p-10 -53.22 -14.74 0.74 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.642 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.32 49.27 0.5 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.32 172.52 3.21 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.515 0.197 . . . . 0.0 110.675 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.771 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -160.29 109.65 1.75 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -155.02 -178.18 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.262 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . 4.9 t30 -83.77 136.94 33.96 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.674 ' HG ' HG23 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -68.81 58.08 0.09 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.076 0.398 . . . . 0.0 111.051 177.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 43' ' ' ASN . 1.4 ttmt -65.78 -14.9 62.26 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.607 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . 0.7 OUTLIER 69.3 -49.01 0.6 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.1 mt -52.77 -26.26 10.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.382 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.81 -39.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.86 -52.92 24.13 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.479 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.607 ' CG2' ' HA ' ' A' ' 46' ' ' SER . 15.2 m -67.06 -35.89 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.932 0.366 . . . . 0.0 110.728 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 63.9 mtt -59.87 -48.04 83.32 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.668 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 p -57.68 -51.48 69.36 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.975 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -67.26 -19.19 65.47 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.03 102.41 0.01 OUTLIER Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.951 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 t -100.79 56.84 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.841 0.353 . . . . 0.0 111.106 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.35 -160.46 8.56 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.763 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 1.7 tttm -73.95 134.91 43.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER 76.9 9.61 2.78 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.542 0.526 . . . . 0.0 110.691 -178.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.16 119.61 8.73 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.487 ' CG ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -95.4 135.85 36.5 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.441 ' CD1' HD22 ' A' ' 81' ' ' LEU . 5.8 pt -138.71 172.88 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.394 0.616 . . . . 0.0 112.385 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 36' ' ' GLU . 7.2 m -151.71 102.54 2.86 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.285 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.568 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -94.0 149.14 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.315 -177.053 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.697 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 38.2 m-85 -146.82 114.19 6.3 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.297 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.541 ' CB ' HG13 ' A' ' 33' ' ' ILE . . . -95.38 126.38 40.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.812 0.339 . . . . 0.0 110.579 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -139.88 92.47 2.56 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.925 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.97 -80.01 0.04 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.439 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.52 -68.74 0.33 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.58 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 5.5 m-20 -89.86 51.53 2.09 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -23.76 63.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.968 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.641 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -86.84 -53.26 5.01 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.604 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.05 -36.69 60.88 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.662 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.86 -54.96 31.31 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.897 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.6 mm -43.31 -51.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.928 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -57.59 -68.88 0.2 Allowed 'General case' 0 C--O 1.239 0.538 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.05 -33.17 68.72 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.723 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.1 mm -62.88 -38.37 81.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.74 -60.23 4.01 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -42.0 -41.04 2.4 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.625 0.578 . . . . 0.0 110.47 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.548 ' CG2' ' HB3' ' A' ' 21' ' ' MET . 7.9 t -65.65 -63.46 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.027 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.441 HD22 ' CD1' ' A' ' 61' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 110.969 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ttt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.732 0.301 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.604 ' CD ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -94.04 164.21 13.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.425 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -160.94 152.26 19.06 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.329 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.07 133.18 5.87 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.771 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 3.0 t -89.97 157.66 17.74 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.944 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.615 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 4.9 m-85 -138.16 176.38 8.75 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.86 0.838 . . . . 0.0 112.251 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.4 m -145.8 75.52 1.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.492 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.454 HD13 HG23 ' A' ' 8' ' ' ILE . 48.2 mt -65.29 163.33 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.489 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.705 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 2.1 pp -136.04 -26.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.761 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 13' ' ' GLY . 10.2 t0 -68.09 87.59 0.27 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.437 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -47.85 -27.54 2.14 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.35 -38.01 27.35 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 10' ' ' ASP . . . 88.56 -114.02 4.17 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.937 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.88 152.59 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.071 0.462 . . . . 0.0 111.855 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.536 ' CE1' ' HD3' ' A' ' 18' ' ' PRO . 24.9 p80 -170.54 -153.53 0.1 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.967 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.87 79.52 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -78.89 -55.18 0.99 Allowed Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HD3' ' CE1' ' A' ' 15' ' ' HIS . 12.3 Cg_exo -62.69 -41.72 29.63 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.623 2.215 . . . . 0.0 113.122 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.08 -64.4 0.93 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -53.93 -33.23 56.13 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.776 0.322 . . . . 0.0 111.086 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.583 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -66.31 -62.47 1.46 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.513 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 46' ' ' SER . 0.9 OUTLIER -58.67 -37.03 75.14 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.7 t -53.51 -60.04 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.429 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.1 tt0 -66.49 -52.91 40.94 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.761 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.429 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 94.9 m -52.45 -58.93 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.464 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.45 -48.29 80.31 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.31 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -59.72 -28.36 67.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.726 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -66.11 -52.9 44.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.644 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 13.9 m-85 -66.68 -41.81 87.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.31 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 74.8 -7.28 1.76 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.53 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.6 p -66.13 152.35 44.94 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -73.95 140.22 45.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.549 ' O ' HG21 ' A' ' 33' ' ' ILE . 3.4 tt -142.59 124.24 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-O 121.137 0.494 . . . . 0.0 111.455 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.63 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 9.8 pt20 -112.0 123.33 50.02 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-O 121.436 0.636 . . . . 0.0 110.217 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.641 ' HB2' HD13 ' A' ' 44' ' ' LEU . 2.1 tt -109.77 123.12 48.98 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.483 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.727 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -103.14 176.41 5.16 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 125.763 1.914 . . . . 0.0 111.585 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -127.16 162.65 25.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.567 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.47 -10.8 1.03 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.72 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.76 45.5 0.57 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.09 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.84 -177.71 0.65 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.661 0.267 . . . . 0.0 110.984 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.727 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 1.2 tmtp? -158.9 124.8 4.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.336 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.9 m -153.45 -173.74 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.269 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -85.75 143.76 28.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.641 HD13 ' HB2' ' A' ' 35' ' ' LEU . 1.1 tt -69.25 57.53 0.11 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -69.64 -38.86 77.31 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.559 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . 2.5 p 70.9 -50.49 0.68 Allowed 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.724 0.64 . . . . 0.0 112.119 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.7 mm -53.44 -25.95 11.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.168 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.413 ' HA ' ' HB2' ' A' ' 51' ' ' MET . 14.4 mtp -166.64 -39.27 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.669 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.66 -52.09 26.0 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.979 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.559 ' CG2' ' HA ' ' A' ' 46' ' ' SER . 6.7 m -72.91 -37.98 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.592 0.196 . . . . 0.0 110.54 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.413 ' HB2' ' HA ' ' A' ' 48' ' ' MET . 0.6 OUTLIER -56.84 -53.19 60.67 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.308 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.5 p -58.02 -37.56 74.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.361 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.2 mt -60.9 -30.81 70.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.409 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.76 -42.57 1.87 Allowed Glycine 0 C--N 1.339 0.716 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.265 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.45 ' CG2' ' HB ' ' A' ' 50' ' ' VAL . 72.4 t 35.9 63.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 11' ' ' GLU . . . -86.94 -172.52 48.37 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.109 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 5.9 tttt -76.11 126.28 30.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 86.45 11.19 0.19 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.885 0.741 . . . . 0.0 110.916 -178.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.92 121.56 13.27 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 120.736 0.303 . . . . 0.0 111.693 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.16 135.99 33.26 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.803 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.615 ' CG1' ' HB2' ' A' ' 6' ' ' TYR . 45.1 pt -147.0 176.64 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.14 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.6 m -152.57 109.9 3.55 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.002 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.1 mm -94.25 154.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.481 -178.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.63 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 57.7 m-85 -141.16 117.61 10.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.539 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.3 129.89 46.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.872 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -134.5 96.05 3.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.138 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.49 -154.47 17.81 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.746 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.0 p -71.95 -59.2 2.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.158 0.479 . . . . 0.0 111.724 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.644 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.6 m-20 -93.47 36.59 1.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.423 0.154 . . . . 0.0 111.407 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.69 -22.36 66.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.91 -56.67 3.29 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.74 -30.34 65.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.738 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.563 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -50.18 -63.11 1.22 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.548 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.604 HG12 ' CD ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -43.75 -43.38 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -58.4 -71.72 0.11 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.778 0.323 . . . . 0.0 111.368 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.04 -33.36 67.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.503 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.16 -38.71 80.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.983 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 -56.12 25.9 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -47.23 -42.71 20.88 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.148 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.583 ' CG2' ' HB3' ' A' ' 21' ' ' MET . 7.8 t -65.76 -63.38 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.461 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 120.856 0.36 . . . . 0.0 110.421 179.548 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.813 0.339 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.641 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mm-40 -95.67 162.48 13.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.388 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.721 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.6 OUTLIER -166.2 152.93 9.39 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -164.83 121.91 1.57 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.629 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 p -89.65 150.71 22.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.807 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 41.8 m-85 -142.5 176.57 8.92 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.569 0.699 . . . . 0.0 111.815 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 t -153.48 111.96 3.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.173 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -132.92 175.3 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -176.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 pp -95.28 15.17 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.124 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -69.48 78.04 0.4 Allowed 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.212 0.53 . . . . 0.0 111.545 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.452 ' HG2' ' CB ' ' A' ' 57' ' ' LYS . 1.1 tm-20 -52.24 -32.08 35.21 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.901 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.0 p -82.43 -35.28 27.74 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.98 -86.28 1.25 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.278 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.534 HD11 ' HB ' ' A' ' 50' ' ' VAL . 4.3 mp -137.39 71.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.21 0.528 . . . . 0.0 110.309 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.417 ' N ' ' HG2' ' A' ' 18' ' ' PRO . 11.2 p80 -69.78 -156.23 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.641 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.1 -33.28 71.9 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.554 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 1.3 ttp85 -73.73 -63.5 0.93 Allowed Pre-proline 0 N--CA 1.467 0.382 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.519 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.554 ' CD ' ' HB3' ' A' ' 17' ' ' ARG . 21.4 Cg_endo -60.42 -29.71 89.32 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.505 2.137 . . . . 0.0 112.719 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 46' ' ' SER . . . -62.5 -64.56 0.89 Allowed 'General case' 0 C--N 1.339 0.132 0 CA-C-N 116.857 -0.156 . . . . 0.0 110.812 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 m -53.73 -32.16 51.05 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 110.604 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -55.43 20.43 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.395 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 mt -58.41 -34.17 70.47 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.115 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 27' ' ' SER . 67.3 t -55.44 -64.57 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -64.93 -44.12 90.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 123.194 0.309 . . . . 0.0 111.672 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.443 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 52.0 m -56.33 -61.32 2.48 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.594 0.235 . . . . 0.0 110.409 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.76 98.0 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.469 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 4.5 m -58.42 -32.95 69.14 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.232 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 25' ' ' THR . 24.9 mtmm -63.55 -52.68 60.01 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.592 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 43.4 m-85 -66.68 -35.54 80.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.667 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER 82.5 -20.84 0.33 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.868 -1.515 . . . . 0.0 111.502 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.44 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 88.7 p -68.7 132.33 46.68 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.725 0.774 . . . . 0.0 112.219 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.24 115.44 19.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.686 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.718 HG22 ' HG ' ' A' ' 44' ' ' LEU . 2.9 mt -97.48 123.62 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.464 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.727 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 1.4 pt20 -94.76 104.15 16.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.543 ' HB2' HD22 ' A' ' 44' ' ' LEU . 5.5 tt -99.44 119.37 37.88 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.029 -1.441 . . . . 0.0 110.176 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.762 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -93.98 169.6 10.16 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 126.023 2.077 . . . . 0.0 110.466 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.589 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -145.52 97.6 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.509 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 49.93 -59.5 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 37' ' ' TYR . . . -138.62 33.05 2.25 Favored Glycine 0 C--N 1.318 -0.468 0 C-N-CA 121.816 -0.23 . . . . 0.0 112.738 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.44 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -138.33 171.04 14.97 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.762 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 1.2 tmtm? -156.56 109.88 2.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.934 0.397 . . . . 0.0 111.736 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.4 m -153.78 173.07 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.084 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -81.89 131.89 35.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.718 ' HG ' HG22 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -67.66 56.81 0.06 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.858 0.361 . . . . 0.0 110.987 177.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HG2' HD12 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -66.89 -17.71 65.03 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.558 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.63 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.95 -47.64 0.67 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.424 HD12 ' HG2' ' A' ' 45' ' ' LYS . 3.2 mt -52.82 -26.44 10.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.329 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.477 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 13.0 mtp -167.79 -37.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.19 60.06 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.182 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.63 ' CG2' ' HA ' ' A' ' 46' ' ' SER . 24.8 m -69.29 -50.2 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.477 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -59.0 -41.36 87.46 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.614 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.4 t -57.9 -41.3 82.32 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.216 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.44 ' CD2' ' HB3' ' A' ' 40' ' ' LYS . 38.7 mt -64.58 -52.57 56.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.821 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.64 -49.03 0.92 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.417 -0.421 . . . . 0.0 113.14 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t 36.49 79.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.418 ' C ' ' HA ' ' A' ' 11' ' ' GLU . . . -76.47 -163.36 15.94 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.902 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 7.3 tttt -74.34 134.86 42.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER 76.69 9.29 2.97 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.519 0.512 . . . . 0.0 110.41 -178.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.18 136.79 58.1 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 152.21 20.62 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.5 pt -145.66 172.7 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.093 0.473 . . . . 0.0 111.924 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 36' ' ' GLU . 5.6 m -149.21 103.28 3.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.446 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.614 HG23 HG21 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -96.64 145.06 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.612 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.727 ' HB2' ' HG3' ' A' ' 34' ' ' GLN . 11.2 m-85 -145.53 111.33 5.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.052 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.502 ' CB ' HG13 ' A' ' 33' ' ' ILE . . . -91.13 133.51 35.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.329 0.585 . . . . 0.0 111.767 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -130.88 101.24 5.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.79 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . 174.57 -158.94 27.52 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.7 p -71.53 -60.79 2.05 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.27 1.035 . . . . 0.0 111.133 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.592 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 9.7 m-20 -91.48 42.92 1.12 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.57 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -66.28 -22.47 66.3 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.974 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.641 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -88.29 -46.77 8.93 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.12 -40.21 64.03 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.541 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -54.99 -54.55 41.5 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.441 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 mm -48.43 -47.49 14.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.502 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -55.52 -70.96 0.09 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.78 -37.26 73.39 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.1 mm -60.85 -41.75 89.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.529 0.204 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 79' ' ' ASP . 14.6 m -60.59 -63.59 1.25 Allowed 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.456 ' C ' ' O ' ' A' ' 78' ' ' THR . 45.8 m-20 -34.39 -43.82 0.17 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.034 0.445 . . . . 0.0 110.142 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.1 t -66.68 -66.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.114 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.194 0.521 . . . . 0.0 110.644 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.577 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mm-40 -99.02 159.21 15.12 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.461 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.703 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -159.58 156.69 28.47 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 2.6 mm-40 -162.25 164.63 27.53 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.422 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.515 ' HB3' HG21 ' A' ' 62' ' ' THR . 46.2 p -153.66 139.5 18.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.906 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -144.7 -177.59 5.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.396 0.617 . . . . 0.0 111.392 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 t -153.19 116.83 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.576 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.481 HD12 HG23 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -134.98 177.5 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -176.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.3 pt -94.07 16.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.747 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -68.58 73.97 0.25 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.329 0.585 . . . . 0.0 111.642 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 57' ' ' LYS . 2.9 tt0 -59.38 -25.26 64.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.048 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -80.01 -33.67 39.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . 48.66 81.43 0.05 OUTLIER Glycine 0 C--N 1.341 0.836 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.894 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 25.5 mm 71.82 127.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.802 0.334 . . . . 0.0 111.031 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.401 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 10.7 p80 -166.76 -119.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.314 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 18' ' ' PRO . . . -69.32 -167.13 0.11 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 118.777 -0.63 . . . . 0.0 109.881 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.664 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 12.29 -73.03 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.664 ' CD ' ' HB3' ' A' ' 17' ' ' ARG . 4.5 Cg_exo -40.31 -45.97 4.26 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.67 2.913 . . . . 0.0 113.212 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 15' ' ' HIS . . . -64.25 -56.22 16.1 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 121.258 -0.177 . . . . 0.0 111.146 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.2 m -50.84 -34.29 27.23 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.921 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 mmm -62.93 -50.45 70.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.291 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -35.61 70.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.852 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.68 -59.06 2.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -66.18 -50.93 62.21 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.301 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.463 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 84.8 m -52.69 -60.46 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.47 89.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.579 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.5 t -59.48 -29.4 67.8 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.375 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 25' ' ' THR . 3.5 mtpm? -63.98 -51.46 64.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.616 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 30.3 m-85 -64.59 -39.66 94.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.746 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 76.5 -14.21 0.84 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.27 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.8 p -68.31 144.91 54.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.384 0.611 . . . . 0.0 112.383 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.48 110.19 13.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.734 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -101.27 119.9 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.46 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.682 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 15.8 pm0 -101.03 113.11 25.8 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.582 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 1.5 tt -103.47 120.83 41.6 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.585 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.755 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.6 OUTLIER -94.87 175.99 6.43 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 126.136 2.147 . . . . 0.0 111.251 -179.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -128.53 166.72 18.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.241 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.426 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 7.6 t-20 -46.62 -21.02 0.15 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.23 55.55 0.39 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.86 -179.7 1.22 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.631 0.253 . . . . 0.0 110.999 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.755 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -158.89 118.81 3.13 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.446 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 m -153.26 -173.68 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.976 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -86.45 144.39 27.31 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.582 ' HB2' ' HB2' ' A' ' 35' ' ' LEU . 6.8 tp -68.81 59.09 0.09 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -67.78 -32.05 72.36 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.472 ' HB3' HG13 ' A' ' 14' ' ' ILE . 0.7 OUTLIER 69.59 -52.28 0.61 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.423 0.63 . . . . 0.0 112.183 -179.471 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.8 mt -53.31 -26.2 11.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.213 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.9 mtp -167.56 -39.19 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.628 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -48.22 -47.51 27.32 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.286 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.458 ' HA ' HD22 ' A' ' 53' ' ' LEU . 33.7 m -69.56 -38.71 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.705 0.288 . . . . 0.0 110.899 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.3 mtt -59.63 -47.07 87.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.798 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.4 p -58.71 -48.44 81.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.479 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -66.88 -11.07 54.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.44 117.04 0.04 OUTLIER Glycine 0 C--N 1.339 0.746 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.223 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.433 HG23 HD11 ' A' ' 53' ' ' LEU . 2.5 t -120.2 70.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.754 0.311 . . . . 0.0 111.814 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.25 -167.03 32.94 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.35 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 7.2 tttm -71.82 134.76 46.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER 76.59 12.8 2.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.553 0.533 . . . . 0.0 111.04 -179.111 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.69 131.92 52.23 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.426 ' CG ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -103.18 144.87 30.75 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.292 179.058 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.476 HD12 HD23 ' A' ' 81' ' ' LEU . 2.2 pt -146.79 169.09 5.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.714 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 5' ' ' SER . 16.9 m -152.44 107.49 3.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.734 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 4.8 mp -96.96 148.09 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.703 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 25.8 m-85 -138.24 114.94 10.62 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.904 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.454 ' CB ' HG13 ' A' ' 33' ' ' ILE . . . -93.46 130.56 39.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.212 0.529 . . . . 0.0 111.459 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -131.48 96.68 4.04 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.751 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.89 -154.77 18.07 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.523 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.4 p -74.63 -60.68 2.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.704 0.752 . . . . 0.0 111.25 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.616 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 5.9 m-20 -91.52 41.22 1.06 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.897 0.38 . . . . 0.0 110.573 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.426 ' HG3' ' CG ' ' A' ' 2' ' ' GLU . 15.0 pt-20 -66.2 -28.52 68.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.974 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.577 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -85.78 -44.02 12.84 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.89 -40.89 67.0 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.597 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -54.68 -54.39 42.38 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.105 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.7 mm -49.6 -49.85 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.961 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -54.78 -69.04 0.14 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.62 -38.07 68.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.607 0.242 . . . . 0.0 111.35 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.4 mm -61.33 -37.71 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.638 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -62.05 2.14 Favored 'General case' 0 C--O 1.207 -1.164 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -39.56 -43.87 1.37 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.594 0.559 . . . . 0.0 110.436 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.5 t -63.74 -64.64 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.448 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.481 HD21 HD13 ' A' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.374 0 CA-C-O 121.011 0.434 . . . . 0.0 110.651 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptp . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.577 ' HG2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -98.05 164.51 12.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.738 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -157.49 160.19 38.01 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.513 ' HG3' HD13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -160.82 123.09 3.14 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.173 179.423 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 p -94.07 156.59 16.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.692 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -144.48 177.53 8.59 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.654 0.74 . . . . 0.0 111.992 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.423 ' C ' HG12 ' A' ' 8' ' ' ILE . 14.6 t -160.43 104.1 1.42 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.469 -1.242 . . . . 0.0 107.918 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.423 HG12 ' C ' ' A' ' 7' ' ' THR . 0.4 OUTLIER -142.69 -175.74 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.036 -175.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.56 HG23 ' HA ' ' A' ' 57' ' ' LYS . 14.7 pt -136.89 -41.35 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 t70 44.89 27.7 0.29 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.771 0.26 . . . . 0.0 111.634 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 33.5 34.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.451 0.7 . . . . 0.0 112.741 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 175.94 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.922 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.74 -56.93 0.97 Allowed Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.11 174.25 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -171.64 -59.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -174.95 -35.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.442 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -72.13 -56.73 4.21 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 -179.399 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 36.9 Cg_endo -65.29 -33.49 48.26 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.292 1.995 . . . . 0.0 112.149 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.581 ' HA ' ' HB2' ' A' ' 46' ' ' SER . . . -62.73 -65.0 0.75 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.084 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.1 p -55.29 -28.91 56.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.282 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.585 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 1.4 mtt -63.16 -55.59 23.85 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.797 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.443 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 0.3 OUTLIER -58.91 -34.57 71.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.075 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 27' ' ' SER . 73.8 t -54.55 -57.28 6.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.64 -55.97 14.67 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.504 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 29.4 p -52.89 -57.5 10.05 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.547 0.202 . . . . 0.0 111.547 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.14 -47.72 84.91 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.822 -0.172 . . . . 0.0 110.979 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 23.5 m -60.28 -30.97 69.8 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.784 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.504 ' HE3' ' HA ' ' A' ' 25' ' ' THR . 4.9 mtmp? -63.76 -51.38 65.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.466 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 14.2 m-85 -64.58 -37.49 87.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.984 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 80.84 -15.5 0.73 Allowed 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.582 -1.644 . . . . 0.0 112.681 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.435 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 83.4 p -66.09 145.6 55.65 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.416 0.626 . . . . 0.0 112.263 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.04 109.11 13.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.098 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.666 HG13 ' CB ' ' A' ' 65' ' ' ALA . 1.3 mt -99.53 125.15 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.909 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.642 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -103.77 113.45 26.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.643 0.735 . . . . 0.0 109.258 178.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -101.34 114.12 27.83 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.935 -179.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.523 ' HG3' ' HG2' ' A' ' 41' ' ' LYS . 1.5 tt0 -91.72 173.65 7.76 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 126.262 2.226 . . . . 0.0 110.772 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.413 ' CG ' ' HB2' ' A' ' 53' ' ' LEU . 32.3 t80 -132.35 163.57 28.41 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.084 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.602 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -51.65 -15.48 0.47 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -156.68 50.12 0.44 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.197 -0.525 . . . . 0.0 111.826 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -178.88 -178.51 0.55 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.666 0.27 . . . . 0.0 110.906 -179.353 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.523 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 1.7 tmtt? -157.83 120.84 3.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.448 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.4 m -151.43 -175.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.512 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.25 140.87 29.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.662 ' HB3' HG22 ' A' ' 33' ' ' ILE . 1.6 tp -69.65 56.83 0.13 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.593 0.235 . . . . 0.0 110.582 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -73.16 9.56 1.2 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.581 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . 89.8 p 39.64 34.24 0.15 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 46' ' ' SER . 2.2 mp -166.16 -84.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.4 tpp -63.98 -37.27 86.82 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -82.43 0.1 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.475 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.439 ' HB ' ' CG2' ' A' ' 55' ' ' VAL . 3.1 m -40.0 -42.06 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.0 mtt -59.07 -50.11 75.32 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.509 0.195 . . . . 0.0 111.233 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.4 t -56.47 -52.64 63.94 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.226 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.413 ' HB2' ' CG ' ' A' ' 37' ' ' TYR . 0.6 OUTLIER -67.31 -18.01 65.0 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.59 101.3 0.05 OUTLIER Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.55 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.439 ' CG2' ' HB ' ' A' ' 50' ' ' VAL . 19.5 t -90.98 75.99 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.939 0.4 . . . . 0.0 111.22 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.12 -161.99 37.12 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.375 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.612 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -72.63 127.43 32.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.612 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 82.33 18.24 0.34 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.698 0.624 . . . . 0.0 110.42 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.88 115.27 2.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.299 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 2.1 tt0 -96.83 139.63 32.58 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.753 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.82 170.11 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.154 0.502 . . . . 0.0 111.812 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.0 m -152.55 107.0 3.16 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.928 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.562 HG21 HG21 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -94.99 146.59 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.738 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 40.8 m-85 -145.49 108.82 4.63 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.468 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.666 ' CB ' HG13 ' A' ' 33' ' ' ILE . . . -98.0 133.54 42.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.838 0.351 . . . . 0.0 110.559 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.82 78.17 1.66 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.569 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -147.76 -89.7 0.08 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.702 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.3 p -132.39 -65.65 0.72 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.918 0.359 . . . . 0.0 111.285 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.4 m-20 -89.69 41.19 1.03 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.867 0.365 . . . . 0.0 110.639 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -24.28 66.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.055 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.28 -53.21 5.92 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -32.91 66.13 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.989 0.423 . . . . 0.0 109.876 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.462 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -49.09 -56.49 8.94 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.992 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.577 HD11 ' HG2' ' A' ' 2' ' ' GLU . 15.1 mm -42.64 -55.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.83 -67.62 0.25 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.78 68.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.47 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.92 -37.76 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.558 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -56.32 23.57 Favored 'General case' 0 C--O 1.209 -1.055 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -45.6 -41.07 9.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.089 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.585 ' CG2' ' HB3' ' A' ' 21' ' ' MET . 6.2 t -65.26 -62.97 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.181 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.973 0.416 . . . . 0.0 110.617 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ttt . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.735 0.302 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.591 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 3.1 mm-40 -95.28 164.58 12.78 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.525 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.683 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 2.3 pt20 -161.78 152.77 18.05 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.777 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.478 ' HB3' ' CE1' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -160.87 122.61 3.03 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.986 0.422 . . . . 0.0 111.967 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.7 p -90.71 155.06 19.1 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.994 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.478 ' CE1' ' HB3' ' A' ' 4' ' ' GLN . 87.4 m-85 -143.45 -179.92 6.72 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 122.009 0.909 . . . . 0.0 112.814 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 7' ' ' THR . 11.8 t -152.06 95.8 2.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.606 -1.633 . . . . 0.0 106.833 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.433 ' H ' HG13 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -93.4 179.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.721 -175.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 1.6 pp -148.5 27.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.665 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.34 78.13 1.01 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.98 0.419 . . . . 0.0 110.343 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.607 ' HG3' ' HB2' ' A' ' 57' ' ' LYS . 1.8 mp0 -54.06 -22.72 11.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.788 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -41.27 37.85 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.75 85.97 0.09 OUTLIER Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.773 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER 69.17 145.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.134 0.492 . . . . 0.0 111.795 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -171.56 -63.65 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.605 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.645 ' C ' ' HD2' ' A' ' 18' ' ' PRO . . . -178.06 163.51 1.74 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.799 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER 98.51 -60.49 0.0 OUTLIER Pre-proline 0 C--N 1.364 1.229 0 CA-C-N 118.934 0.788 . . . . 0.0 112.743 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.645 ' HD2' ' C ' ' A' ' 16' ' ' ALA . 56.5 Cg_endo -70.65 -27.77 21.79 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.804 1.669 . . . . 0.0 112.471 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.47 -65.61 0.66 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.695 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.6 m -55.02 -32.98 62.25 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.704 0.288 . . . . 0.0 110.51 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.45 ' HE1' ' HA ' ' A' ' 18' ' ' PRO . 21.1 mtm -64.83 -53.78 41.37 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.408 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -57.98 -37.38 74.11 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.19 179.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.3 t -54.1 -60.16 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -49.65 64.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.431 ' O ' ' CD2' ' A' ' 29' ' ' PHE . 73.5 p -58.13 -58.96 6.13 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.389 0.086 . . . . 0.0 111.051 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.59 85.69 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.744 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.5 t -59.37 -33.07 70.73 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -66.49 -51.4 57.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.602 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.603 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 13.9 m-85 -66.33 -40.78 90.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.509 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 78.36 -20.41 0.39 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.593 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.55 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 93.2 p -66.52 140.09 57.97 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.623 0.725 . . . . 0.0 112.415 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.57 112.84 19.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.112 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.62 HG13 ' CB ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -97.73 121.38 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.677 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.646 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 1.8 pt20 -101.61 107.41 18.67 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.598 ' CD1' ' HG ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -99.63 116.25 31.31 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.085 -179.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.68 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -93.91 172.23 8.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 125.973 2.046 . . . . 0.0 110.736 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.458 ' HA ' HG22 ' A' ' 61' ' ' ILE . 13.0 t80 -125.4 166.82 15.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.092 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.552 ' HB3' ' CG ' ' A' ' 60' ' ' GLU . 0.7 OUTLIER -53.58 -14.98 0.96 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.82 46.69 0.51 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.102 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.04 -177.36 1.57 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.798 0.333 . . . . 0.0 111.244 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.68 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 3.0 tmtm? -158.12 117.76 3.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.802 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 m -152.3 -172.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.095 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -86.59 142.67 28.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.598 ' HG ' ' CD1' ' A' ' 35' ' ' LEU . 4.2 tt -68.68 58.45 0.09 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -41.9 71.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.571 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . 1.0 OUTLIER 71.27 -51.99 0.69 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.425 0.631 . . . . 0.0 111.897 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -53.06 -27.28 13.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.316 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.529 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 12.8 mtp -167.3 -39.07 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.76 -56.1 12.57 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.17 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.571 ' CG2' ' HA ' ' A' ' 46' ' ' SER . 18.6 m -68.05 -50.26 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.567 ' HA ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.48 -40.14 85.97 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.375 0.131 . . . . 0.0 111.3 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -57.21 -51.54 68.92 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.625 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -66.97 -35.09 79.2 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.07 179.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.402 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . 128.69 126.52 2.87 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.711 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 51' ' ' MET . 44.1 t -127.1 107.57 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.591 0.234 . . . . 0.0 111.127 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.0 174.09 18.3 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.513 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.607 ' HB2' ' HG3' ' A' ' 11' ' ' GLU . 15.1 tttt -70.06 136.39 50.26 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 86.2 5.2 0.42 Allowed 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.651 0.594 . . . . 0.0 111.061 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.86 119.13 7.13 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.552 ' CG ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -94.81 145.74 24.67 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 35' ' ' LEU . 5.5 pt -147.48 175.65 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 m -151.86 107.03 3.28 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.767 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 0.8 OUTLIER -96.05 152.3 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.114 -177.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.683 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 51.9 m-85 -146.26 110.24 4.95 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.66 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.62 ' CB ' HG13 ' A' ' 33' ' ' ILE . . . -93.47 126.51 38.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.025 0.441 . . . . 0.0 110.705 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -125.8 94.68 4.18 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.109 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.55 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . 179.88 -159.17 23.38 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.067 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.2 p -69.95 -60.97 1.97 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.104 0.952 . . . . 0.0 111.605 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.568 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 4.2 m-20 -91.79 45.26 1.21 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.849 0.357 . . . . 0.0 110.824 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.591 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 9.5 pt-20 -67.1 -22.53 65.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.12 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.572 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -88.63 -45.58 9.74 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -38.64 67.33 Favored 'General case' 0 C--N 1.342 0.281 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.603 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -52.34 -56.88 11.95 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.49 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.0 mm -44.82 -45.64 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.791 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.73 -70.76 0.15 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.86 -32.49 65.88 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.12 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.0 mm -62.43 -36.55 75.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -51.78 68.36 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -46.11 -42.85 14.25 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.743 0.652 . . . . 0.0 109.923 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.14 -57.79 10.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.152 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.679 0.276 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.582 ' CG ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -101.5 160.04 14.77 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.601 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.715 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -150.31 149.86 30.69 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.684 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.83 162.43 32.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.366 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.448 ' HB3' HG21 ' A' ' 62' ' ' THR . 30.6 p -154.17 148.16 25.64 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.745 0.307 . . . . 0.0 111.527 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -144.01 -176.9 5.18 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.415 0.626 . . . . 0.0 111.329 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -153.53 113.31 3.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.76 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.65 -172.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.439 HG23 ' HG3' ' A' ' 57' ' ' LYS . 21.4 pt -137.24 -40.69 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.489 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 12' ' ' THR . 36.3 t70 46.27 22.41 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 10' ' ' ASP . 20.5 mm-40 25.25 41.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.743 0.817 . . . . 0.0 112.325 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 10' ' ' ASP . 2.8 m -176.4 -37.09 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.833 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.88 -75.06 1.45 Allowed Glycine 0 C--N 1.347 1.186 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.773 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.2 mm -139.54 81.94 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.848 0.356 . . . . 0.0 110.063 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.402 ' HB3' HG22 ' A' ' 12' ' ' THR . 10.4 p80 -66.27 -52.56 46.38 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.054 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -178.42 -35.39 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.548 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 3.2 tmm_? -71.47 -53.54 7.57 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 10.0 Cg_endo -52.52 -45.18 41.75 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.541 2.161 . . . . 0.0 112.765 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HA ' ' HB2' ' A' ' 46' ' ' SER . . . -64.36 -64.7 0.81 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.2 m -52.9 -32.14 43.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.374 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.545 ' HG3' ' HD2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -66.1 -49.27 68.13 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.972 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.553 HD23 HD23 ' A' ' 44' ' ' LEU . 3.8 mt -55.75 -38.91 70.45 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.919 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.407 ' O ' ' CB ' ' A' ' 27' ' ' SER . 58.3 t -57.45 -65.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.422 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -45.68 84.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.434 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 95.0 m -57.15 -62.35 1.82 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.441 0.163 . . . . 0.0 110.783 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.38 -46.49 88.53 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.636 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 33.0 t -59.01 -29.64 67.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.595 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' A' ' 25' ' ' THR . 17.4 mtmm -64.18 -52.78 57.29 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.676 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 38.4 m-85 -64.52 -36.5 84.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.047 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 82.44 -16.19 0.62 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.216 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.741 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 86.4 p -66.94 135.13 53.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.459 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.97 110.31 9.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.228 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.709 HG22 HG22 ' A' ' 63' ' ' ILE . 4.1 mt -98.64 126.59 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.613 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.615 ' CG ' ' HB2' ' A' ' 64' ' ' TYR . 3.6 pt20 -98.18 105.44 17.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 6.2 tt -96.63 112.47 24.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.313 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.769 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -95.16 175.84 6.46 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 125.904 2.003 . . . . 0.0 112.471 -178.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -129.12 163.12 26.18 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.494 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 0.7 OUTLIER -55.02 -11.36 0.64 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.66 48.18 0.51 Allowed Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.72 -179.19 0.61 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.714 0.292 . . . . 0.0 110.983 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.769 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -159.18 119.94 3.22 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.493 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.4 m -153.34 -172.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.708 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -89.26 148.73 23.42 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.688 ' HG ' HG21 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -62.92 50.97 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 177.128 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -59.34 -41.23 88.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.56 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.12 -52.17 0.7 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.449 0.643 . . . . 0.0 111.737 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.03 -24.15 14.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.774 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.1 mtm -167.27 -39.29 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.246 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -50.12 -49.32 37.22 Favored Glycine 0 C--N 1.34 0.788 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.113 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.56 ' CG2' ' HA ' ' A' ' 46' ' ' SER . 16.7 m -71.49 -36.3 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.811 0.305 . . . . 0.0 110.559 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 56.3 mtt -59.72 -46.76 88.12 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.464 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.7 p -58.78 -49.82 76.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.934 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 50' ' ' VAL . 1.1 pp -66.96 -12.73 60.56 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.31 109.8 0.06 OUTLIER Glycine 0 C--N 1.34 0.762 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.927 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 t -107.12 59.82 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.989 0.424 . . . . 0.0 110.924 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.87 -156.96 24.42 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.788 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.594 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 3.7 tttt -74.28 126.13 29.95 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.594 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 85.28 13.38 0.21 Allowed 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.822 0.701 . . . . 0.0 110.69 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.64 117.38 4.87 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.779 0.323 . . . . 0.0 111.425 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 1.5 tt0 -99.88 139.71 35.15 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.639 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.35 167.71 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.768 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.448 HG21 ' HB3' ' A' ' 5' ' ' SER . 18.7 m -151.21 114.74 4.87 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.48 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.709 HG22 HG22 ' A' ' 33' ' ' ILE . 3.2 mp -99.58 133.6 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.19 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.715 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 50.6 m-85 -129.91 104.24 7.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.362 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.634 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . . . -95.0 132.07 40.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.176 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.45 78.17 1.5 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.055 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.741 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -164.95 20.8 0.12 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.712 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 67' ' ' GLY . 59.5 p 121.96 -81.94 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.256 1.022 . . . . 0.0 111.914 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.676 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 8.0 m-20 -87.2 46.22 1.35 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.439 0.638 . . . . 0.0 109.997 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -70.5 -21.43 62.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.267 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.96 -51.75 6.17 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -34.52 62.54 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.199 178.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.631 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.75 -63.78 1.04 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.171 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.582 HG12 ' CG ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -48.08 -41.51 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -59.1 -69.33 0.2 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.641 0.258 . . . . 0.0 111.234 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.97 67.79 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.472 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.4 mm -60.26 -38.74 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.152 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.78 -57.9 10.45 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -44.47 -39.8 5.07 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.762 0.664 . . . . 0.0 110.525 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 21' ' ' MET . 3.3 t -64.17 -60.84 2.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.605 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 110.62 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.725 0.298 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.61 ' HG3' ' N ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -100.39 164.07 12.09 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.57 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.694 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -155.41 159.11 39.61 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -156.41 174.39 15.48 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.495 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.7 p -153.03 146.85 25.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.005 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -138.45 -175.43 4.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.864 0.84 . . . . 0.0 113.19 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 7' ' ' THR . 6.7 t -150.31 74.8 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.917 -1.492 . . . . 0.0 107.685 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.453 HG23 HD13 ' A' ' 8' ' ' ILE . 73.0 mt -51.02 160.04 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 113.764 -1.562 . . . . 0.0 113.298 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 pp -151.09 4.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 4.4 t70 -74.13 15.54 0.31 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 8.1 mp0 72.1 -63.25 0.43 Allowed 'General case' 0 C--O 1.231 0.124 0 C-N-CA 122.915 0.486 . . . . 0.0 110.422 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 m -85.7 -25.5 26.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.58 -81.09 1.38 Allowed Glycine 0 C--N 1.343 0.963 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.735 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' A' ' 14' ' ' ILE . 1.1 tp -103.98 62.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.887 0.851 . . . . 0.0 110.548 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -61.34 -52.58 64.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.854 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.56 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -70.33 -57.09 6.1 Favored Pre-proline 0 CA--C 1.53 0.184 0 N-CA-C 110.696 -0.113 . . . . 0.0 110.696 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.477 ' HG2' ' HA ' ' A' ' 14' ' ' ILE . 32.4 Cg_endo -63.18 -31.23 74.98 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.167 1.912 . . . . 0.0 111.925 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HA ' ' HB2' ' A' ' 46' ' ' SER . . . -63.62 -64.9 0.77 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.22 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.2 p -53.62 -31.9 49.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.004 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.504 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.5 mmt -65.64 -52.7 49.81 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.71 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.429 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 0.2 OUTLIER -56.78 -37.63 71.39 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 179.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 27' ' ' SER . 57.6 t -55.29 -57.07 8.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.9 tt0 -66.24 -55.96 13.63 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.937 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 22' ' ' LEU . 54.1 p -53.48 -57.77 9.5 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.917 -0.129 . . . . 0.0 111.299 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.51 -46.62 86.36 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 7.7 m -59.26 -34.7 72.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.057 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 37.1 mtmt -65.39 -49.96 67.31 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.635 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 19.5 m-85 -64.82 -37.31 87.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.29 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 76.49 -13.35 0.93 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.868 -1.515 . . . . 0.0 112.184 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.486 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 92.6 p -67.97 139.89 56.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.483 0.659 . . . . 0.0 112.179 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.73 107.94 12.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.258 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.634 HG22 ' HB3' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -97.84 126.0 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.285 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.724 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 4.7 pt20 -105.87 106.86 17.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.605 ' CB ' ' HB2' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -101.22 121.11 41.28 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.881 -178.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.727 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -96.35 172.96 7.62 Favored 'General case' 0 C--N 1.341 0.217 0 O-C-N 126.211 2.194 . . . . 0.0 109.911 179.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 39' ' ' GLY . 2.1 t80 -146.7 100.92 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.829 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.424 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER 49.6 -59.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 37' ' ' TYR . . . -143.17 37.26 1.51 Allowed Glycine 0 C--N 1.317 -0.515 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -142.65 174.19 10.87 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.727 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -155.19 117.44 4.19 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.081 0.467 . . . . 0.0 111.561 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.9 m -152.37 -176.81 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.971 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -83.51 139.42 32.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.634 ' HB3' HG22 ' A' ' 33' ' ' ILE . 1.5 tp -67.62 55.62 0.06 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.715 0.293 . . . . 0.0 110.709 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -71.73 -4.46 27.72 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.547 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . 81.4 p 38.59 47.5 1.13 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 46' ' ' SER . 38.1 mm -166.43 -95.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.537 0.735 . . . . 0.0 109.217 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 34.1 mmt -68.09 -51.32 47.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.32 -81.35 0.07 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.671 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 46' ' ' SER . 7.2 p -37.55 -43.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 47' ' ' ILE . 1.8 mmt -61.99 -48.86 78.46 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.1 t -53.23 -51.46 62.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.062 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -35.39 80.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.004 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.32 108.36 1.89 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.529 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.8 t -139.27 82.39 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 59' ' ' ALA . . . -102.02 -139.74 10.74 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.454 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 13.8 tttt -73.75 131.88 42.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.582 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 84.6 -5.19 1.0 Allowed 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.7 0.625 . . . . 0.0 111.511 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 56' ' ' GLY . . . -62.72 125.02 22.53 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.722 0.296 . . . . 0.0 111.492 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.98 142.63 27.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.421 HG23 ' HA ' ' A' ' 37' ' ' TYR . 12.7 pt -147.42 172.34 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 6.6 m -150.57 115.15 5.2 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.151 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.6 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -100.46 147.62 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.724 ' HB2' ' HG3' ' A' ' 34' ' ' GLN . 45.3 m-85 -143.09 107.54 4.8 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.899 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.575 ' CB ' HG13 ' A' ' 33' ' ' ILE . . . -93.31 131.08 38.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.116 0.484 . . . . 0.0 111.346 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.54 83.41 2.16 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.96 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -166.72 -154.48 8.4 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.649 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 p -76.28 -55.81 5.22 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.866 0.833 . . . . 0.0 111.893 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.635 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 2.8 m-20 -92.62 40.86 1.06 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.568 0.223 . . . . 0.0 111.224 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 4.9 pt-20 -67.17 -18.77 65.41 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.6 -54.81 3.99 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.89 -34.18 62.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.638 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.542 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -51.74 -62.63 1.5 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.176 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.582 HG12 ' CG ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -49.79 -46.08 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -57.76 -67.92 0.29 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.629 0.252 . . . . 0.0 111.462 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.44 -37.63 67.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.033 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.4 mm -60.85 -39.27 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.463 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.0 -54.76 43.06 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -46.05 -41.62 12.32 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 109.945 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.504 HG23 ' HB3' ' A' ' 21' ' ' MET . 3.4 t -65.19 -61.02 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.007 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.0 mt . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 121.037 0.446 . . . . 0.0 110.559 179.146 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.765 0.317 . . . . 0.0 111.394 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.619 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 7.2 mm-40 -97.59 169.62 9.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.712 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -164.34 153.38 13.41 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.018 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -161.94 121.94 2.51 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.008 0.432 . . . . 0.0 112.009 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.7 p -89.73 153.56 20.6 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.765 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 92.2 m-85 -142.2 -176.88 4.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.697 0.76 . . . . 0.0 112.76 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 7' ' ' THR . 5.5 t -149.18 87.43 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.136 -1.393 . . . . 0.0 107.913 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.456 HG23 HD13 ' A' ' 8' ' ' ILE . 36.0 mt -73.87 169.06 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.751 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 1.9 pp -140.11 -26.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.833 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -69.15 82.16 0.34 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.235 0.54 . . . . 0.0 110.502 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.511 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 1.2 pm0 -56.96 -7.91 0.54 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.76 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.7 m -78.7 -30.18 45.88 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.55 -164.66 18.94 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.758 -0.735 . . . . 0.0 113.219 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.412 HG23 ' HB2' ' A' ' 18' ' ' PRO . 23.4 mt -77.02 86.94 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.736 0.303 . . . . 0.0 110.67 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -69.98 -163.98 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.88 -32.95 68.19 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.443 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -74.22 -61.06 1.3 Allowed Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 29.6 Cg_endo -62.56 -31.24 79.96 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.327 2.018 . . . . 0.0 112.613 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.45 -63.19 1.25 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.085 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.6 m -52.72 -33.18 46.65 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.683 0.278 . . . . 0.0 110.719 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -55.61 17.46 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.696 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.3 -38.97 74.8 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.316 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.9 t -53.84 -57.89 4.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.1 tt0 -66.84 -55.47 14.64 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.412 ' O ' ' CD2' ' A' ' 29' ' ' PHE . 76.7 p -53.35 -59.44 4.57 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.039 0.212 . . . . 0.0 111.385 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.6 -48.04 82.28 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 122.944 0.152 . . . . 0.0 111.039 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.8 t -60.53 -31.2 70.29 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.649 0.261 . . . . 0.0 111.298 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -68.11 -50.43 54.83 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.591 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 10.6 m-85 -64.92 -42.58 94.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.911 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.32 -11.72 0.78 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.241 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.437 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 99.8 p -68.05 145.37 54.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.453 0.644 . . . . 0.0 112.45 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.95 108.94 15.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.209 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.581 HG13 ' CB ' ' A' ' 65' ' ' ALA . 0.6 OUTLIER -98.6 123.21 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.175 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.691 ' CG ' ' HB2' ' A' ' 64' ' ' TYR . 4.5 pt20 -98.56 106.05 18.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 5.5 tt -98.69 115.66 29.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.485 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.76 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -94.65 172.82 7.94 Favored 'General case' 0 C--N 1.34 0.179 0 O-C-N 126.07 2.106 . . . . 0.0 111.653 -179.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -126.17 165.27 19.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.637 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.453 ' HB3' ' HG3' ' A' ' 60' ' ' GLU . 1.3 p-10 -53.33 -14.1 0.67 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.49 49.4 0.48 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.05 178.65 1.72 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.704 0.287 . . . . 0.0 111.006 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.76 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -159.77 115.59 2.45 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.367 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.9 m -153.34 -175.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.05 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.231 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -85.21 141.18 30.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -65.31 52.7 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 121.907 0.86 . . . . 0.0 111.552 177.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -63.35 -34.47 77.78 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.701 ' HA ' ' HB ' ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.77 -50.62 0.7 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.283 0.563 . . . . 0.0 111.92 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.84 -22.93 7.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.108 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.52 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -169.45 -39.98 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.974 -178.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.91 -56.06 27.18 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.879 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.701 ' HB ' ' HA ' ' A' ' 46' ' ' SER . 5.3 t -69.08 -45.95 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.657 0.228 . . . . 0.0 111.332 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.52 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -60.23 -36.92 78.82 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.721 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.0 t -60.27 -51.72 68.33 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.041 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -64.75 -11.33 35.17 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.92 119.65 0.1 OUTLIER Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.803 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.0 t -117.03 63.88 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.996 0.427 . . . . 0.0 111.378 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 11' ' ' GLU . . . -80.92 -166.78 36.32 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.057 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -75.86 125.63 29.45 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.606 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 89.01 7.05 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.879 0.737 . . . . 0.0 111.089 -178.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.63 117.73 5.69 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-O 120.513 0.197 . . . . 0.0 111.133 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -94.29 142.44 27.41 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.1 pt -143.11 175.12 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.766 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 m -151.67 104.87 3.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.702 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.536 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 0.7 OUTLIER -96.49 151.01 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.712 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 22.7 m-85 -146.45 110.98 5.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.515 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.581 ' CB ' HG13 ' A' ' 33' ' ' ILE . . . -93.48 127.62 39.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.24 0.543 . . . . 0.0 111.187 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.89 89.15 3.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.756 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -174.02 -153.68 10.05 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.601 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.6 p -75.59 -58.08 3.5 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.714 0.757 . . . . 0.0 111.767 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.574 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 3.2 m-20 -91.87 42.7 1.11 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.865 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.595 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 5.9 pt-20 -67.45 -22.26 65.51 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.619 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -89.05 -48.64 7.27 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.06 -37.66 64.41 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.591 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.68 -57.04 12.23 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.715 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.8 mm -49.61 -49.06 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.93 -67.48 0.36 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.79 -34.16 67.37 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.537 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.4 ' O ' ' HB ' ' A' ' 80' ' ' VAL . 9.6 mm -62.29 -37.43 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -51.86 68.07 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -47.88 -40.55 21.98 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 123.607 0.567 . . . . 0.0 110.004 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 77' ' ' ILE . 2.5 t -62.09 -57.42 12.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.08 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.437 ' CD2' HG12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 120.96 0.409 . . . . 0.0 110.076 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 ttm . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.703 0.287 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.598 ' CD ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -96.11 163.58 13.05 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.308 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.622 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.9 OUTLIER -153.66 152.5 30.9 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -159.55 165.57 32.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.297 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.5 p -153.87 141.07 19.51 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.82 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.29 -161.98 1.3 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.7 m -153.98 106.88 2.88 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 mt -102.18 -171.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.736 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 1.0 OUTLIER -144.93 10.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.63 83.97 1.57 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.12 -23.92 2.43 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.794 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -82.82 -36.97 25.07 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.406 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . 73.31 95.38 0.1 OUTLIER Glycine 0 C--N 1.344 0.995 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.911 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 31.0 mm 67.84 125.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.897 0.379 . . . . 0.0 111.32 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -167.99 128.11 1.33 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.72 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 18' ' ' PRO . . . 43.95 -161.8 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 119.144 -0.455 . . . . 0.0 111.325 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.603 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER 15.51 -77.01 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.603 ' CD ' ' HB3' ' A' ' 17' ' ' ARG . 10.1 Cg_endo -50.34 -42.48 47.67 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.594 2.863 . . . . 0.0 113.509 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.35 -63.97 1.11 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.419 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.5 m -54.82 -31.75 59.59 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.448 ' HB3' HG23 ' A' ' 80' ' ' VAL . 27.7 mtm -64.93 -51.85 59.6 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.692 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 46' ' ' SER . 0.5 OUTLIER -56.65 -36.98 70.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.082 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.62 -60.59 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -66.47 -51.17 59.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.399 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.7 m -51.93 -60.24 3.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.275 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.412 ' HB3' HD22 ' A' ' 22' ' ' LEU . . . -61.9 -48.24 81.35 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.949 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.0 t -58.56 -28.79 65.85 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.542 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -66.13 -49.8 66.21 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.657 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 14.1 m-85 -64.62 -40.94 96.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.998 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.43 -9.44 1.4 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.434 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.0 p -66.72 154.7 40.02 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.64 140.64 46.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 5.1 tt -146.96 114.1 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.181 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.644 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 17.9 pm0 -104.35 128.86 52.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.456 0.646 . . . . 0.0 110.37 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 44' ' ' LEU . 5.8 tt -113.97 121.94 45.43 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.71 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -100.56 177.83 4.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 125.733 1.896 . . . . 0.0 111.494 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -128.02 162.83 25.91 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.868 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -55.43 -12.49 1.11 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.531 179.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.7 46.92 0.51 Allowed Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.41 -177.68 1.05 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.757 0.313 . . . . 0.0 110.919 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.71 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 4.9 tmtm? -159.05 122.79 3.84 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 m -152.24 -174.75 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.025 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -84.11 145.09 28.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.589 ' HA ' ' HB3' ' A' ' 35' ' ' LEU . 1.3 tt -67.66 58.55 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.497 ' HB2' ' HA3' ' A' ' 49' ' ' GLY . 4.5 mtpm? -69.31 -49.44 55.78 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.525 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER 73.78 -54.1 0.68 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.352 -178.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.18 -25.58 13.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.289 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.558 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -169.78 -39.02 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -178.053 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -48.68 -56.03 10.32 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.139 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.525 ' CG2' ' HA ' ' A' ' 46' ' ' SER . 32.0 m -68.57 -50.25 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.558 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -60.22 -40.95 91.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.3 p -58.43 -48.39 80.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.941 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.09 -34.56 78.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.921 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.79 126.22 3.08 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.975 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 51' ' ' MET . 2.9 t -129.13 84.16 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.571 0.224 . . . . 0.0 110.953 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.47 176.86 48.44 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 4.7 tttm -71.95 131.08 42.46 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 85.07 12.06 0.26 Allowed 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.671 0.607 . . . . 0.0 110.467 -178.546 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.97 121.59 12.2 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.321 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 2.8 tt0 -93.9 143.39 26.38 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.2 pt -146.14 172.82 3.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 4.4 m -148.13 109.47 4.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.858 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.57 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 1.3 mp -96.16 142.04 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.707 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.644 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 84.0 m-85 -132.24 116.21 16.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.784 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 70' ' ' GLU . . . -101.8 127.78 48.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.023 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -133.25 103.95 6.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.005 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.56 -155.53 26.54 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.765 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.2 p -69.18 -61.09 1.94 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 117.282 0.541 . . . . 0.0 111.659 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.657 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.9 m-20 -92.2 37.92 0.99 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.544 0.211 . . . . 0.0 111.252 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.459 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 10.1 pt-20 -65.03 -22.45 66.98 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.35 -55.07 3.96 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.29 -34.6 66.62 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.461 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -50.28 -58.88 4.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.24 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.598 HG12 ' CD ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -43.48 -51.02 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 123.218 0.324 . . . . 0.0 111.872 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -54.71 -68.7 0.16 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.83 71.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.454 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.1 mm -62.09 -38.64 81.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.652 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -57.68 11.56 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -44.16 -41.94 6.04 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.576 0.547 . . . . 0.0 110.288 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 21' ' ' MET . 3.8 t -62.91 -63.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.67 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 121.066 0.46 . . . . 0.0 110.763 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptp . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.641 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 2.4 mm-40 -95.3 165.34 12.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.703 0.287 . . . . 0.0 110.812 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.697 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 2.2 pt20 -163.65 156.38 18.12 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -163.15 118.95 1.76 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.032 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 p -89.31 152.34 21.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.918 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 59.4 m-85 -142.96 -179.89 6.63 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.899 0.857 . . . . 0.0 112.877 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.413 ' O ' HG21 ' A' ' 7' ' ' THR . 9.7 t -152.88 96.47 2.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.022 -1.444 . . . . 0.0 107.976 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.4 HG22 ' HB3' ' A' ' 84' ' ' GLU . 1.7 mt -96.29 -168.97 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.043 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.614 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 2.7 pp -145.86 15.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 122.314 0.246 . . . . 0.0 111.612 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.463 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 12.0 t0 -75.86 80.98 2.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.625 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -52.4 -22.39 4.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.478 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -37.98 23.21 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.11 -166.25 19.97 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.757 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.5 mt -69.42 81.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.006 0.432 . . . . 0.0 110.815 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.517 ' CE1' ' HB3' ' A' ' 17' ' ' ARG . 14.3 p80 -70.78 -162.16 0.06 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.261 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.51 -28.72 67.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.562 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 31.1 ttp180 -74.94 -62.0 0.95 Allowed Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 36.0 Cg_endo -64.49 -33.34 57.44 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.306 2.004 . . . . 0.0 112.888 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.9 -63.21 1.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.883 -0.144 . . . . 0.0 111.062 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.1 m -54.29 -31.85 54.89 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.698 0.285 . . . . 0.0 110.719 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.548 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -64.27 -54.57 31.18 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.596 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 mt -58.74 -35.7 73.14 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 27' ' ' SER . 62.6 t -54.45 -62.24 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.92 -51.51 61.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.747 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 97.0 m -52.73 -61.37 2.33 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.105 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.31 -47.75 84.67 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.102 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 50.2 p -59.82 -29.02 67.96 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 25' ' ' THR . 3.7 mtpm? -63.43 -54.28 39.02 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.662 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 28.3 m-85 -65.65 -37.68 87.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.125 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 84.07 -20.26 0.32 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.533 -1.667 . . . . 0.0 112.275 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 81.6 p -67.73 143.19 56.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.475 0.655 . . . . 0.0 112.399 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.34 114.84 18.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.521 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.674 HG23 ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -100.89 114.28 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.851 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.688 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 14.9 pm0 -90.3 107.19 18.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 122.089 0.947 . . . . 0.0 109.318 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.576 ' CB ' ' HB3' ' A' ' 44' ' ' LEU . 4.5 tt -97.09 114.09 25.72 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.777 -1.556 . . . . 0.0 108.831 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.771 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -92.96 174.77 7.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 125.936 2.022 . . . . 0.0 111.641 -179.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 28.9 t80 -133.22 165.05 25.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.714 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.487 ' HB3' ' CG ' ' A' ' 60' ' ' GLU . 1.2 p-10 -53.22 -14.74 0.74 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.642 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.32 49.27 0.5 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.32 172.52 3.21 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.515 0.197 . . . . 0.0 110.675 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.771 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -160.29 109.65 1.75 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -155.02 -178.18 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.262 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . 4.9 t30 -83.77 136.94 33.96 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.674 ' HG ' HG23 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -68.81 58.08 0.09 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.076 0.398 . . . . 0.0 111.051 177.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 43' ' ' ASN . 1.4 ttmt -65.78 -14.9 62.26 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.607 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . 0.7 OUTLIER 69.3 -49.01 0.6 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.1 mt -52.77 -26.26 10.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.382 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.81 -39.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.86 -52.92 24.13 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.479 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.607 ' CG2' ' HA ' ' A' ' 46' ' ' SER . 15.2 m -67.06 -35.89 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.932 0.366 . . . . 0.0 110.728 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 63.9 mtt -59.87 -48.04 83.32 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.668 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 p -57.68 -51.48 69.36 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.975 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -67.26 -19.19 65.47 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.03 102.41 0.01 OUTLIER Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.951 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 t -100.79 56.84 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.841 0.353 . . . . 0.0 111.106 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.35 -160.46 8.56 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.763 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 1.7 tttm -73.95 134.91 43.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER 76.9 9.61 2.78 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.542 0.526 . . . . 0.0 110.691 -178.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.16 119.61 8.73 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.487 ' CG ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -95.4 135.85 36.5 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.441 ' CD1' HD22 ' A' ' 81' ' ' LEU . 5.8 pt -138.71 172.88 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.394 0.616 . . . . 0.0 112.385 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 36' ' ' GLU . 7.2 m -151.71 102.54 2.86 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.285 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.568 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -94.0 149.14 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.315 -177.053 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.697 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 38.2 m-85 -146.82 114.19 6.3 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.297 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.541 ' CB ' HG13 ' A' ' 33' ' ' ILE . . . -95.38 126.38 40.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.812 0.339 . . . . 0.0 110.579 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -139.88 92.47 2.56 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.925 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.97 -80.01 0.04 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.439 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.52 -68.74 0.33 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.58 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 5.5 m-20 -89.86 51.53 2.09 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -23.76 63.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.968 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.641 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -86.84 -53.26 5.01 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.604 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.05 -36.69 60.88 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.662 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.86 -54.96 31.31 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.897 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.6 mm -43.31 -51.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.928 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -57.59 -68.88 0.2 Allowed 'General case' 0 C--O 1.239 0.538 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.05 -33.17 68.72 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.723 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.1 mm -62.88 -38.37 81.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.516 ' O ' ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -57.74 -60.23 4.01 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -42.0 -41.04 2.4 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.625 0.578 . . . . 0.0 110.47 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.548 ' CG2' ' HB3' ' A' ' 21' ' ' MET . 7.9 t -65.65 -63.46 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.027 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -61.96 -28.05 69.27 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 110.969 179.299 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.516 ' HB3' ' O ' ' A' ' 78' ' ' THR . 1.4 p -63.47 -32.02 73.35 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.973 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.45 -28.38 65.25 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.245 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 81' ' ' LEU . 13.9 mt-10 -60.32 -34.77 74.27 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 122.481 0.312 . . . . 0.0 111.23 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.13 -10.52 78.29 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.904 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.89 9.31 8.38 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.993 0.396 . . . . 0.0 111.541 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 52.7 p -96.88 -96.17 0.2 Allowed 'General case' 0 CA--C 1.536 0.411 0 O-C-N 122.391 -0.193 . . . . 0.0 111.481 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 . . . . . 0 C--O 1.253 1.242 0 CA-C-O 118.877 -0.583 . . . . 0.0 111.41 -179.534 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ttt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.732 0.301 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.604 ' CD ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -94.04 164.21 13.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.425 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -160.94 152.26 19.06 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.329 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.07 133.18 5.87 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.771 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 3.0 t -89.97 157.66 17.74 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.944 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.615 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 4.9 m-85 -138.16 176.38 8.75 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.86 0.838 . . . . 0.0 112.251 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.4 m -145.8 75.52 1.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.492 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.454 HD13 HG23 ' A' ' 8' ' ' ILE . 48.2 mt -65.29 163.33 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.489 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.705 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 2.1 pp -136.04 -26.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.761 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.475 ' HB2' ' HG3' ' A' ' 84' ' ' GLU . 10.2 t0 -68.09 87.59 0.27 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.437 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -47.85 -27.54 2.14 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.35 -38.01 27.35 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 10' ' ' ASP . . . 88.56 -114.02 4.17 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.937 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.88 152.59 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.071 0.462 . . . . 0.0 111.855 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.536 ' CE1' ' HD3' ' A' ' 18' ' ' PRO . 24.9 p80 -170.54 -153.53 0.1 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.967 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.87 79.52 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -78.89 -55.18 0.99 Allowed Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HD3' ' CE1' ' A' ' 15' ' ' HIS . 12.3 Cg_exo -62.69 -41.72 29.63 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.623 2.215 . . . . 0.0 113.122 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.08 -64.4 0.93 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -53.93 -33.23 56.13 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.776 0.322 . . . . 0.0 111.086 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.583 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -66.31 -62.47 1.46 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.513 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 46' ' ' SER . 0.9 OUTLIER -58.67 -37.03 75.14 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.7 t -53.51 -60.04 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.429 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.1 tt0 -66.49 -52.91 40.94 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.761 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.429 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 94.9 m -52.45 -58.93 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.464 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.45 -48.29 80.31 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.31 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -59.72 -28.36 67.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.726 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -66.11 -52.9 44.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.644 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 13.9 m-85 -66.68 -41.81 87.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.31 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 74.8 -7.28 1.76 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.53 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.6 p -66.13 152.35 44.94 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -73.95 140.22 45.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.549 ' O ' HG21 ' A' ' 33' ' ' ILE . 3.4 tt -142.59 124.24 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-O 121.137 0.494 . . . . 0.0 111.455 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.63 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 9.8 pt20 -112.0 123.33 50.02 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-O 121.436 0.636 . . . . 0.0 110.217 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.641 ' HB2' HD13 ' A' ' 44' ' ' LEU . 2.1 tt -109.77 123.12 48.98 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.483 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.727 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -103.14 176.41 5.16 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 125.763 1.914 . . . . 0.0 111.585 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -127.16 162.65 25.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.567 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.47 -10.8 1.03 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.72 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.76 45.5 0.57 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.09 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.84 -177.71 0.65 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.661 0.267 . . . . 0.0 110.984 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.727 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 1.2 tmtp? -158.9 124.8 4.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.336 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.9 m -153.45 -173.74 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.269 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -85.75 143.76 28.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.641 HD13 ' HB2' ' A' ' 35' ' ' LEU . 1.1 tt -69.25 57.53 0.11 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -69.64 -38.86 77.31 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.559 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . 2.5 p 70.9 -50.49 0.68 Allowed 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.724 0.64 . . . . 0.0 112.119 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.7 mm -53.44 -25.95 11.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.168 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.413 ' HA ' ' HB2' ' A' ' 51' ' ' MET . 14.4 mtp -166.64 -39.27 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.669 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.66 -52.09 26.0 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.979 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.559 ' CG2' ' HA ' ' A' ' 46' ' ' SER . 6.7 m -72.91 -37.98 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.592 0.196 . . . . 0.0 110.54 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.413 ' HB2' ' HA ' ' A' ' 48' ' ' MET . 0.6 OUTLIER -56.84 -53.19 60.67 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.308 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.5 p -58.02 -37.56 74.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.361 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.2 mt -60.9 -30.81 70.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.409 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.76 -42.57 1.87 Allowed Glycine 0 C--N 1.339 0.716 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.265 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.45 ' CG2' ' HB ' ' A' ' 50' ' ' VAL . 72.4 t 35.9 63.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 11' ' ' GLU . . . -86.94 -172.52 48.37 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.109 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 5.9 tttt -76.11 126.28 30.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 86.45 11.19 0.19 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.885 0.741 . . . . 0.0 110.916 -178.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.92 121.56 13.27 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 120.736 0.303 . . . . 0.0 111.693 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.16 135.99 33.26 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.803 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.615 ' CG1' ' HB2' ' A' ' 6' ' ' TYR . 45.1 pt -147.0 176.64 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.14 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.6 m -152.57 109.9 3.55 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.002 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 1.1 mm -94.25 154.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.481 -178.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.63 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 57.7 m-85 -141.16 117.61 10.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.539 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.3 129.89 46.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.872 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -134.5 96.05 3.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.138 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.49 -154.47 17.81 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.746 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.0 p -71.95 -59.2 2.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.158 0.479 . . . . 0.0 111.724 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.644 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.6 m-20 -93.47 36.59 1.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.423 0.154 . . . . 0.0 111.407 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.69 -22.36 66.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.91 -56.67 3.29 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.74 -30.34 65.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.738 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.563 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -50.18 -63.11 1.22 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.548 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.604 HG12 ' CD ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -43.75 -43.38 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -58.4 -71.72 0.11 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.778 0.323 . . . . 0.0 111.368 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.04 -33.36 67.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.503 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.16 -38.71 80.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.983 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 82' ' ' SER . 0.2 OUTLIER -57.34 -56.12 25.9 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -47.23 -42.71 20.88 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.148 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.583 ' CG2' ' HB3' ' A' ' 21' ' ' MET . 7.8 t -65.76 -63.38 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.461 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.49 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 6.9 mt -59.38 -39.37 83.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.856 0.36 . . . . 0.0 110.421 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 78' ' ' THR . 4.4 t -60.73 -26.87 67.5 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.52 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -59.71 -32.82 70.88 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.416 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 81' ' ' LEU . 9.2 pt-20 -63.75 -25.17 68.07 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.725 0.297 . . . . 0.0 110.472 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.502 ' HA2' ' CD1' ' A' ' 9' ' ' ILE . . . -63.11 -11.22 37.71 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.001 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 pp -66.92 -3.41 6.94 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.0 p -94.46 -94.26 0.17 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 119.542 -0.266 . . . . 0.0 111.648 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 9' ' ' ILE . 5.9 pt-20 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 117.836 -1.078 . . . . 0.0 111.78 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.813 0.339 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.641 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mm-40 -95.67 162.48 13.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.388 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.721 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.6 OUTLIER -166.2 152.93 9.39 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -164.83 121.91 1.57 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.629 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 p -89.65 150.71 22.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.807 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 41.8 m-85 -142.5 176.57 8.92 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.569 0.699 . . . . 0.0 111.815 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 t -153.48 111.96 3.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.173 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -132.92 175.3 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -176.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 pp -95.28 15.17 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.124 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.719 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 29.3 p-10 -69.48 78.04 0.4 Allowed 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.212 0.53 . . . . 0.0 111.545 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.452 ' HG2' ' CB ' ' A' ' 57' ' ' LYS . 1.1 tm-20 -52.24 -32.08 35.21 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.901 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.0 p -82.43 -35.28 27.74 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.98 -86.28 1.25 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.278 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.534 HD11 ' HB ' ' A' ' 50' ' ' VAL . 4.3 mp -137.39 71.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.21 0.528 . . . . 0.0 110.309 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.417 ' N ' ' HG2' ' A' ' 18' ' ' PRO . 11.2 p80 -69.78 -156.23 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.641 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.1 -33.28 71.9 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.554 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 1.3 ttp85 -73.73 -63.5 0.93 Allowed Pre-proline 0 N--CA 1.467 0.382 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.519 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.554 ' CD ' ' HB3' ' A' ' 17' ' ' ARG . 21.4 Cg_endo -60.42 -29.71 89.32 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.505 2.137 . . . . 0.0 112.719 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 46' ' ' SER . . . -62.5 -64.56 0.89 Allowed 'General case' 0 C--N 1.339 0.132 0 CA-C-N 116.857 -0.156 . . . . 0.0 110.812 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 m -53.73 -32.16 51.05 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 110.604 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -55.43 20.43 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.395 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 mt -58.41 -34.17 70.47 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.115 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 27' ' ' SER . 67.3 t -55.44 -64.57 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -64.93 -44.12 90.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 123.194 0.309 . . . . 0.0 111.672 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.443 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 52.0 m -56.33 -61.32 2.48 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.594 0.235 . . . . 0.0 110.409 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.76 98.0 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.469 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 4.5 m -58.42 -32.95 69.14 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.232 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 25' ' ' THR . 24.9 mtmm -63.55 -52.68 60.01 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.592 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 43.4 m-85 -66.68 -35.54 80.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.667 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER 82.5 -20.84 0.33 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.868 -1.515 . . . . 0.0 111.502 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.44 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 88.7 p -68.7 132.33 46.68 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.725 0.774 . . . . 0.0 112.219 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.24 115.44 19.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.686 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.718 HG22 ' HG ' ' A' ' 44' ' ' LEU . 2.9 mt -97.48 123.62 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.464 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.727 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 1.4 pt20 -94.76 104.15 16.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.543 ' HB2' HD22 ' A' ' 44' ' ' LEU . 5.5 tt -99.44 119.37 37.88 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.029 -1.441 . . . . 0.0 110.176 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.762 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -93.98 169.6 10.16 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 126.023 2.077 . . . . 0.0 110.466 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.589 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -145.52 97.6 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.509 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 49.93 -59.5 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 37' ' ' TYR . . . -138.62 33.05 2.25 Favored Glycine 0 C--N 1.318 -0.468 0 C-N-CA 121.816 -0.23 . . . . 0.0 112.738 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.44 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -138.33 171.04 14.97 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.762 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 1.2 tmtm? -156.56 109.88 2.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.934 0.397 . . . . 0.0 111.736 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.4 m -153.78 173.07 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.084 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -81.89 131.89 35.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.718 ' HG ' HG22 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -67.66 56.81 0.06 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.858 0.361 . . . . 0.0 110.987 177.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HG2' HD12 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -66.89 -17.71 65.03 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.558 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.63 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.95 -47.64 0.67 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.424 HD12 ' HG2' ' A' ' 45' ' ' LYS . 3.2 mt -52.82 -26.44 10.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.329 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.477 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 13.0 mtp -167.79 -37.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.19 60.06 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.182 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.63 ' CG2' ' HA ' ' A' ' 46' ' ' SER . 24.8 m -69.29 -50.2 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.477 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -59.0 -41.36 87.46 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.614 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.4 t -57.9 -41.3 82.32 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.216 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.44 ' CD2' ' HB3' ' A' ' 40' ' ' LYS . 38.7 mt -64.58 -52.57 56.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.821 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.64 -49.03 0.92 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.417 -0.421 . . . . 0.0 113.14 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t 36.49 79.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.418 ' C ' ' HA ' ' A' ' 11' ' ' GLU . . . -76.47 -163.36 15.94 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.902 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 7.3 tttt -74.34 134.86 42.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER 76.69 9.29 2.97 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.519 0.512 . . . . 0.0 110.41 -178.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.18 136.79 58.1 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 152.21 20.62 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.5 pt -145.66 172.7 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.093 0.473 . . . . 0.0 111.924 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 36' ' ' GLU . 5.6 m -149.21 103.28 3.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.446 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.614 HG23 HG21 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -96.64 145.06 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.612 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.727 ' HB2' ' HG3' ' A' ' 34' ' ' GLN . 11.2 m-85 -145.53 111.33 5.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.052 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.502 ' CB ' HG13 ' A' ' 33' ' ' ILE . . . -91.13 133.51 35.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.329 0.585 . . . . 0.0 111.767 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -130.88 101.24 5.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.79 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . 174.57 -158.94 27.52 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.7 p -71.53 -60.79 2.05 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.27 1.035 . . . . 0.0 111.133 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.592 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 9.7 m-20 -91.48 42.92 1.12 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.57 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -66.28 -22.47 66.3 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.974 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.641 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -88.29 -46.77 8.93 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.12 -40.21 64.03 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.541 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -54.99 -54.55 41.5 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.441 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 mm -48.43 -47.49 14.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.502 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -55.52 -70.96 0.09 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.78 -37.26 73.39 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.1 mm -60.85 -41.75 89.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.529 0.204 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 79' ' ' ASP . 14.6 m -60.59 -63.59 1.25 Allowed 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.456 ' C ' ' O ' ' A' ' 78' ' ' THR . 45.8 m-20 -34.39 -43.82 0.17 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.034 0.445 . . . . 0.0 110.142 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.1 t -66.68 -66.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.114 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.84 -40.75 96.38 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.194 0.521 . . . . 0.0 110.644 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 78' ' ' THR . 0.5 OUTLIER -59.4 -26.26 64.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.626 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -67.07 0.3 Allowed 'General case' 0 C--N 1.349 0.572 0 CA-C-O 120.878 0.371 . . . . 0.0 110.108 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -174.89 37.29 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.95 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.719 ' HA3' ' HB3' ' A' ' 10' ' ' ASP . . . 61.35 21.85 60.39 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 mp 59.06 32.16 21.97 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-O 120.524 0.202 . . . . 0.0 111.447 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.522 HG22 ' HA ' ' A' ' 10' ' ' ASP . 55.3 p -123.72 -116.99 0.29 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.244 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.423 -0.798 . . . . 0.0 110.988 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.577 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mm-40 -99.02 159.21 15.12 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.461 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.703 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -159.58 156.69 28.47 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 2.6 mm-40 -162.25 164.63 27.53 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.422 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.515 ' HB3' HG21 ' A' ' 62' ' ' THR . 46.2 p -153.66 139.5 18.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.906 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -144.7 -177.59 5.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.396 0.617 . . . . 0.0 111.392 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 t -153.19 116.83 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.576 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.481 HD12 HG23 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -134.98 177.5 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -176.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.424 HG13 ' HB3' ' A' ' 88' ' ' GLU . 17.3 pt -94.07 16.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.747 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.72 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 13.5 p-10 -68.58 73.97 0.25 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.329 0.585 . . . . 0.0 111.642 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 57' ' ' LYS . 2.9 tt0 -59.38 -25.26 64.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.048 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -80.01 -33.67 39.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . 48.66 81.43 0.05 OUTLIER Glycine 0 C--N 1.341 0.836 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.894 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 25.5 mm 71.82 127.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.802 0.334 . . . . 0.0 111.031 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.401 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 10.7 p80 -166.76 -119.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.314 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 18' ' ' PRO . . . -69.32 -167.13 0.11 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 118.777 -0.63 . . . . 0.0 109.881 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.664 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 12.29 -73.03 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.664 ' CD ' ' HB3' ' A' ' 17' ' ' ARG . 4.5 Cg_exo -40.31 -45.97 4.26 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.67 2.913 . . . . 0.0 113.212 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 15' ' ' HIS . . . -64.25 -56.22 16.1 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 121.258 -0.177 . . . . 0.0 111.146 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.2 m -50.84 -34.29 27.23 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.921 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 mmm -62.93 -50.45 70.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.291 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -35.61 70.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.852 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.68 -59.06 2.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -66.18 -50.93 62.21 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.301 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.463 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 84.8 m -52.69 -60.46 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.47 89.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.579 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.5 t -59.48 -29.4 67.8 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.375 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 25' ' ' THR . 3.5 mtpm? -63.98 -51.46 64.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.616 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 30.3 m-85 -64.59 -39.66 94.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.746 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 76.5 -14.21 0.84 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.27 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.8 p -68.31 144.91 54.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.384 0.611 . . . . 0.0 112.383 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.48 110.19 13.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.734 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -101.27 119.9 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.46 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.682 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 15.8 pm0 -101.03 113.11 25.8 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.582 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 1.5 tt -103.47 120.83 41.6 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.585 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.755 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.6 OUTLIER -94.87 175.99 6.43 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 126.136 2.147 . . . . 0.0 111.251 -179.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -128.53 166.72 18.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.241 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.426 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 7.6 t-20 -46.62 -21.02 0.15 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.23 55.55 0.39 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.86 -179.7 1.22 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.631 0.253 . . . . 0.0 110.999 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.755 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -158.89 118.81 3.13 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.446 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 m -153.26 -173.68 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.976 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -86.45 144.39 27.31 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.582 ' HB2' ' HB2' ' A' ' 35' ' ' LEU . 6.8 tp -68.81 59.09 0.09 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -67.78 -32.05 72.36 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.472 ' HB3' HG13 ' A' ' 14' ' ' ILE . 0.7 OUTLIER 69.59 -52.28 0.61 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.423 0.63 . . . . 0.0 112.183 -179.471 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.8 mt -53.31 -26.2 11.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.213 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.9 mtp -167.56 -39.19 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.628 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -48.22 -47.51 27.32 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.286 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.458 ' HA ' HD22 ' A' ' 53' ' ' LEU . 33.7 m -69.56 -38.71 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.705 0.288 . . . . 0.0 110.899 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.3 mtt -59.63 -47.07 87.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.798 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.4 p -58.71 -48.44 81.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.479 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -66.88 -11.07 54.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.44 117.04 0.04 OUTLIER Glycine 0 C--N 1.339 0.746 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.223 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.433 HG23 HD11 ' A' ' 53' ' ' LEU . 2.5 t -120.2 70.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.754 0.311 . . . . 0.0 111.814 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.25 -167.03 32.94 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.35 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 7.2 tttm -71.82 134.76 46.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER 76.59 12.8 2.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.553 0.533 . . . . 0.0 111.04 -179.111 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.69 131.92 52.23 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.426 ' CG ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -103.18 144.87 30.75 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.292 179.058 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.476 HD12 HD23 ' A' ' 81' ' ' LEU . 2.2 pt -146.79 169.09 5.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.714 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 5' ' ' SER . 16.9 m -152.44 107.49 3.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.734 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 4.8 mp -96.96 148.09 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.703 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 25.8 m-85 -138.24 114.94 10.62 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.904 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.454 ' CB ' HG13 ' A' ' 33' ' ' ILE . . . -93.46 130.56 39.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.212 0.529 . . . . 0.0 111.459 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -131.48 96.68 4.04 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.751 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.89 -154.77 18.07 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.523 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.4 p -74.63 -60.68 2.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.704 0.752 . . . . 0.0 111.25 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.616 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 5.9 m-20 -91.52 41.22 1.06 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.897 0.38 . . . . 0.0 110.573 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.426 ' HG3' ' CG ' ' A' ' 2' ' ' GLU . 15.0 pt-20 -66.2 -28.52 68.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.974 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.577 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -85.78 -44.02 12.84 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.89 -40.89 67.0 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.597 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -54.68 -54.39 42.38 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.105 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.7 mm -49.6 -49.85 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.961 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -54.78 -69.04 0.14 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.62 -38.07 68.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.607 0.242 . . . . 0.0 111.35 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.4 mm -61.33 -37.71 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.638 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -58.48 -62.05 2.14 Favored 'General case' 0 C--O 1.207 -1.164 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -39.56 -43.87 1.37 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.594 0.559 . . . . 0.0 110.436 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.5 t -63.74 -64.64 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.448 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.481 HD21 HD13 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -62.35 -24.36 67.31 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.011 0.434 . . . . 0.0 110.651 179.18 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 78' ' ' THR . 8.8 t -61.44 -31.19 71.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.882 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -55.96 -70.4 0.11 Allowed 'General case' 0 C--N 1.348 0.51 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 2.6 pt-20 -176.93 39.8 0.01 OUTLIER 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.34 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 86' ' ' LEU . . . 71.68 29.71 67.25 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.774 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.489 ' HB3' ' CB ' ' A' ' 18' ' ' PRO . 5.8 mp 69.67 52.47 0.43 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.838 0.352 . . . . 0.0 110.068 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 65.03 139.08 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.877 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.72 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.516 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptp . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.577 ' HG2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -98.05 164.51 12.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.738 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -157.49 160.19 38.01 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.513 ' HG3' HD13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -160.82 123.09 3.14 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.173 179.423 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 p -94.07 156.59 16.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.692 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -144.48 177.53 8.59 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.654 0.74 . . . . 0.0 111.992 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.423 ' C ' HG12 ' A' ' 8' ' ' ILE . 14.6 t -160.43 104.1 1.42 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.469 -1.242 . . . . 0.0 107.918 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.423 HG12 ' C ' ' A' ' 7' ' ' THR . 0.4 OUTLIER -142.69 -175.74 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.036 -175.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.56 HG23 ' HA ' ' A' ' 57' ' ' LYS . 14.7 pt -136.89 -41.35 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 25.3 t70 44.89 27.7 0.29 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.771 0.26 . . . . 0.0 111.634 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.481 ' HG2' ' HA ' ' A' ' 88' ' ' GLU . 19.2 mm-40 33.5 34.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.451 0.7 . . . . 0.0 112.741 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 175.94 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.922 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.74 -56.93 0.97 Allowed Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.11 174.25 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -171.64 -59.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -174.95 -35.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.442 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -72.13 -56.73 4.21 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 -179.399 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 36.9 Cg_endo -65.29 -33.49 48.26 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.292 1.995 . . . . 0.0 112.149 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.581 ' HA ' ' HB2' ' A' ' 46' ' ' SER . . . -62.73 -65.0 0.75 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.084 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.1 p -55.29 -28.91 56.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.282 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.585 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . 1.4 mtt -63.16 -55.59 23.85 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.797 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.443 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 0.3 OUTLIER -58.91 -34.57 71.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.075 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 27' ' ' SER . 73.8 t -54.55 -57.28 6.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.64 -55.97 14.67 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.504 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 29.4 p -52.89 -57.5 10.05 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.547 0.202 . . . . 0.0 111.547 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.14 -47.72 84.91 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.822 -0.172 . . . . 0.0 110.979 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 23.5 m -60.28 -30.97 69.8 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.784 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.504 ' HE3' ' HA ' ' A' ' 25' ' ' THR . 4.9 mtmp? -63.76 -51.38 65.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.466 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 14.2 m-85 -64.58 -37.49 87.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.984 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 80.84 -15.5 0.73 Allowed 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.582 -1.644 . . . . 0.0 112.681 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.435 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 83.4 p -66.09 145.6 55.65 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.416 0.626 . . . . 0.0 112.263 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.04 109.11 13.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.098 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.666 HG13 ' CB ' ' A' ' 65' ' ' ALA . 1.3 mt -99.53 125.15 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.909 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.642 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -103.77 113.45 26.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.643 0.735 . . . . 0.0 109.258 178.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -101.34 114.12 27.83 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.935 -179.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.523 ' HG3' ' HG2' ' A' ' 41' ' ' LYS . 1.5 tt0 -91.72 173.65 7.76 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 126.262 2.226 . . . . 0.0 110.772 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.413 ' CG ' ' HB2' ' A' ' 53' ' ' LEU . 32.3 t80 -132.35 163.57 28.41 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.084 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.602 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -51.65 -15.48 0.47 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -156.68 50.12 0.44 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.197 -0.525 . . . . 0.0 111.826 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -178.88 -178.51 0.55 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.666 0.27 . . . . 0.0 110.906 -179.353 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.523 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 1.7 tmtt? -157.83 120.84 3.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.448 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.4 m -151.43 -175.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.512 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.25 140.87 29.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.662 ' HB3' HG22 ' A' ' 33' ' ' ILE . 1.6 tp -69.65 56.83 0.13 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.593 0.235 . . . . 0.0 110.582 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -73.16 9.56 1.2 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.581 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . 89.8 p 39.64 34.24 0.15 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 46' ' ' SER . 2.2 mp -166.16 -84.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.4 tpp -63.98 -37.27 86.82 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -82.43 0.1 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.475 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.439 ' HB ' ' CG2' ' A' ' 55' ' ' VAL . 3.1 m -40.0 -42.06 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.0 mtt -59.07 -50.11 75.32 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.509 0.195 . . . . 0.0 111.233 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.4 t -56.47 -52.64 63.94 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.226 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.413 ' HB2' ' CG ' ' A' ' 37' ' ' TYR . 0.6 OUTLIER -67.31 -18.01 65.0 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.59 101.3 0.05 OUTLIER Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.55 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.439 ' CG2' ' HB ' ' A' ' 50' ' ' VAL . 19.5 t -90.98 75.99 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.939 0.4 . . . . 0.0 111.22 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.12 -161.99 37.12 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.375 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.612 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -72.63 127.43 32.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.612 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 82.33 18.24 0.34 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.698 0.624 . . . . 0.0 110.42 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.88 115.27 2.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.299 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 2.1 tt0 -96.83 139.63 32.58 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.753 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.82 170.11 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.154 0.502 . . . . 0.0 111.812 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.0 m -152.55 107.0 3.16 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.928 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.562 HG21 HG21 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -94.99 146.59 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.738 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 40.8 m-85 -145.49 108.82 4.63 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.468 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.666 ' CB ' HG13 ' A' ' 33' ' ' ILE . . . -98.0 133.54 42.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.838 0.351 . . . . 0.0 110.559 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.82 78.17 1.66 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.569 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -147.76 -89.7 0.08 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.702 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.3 p -132.39 -65.65 0.72 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.918 0.359 . . . . 0.0 111.285 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.4 m-20 -89.69 41.19 1.03 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.867 0.365 . . . . 0.0 110.639 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -24.28 66.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.055 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.28 -53.21 5.92 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -32.91 66.13 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.989 0.423 . . . . 0.0 109.876 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.462 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -49.09 -56.49 8.94 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.992 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.577 HD11 ' HG2' ' A' ' 2' ' ' GLU . 15.1 mm -42.64 -55.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.83 -67.62 0.25 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.78 68.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.47 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.92 -37.76 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.558 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -58.41 -56.32 23.57 Favored 'General case' 0 C--O 1.209 -1.055 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.312 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -45.6 -41.07 9.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.089 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.585 ' CG2' ' HB3' ' A' ' 21' ' ' MET . 6.2 t -65.26 -62.97 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.181 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.403 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -60.8 -33.95 73.77 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.973 0.416 . . . . 0.0 110.617 179.363 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 78' ' ' THR . 5.8 t -61.46 -28.01 68.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.413 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.417 ' HG2' ' HD2' ' A' ' 17' ' ' ARG . 5.1 tptp -59.65 -30.39 68.7 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 121.324 -0.151 . . . . 0.0 111.014 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 2.7 pt-20 -63.83 -26.78 68.78 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.819 0.343 . . . . 0.0 110.427 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.47 -13.06 70.64 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.192 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.69 -27.07 58.21 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 116.754 0.277 . . . . 0.0 110.648 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.25 -97.23 0.28 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.599 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 11' ' ' GLU . 4.4 pt-20 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.934 -0.555 . . . . 0.0 112.256 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ttt . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.735 0.302 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.591 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 3.1 mm-40 -95.28 164.58 12.78 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.525 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.683 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 2.3 pt20 -161.78 152.77 18.05 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.777 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.478 ' HB3' ' CE1' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -160.87 122.61 3.03 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.986 0.422 . . . . 0.0 111.967 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.7 p -90.71 155.06 19.1 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.994 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.478 ' CE1' ' HB3' ' A' ' 4' ' ' GLN . 87.4 m-85 -143.45 -179.92 6.72 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 122.009 0.909 . . . . 0.0 112.814 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 7' ' ' THR . 11.8 t -152.06 95.8 2.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.606 -1.633 . . . . 0.0 106.833 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.528 ' CG2' ' HG2' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -93.4 179.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.721 -175.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 1.6 pp -148.5 27.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.665 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.34 78.13 1.01 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.98 0.419 . . . . 0.0 110.343 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.607 ' HG3' ' HB2' ' A' ' 57' ' ' LYS . 1.8 mp0 -54.06 -22.72 11.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.788 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -41.27 37.85 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.75 85.97 0.09 OUTLIER Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.773 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER 69.17 145.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.134 0.492 . . . . 0.0 111.795 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -171.56 -63.65 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.605 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.645 ' C ' ' HD2' ' A' ' 18' ' ' PRO . . . -178.06 163.51 1.74 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.799 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER 98.51 -60.49 0.0 OUTLIER Pre-proline 0 C--N 1.364 1.229 0 CA-C-N 118.934 0.788 . . . . 0.0 112.743 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.645 ' HD2' ' C ' ' A' ' 16' ' ' ALA . 56.5 Cg_endo -70.65 -27.77 21.79 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.804 1.669 . . . . 0.0 112.471 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.47 -65.61 0.66 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.695 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.6 m -55.02 -32.98 62.25 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.704 0.288 . . . . 0.0 110.51 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.45 ' HE1' ' HA ' ' A' ' 18' ' ' PRO . 21.1 mtm -64.83 -53.78 41.37 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.408 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -57.98 -37.38 74.11 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.19 179.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.3 t -54.1 -60.16 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -49.65 64.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.431 ' O ' ' CD2' ' A' ' 29' ' ' PHE . 73.5 p -58.13 -58.96 6.13 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.389 0.086 . . . . 0.0 111.051 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.59 85.69 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.744 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.5 t -59.37 -33.07 70.73 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -66.49 -51.4 57.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.602 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.603 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 13.9 m-85 -66.33 -40.78 90.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.509 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 78.36 -20.41 0.39 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.593 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.55 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 93.2 p -66.52 140.09 57.97 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.623 0.725 . . . . 0.0 112.415 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.57 112.84 19.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.112 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.62 HG13 ' CB ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -97.73 121.38 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.677 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.646 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 1.8 pt20 -101.61 107.41 18.67 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.598 ' CD1' ' HG ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -99.63 116.25 31.31 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.085 -179.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.68 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -93.91 172.23 8.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 125.973 2.046 . . . . 0.0 110.736 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.458 ' HA ' HG22 ' A' ' 61' ' ' ILE . 13.0 t80 -125.4 166.82 15.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.092 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.552 ' HB3' ' CG ' ' A' ' 60' ' ' GLU . 0.7 OUTLIER -53.58 -14.98 0.96 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.82 46.69 0.51 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.102 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.04 -177.36 1.57 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.798 0.333 . . . . 0.0 111.244 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.68 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 3.0 tmtm? -158.12 117.76 3.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.802 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 m -152.3 -172.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.095 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -86.59 142.67 28.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.598 ' HG ' ' CD1' ' A' ' 35' ' ' LEU . 4.2 tt -68.68 58.45 0.09 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -41.9 71.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.571 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . 1.0 OUTLIER 71.27 -51.99 0.69 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.425 0.631 . . . . 0.0 111.897 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -53.06 -27.28 13.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.316 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.529 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 12.8 mtp -167.3 -39.07 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.76 -56.1 12.57 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.17 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.571 ' CG2' ' HA ' ' A' ' 46' ' ' SER . 18.6 m -68.05 -50.26 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.567 ' HA ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.48 -40.14 85.97 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.375 0.131 . . . . 0.0 111.3 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -57.21 -51.54 68.92 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.625 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -66.97 -35.09 79.2 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.07 179.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.402 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . 128.69 126.52 2.87 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.711 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 51' ' ' MET . 44.1 t -127.1 107.57 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.591 0.234 . . . . 0.0 111.127 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.0 174.09 18.3 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.513 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.607 ' HB2' ' HG3' ' A' ' 11' ' ' GLU . 15.1 tttt -70.06 136.39 50.26 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 86.2 5.2 0.42 Allowed 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.651 0.594 . . . . 0.0 111.061 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.86 119.13 7.13 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.552 ' CG ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -94.81 145.74 24.67 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 35' ' ' LEU . 5.5 pt -147.48 175.65 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.2 m -151.86 107.03 3.28 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.767 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 0.8 OUTLIER -96.05 152.3 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.114 -177.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.683 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 51.9 m-85 -146.26 110.24 4.95 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.66 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.62 ' CB ' HG13 ' A' ' 33' ' ' ILE . . . -93.47 126.51 38.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.025 0.441 . . . . 0.0 110.705 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -125.8 94.68 4.18 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.109 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.55 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . 179.88 -159.17 23.38 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.067 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.2 p -69.95 -60.97 1.97 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.104 0.952 . . . . 0.0 111.605 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.568 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 4.2 m-20 -91.79 45.26 1.21 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.849 0.357 . . . . 0.0 110.824 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.591 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 9.5 pt-20 -67.1 -22.53 65.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.12 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.572 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -88.63 -45.58 9.74 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -38.64 67.33 Favored 'General case' 0 C--N 1.342 0.281 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.603 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -52.34 -56.88 11.95 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.49 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.0 mm -44.82 -45.64 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.791 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.73 -70.76 0.15 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.86 -32.49 65.88 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.12 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.0 mm -62.43 -36.55 75.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -58.39 -51.78 68.36 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.096 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -46.11 -42.85 14.25 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.743 0.652 . . . . 0.0 109.923 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.14 -57.79 10.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.152 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.419 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -62.17 -30.41 71.04 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 178.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 78' ' ' THR . 4.5 t -61.71 -30.91 71.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.912 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.424 ' HG2' ' HG2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -63.26 -23.45 67.43 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.667 178.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.528 ' HG2' ' CG2' ' A' ' 8' ' ' ILE . 2.2 pp20? -59.79 -31.39 69.65 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.626 0.37 . . . . 0.0 110.457 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.87 -16.02 7.21 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.23 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 pp -63.53 -7.79 7.89 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 53.2 p -97.46 -103.82 0.19 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 121.349 -0.14 . . . . 0.0 111.097 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.995 -179.591 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.679 0.276 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.582 ' CG ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -101.5 160.04 14.77 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.601 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.715 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -150.31 149.86 30.69 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.684 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.83 162.43 32.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.366 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.448 ' HB3' HG21 ' A' ' 62' ' ' THR . 30.6 p -154.17 148.16 25.64 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.745 0.307 . . . . 0.0 111.527 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -144.01 -176.9 5.18 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.415 0.626 . . . . 0.0 111.329 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -153.53 113.31 3.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.76 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.65 -172.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.439 HG23 ' HG3' ' A' ' 57' ' ' LYS . 21.4 pt -137.24 -40.69 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.489 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 36.3 t70 46.27 22.41 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 88' ' ' GLU . 20.5 mm-40 25.25 41.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.743 0.817 . . . . 0.0 112.325 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 10' ' ' ASP . 2.8 m -176.4 -37.09 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.833 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.88 -75.06 1.45 Allowed Glycine 0 C--N 1.347 1.186 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.773 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.2 mm -139.54 81.94 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.848 0.356 . . . . 0.0 110.063 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.402 ' HB3' HG22 ' A' ' 12' ' ' THR . 10.4 p80 -66.27 -52.56 46.38 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.054 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -178.42 -35.39 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.548 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 3.2 tmm_? -71.47 -53.54 7.57 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 10.0 Cg_endo -52.52 -45.18 41.75 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.541 2.161 . . . . 0.0 112.765 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HA ' ' HB2' ' A' ' 46' ' ' SER . . . -64.36 -64.7 0.81 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.2 m -52.9 -32.14 43.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.374 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.545 ' HG3' ' HD2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -66.1 -49.27 68.13 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.972 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.553 HD23 HD23 ' A' ' 44' ' ' LEU . 3.8 mt -55.75 -38.91 70.45 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.919 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.407 ' O ' ' CB ' ' A' ' 27' ' ' SER . 58.3 t -57.45 -65.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.422 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -45.68 84.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.434 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 95.0 m -57.15 -62.35 1.82 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.441 0.163 . . . . 0.0 110.783 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.38 -46.49 88.53 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.636 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 33.0 t -59.01 -29.64 67.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.595 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' A' ' 25' ' ' THR . 17.4 mtmm -64.18 -52.78 57.29 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.676 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 38.4 m-85 -64.52 -36.5 84.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.047 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 82.44 -16.19 0.62 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.216 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.741 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 86.4 p -66.94 135.13 53.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.459 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.97 110.31 9.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.228 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.709 HG22 HG22 ' A' ' 63' ' ' ILE . 4.1 mt -98.64 126.59 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.613 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.615 ' CG ' ' HB2' ' A' ' 64' ' ' TYR . 3.6 pt20 -98.18 105.44 17.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 6.2 tt -96.63 112.47 24.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.313 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.769 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -95.16 175.84 6.46 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 125.904 2.003 . . . . 0.0 112.471 -178.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -129.12 163.12 26.18 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.494 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 0.7 OUTLIER -55.02 -11.36 0.64 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.66 48.18 0.51 Allowed Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.72 -179.19 0.61 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.714 0.292 . . . . 0.0 110.983 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.769 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -159.18 119.94 3.22 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.493 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.4 m -153.34 -172.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.708 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -89.26 148.73 23.42 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.688 ' HG ' HG21 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -62.92 50.97 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 177.128 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -59.34 -41.23 88.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.56 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.12 -52.17 0.7 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.449 0.643 . . . . 0.0 111.737 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.03 -24.15 14.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.774 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.1 mtm -167.27 -39.29 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.246 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -50.12 -49.32 37.22 Favored Glycine 0 C--N 1.34 0.788 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.113 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.56 ' CG2' ' HA ' ' A' ' 46' ' ' SER . 16.7 m -71.49 -36.3 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.811 0.305 . . . . 0.0 110.559 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 56.3 mtt -59.72 -46.76 88.12 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.464 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.7 p -58.78 -49.82 76.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.934 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 50' ' ' VAL . 1.1 pp -66.96 -12.73 60.56 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.31 109.8 0.06 OUTLIER Glycine 0 C--N 1.34 0.762 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.927 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 t -107.12 59.82 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.989 0.424 . . . . 0.0 110.924 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.87 -156.96 24.42 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.788 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.594 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 3.7 tttt -74.28 126.13 29.95 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.594 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 85.28 13.38 0.21 Allowed 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.822 0.701 . . . . 0.0 110.69 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.64 117.38 4.87 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.779 0.323 . . . . 0.0 111.425 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 1.5 tt0 -99.88 139.71 35.15 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.639 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.35 167.71 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.768 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.448 HG21 ' HB3' ' A' ' 5' ' ' SER . 18.7 m -151.21 114.74 4.87 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.48 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.709 HG22 HG22 ' A' ' 33' ' ' ILE . 3.2 mp -99.58 133.6 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.19 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.715 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 50.6 m-85 -129.91 104.24 7.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.362 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.634 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . . . -95.0 132.07 40.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.176 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.45 78.17 1.5 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.055 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.741 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -164.95 20.8 0.12 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.712 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 67' ' ' GLY . 59.5 p 121.96 -81.94 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.256 1.022 . . . . 0.0 111.914 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.676 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 8.0 m-20 -87.2 46.22 1.35 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.439 0.638 . . . . 0.0 109.997 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -70.5 -21.43 62.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.267 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.96 -51.75 6.17 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -34.52 62.54 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.199 178.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.631 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.75 -63.78 1.04 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.171 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.582 HG12 ' CG ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -48.08 -41.51 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -59.1 -69.33 0.2 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.641 0.258 . . . . 0.0 111.234 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.97 67.79 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.472 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.4 mm -60.26 -38.74 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.152 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -56.78 -57.9 10.45 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -44.47 -39.8 5.07 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.762 0.664 . . . . 0.0 110.525 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 21' ' ' MET . 3.3 t -64.17 -60.84 2.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.605 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -32.24 73.57 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 110.62 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 78' ' ' THR . 1.2 p -62.45 -34.02 75.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.636 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -63.01 -27.8 69.66 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.217 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 6.9 mm-40 -62.01 -28.91 69.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.096 0.559 . . . . 0.0 110.756 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.422 ' HA2' ' HG2' ' A' ' 88' ' ' GLU . . . -63.88 -18.42 62.02 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.038 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -29.9 61.47 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.612 0.244 . . . . 0.0 110.623 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.9 p -104.61 -98.97 0.32 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.475 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.505 ' HA ' ' HG2' ' A' ' 11' ' ' GLU . 3.8 pt-20 . . . . . 0 C--O 1.253 1.259 0 CA-C-O 118.957 -0.544 . . . . 0.0 112.145 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.725 0.298 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.61 ' HG3' ' N ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -100.39 164.07 12.09 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.57 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.694 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -155.41 159.11 39.61 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -156.41 174.39 15.48 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.495 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.7 p -153.03 146.85 25.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.005 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -138.45 -175.43 4.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.864 0.84 . . . . 0.0 113.19 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 7' ' ' THR . 6.7 t -150.31 74.8 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.917 -1.492 . . . . 0.0 107.685 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.453 HG23 HD13 ' A' ' 8' ' ' ILE . 73.0 mt -51.02 160.04 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 113.764 -1.562 . . . . 0.0 113.298 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' A' ' 88' ' ' GLU . 2.7 pp -151.09 4.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.607 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 4.4 t70 -74.13 15.54 0.31 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 8.1 mp0 72.1 -63.25 0.43 Allowed 'General case' 0 C--O 1.231 0.124 0 C-N-CA 122.915 0.486 . . . . 0.0 110.422 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 m -85.7 -25.5 26.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.58 -81.09 1.38 Allowed Glycine 0 C--N 1.343 0.963 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.735 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' A' ' 14' ' ' ILE . 1.1 tp -103.98 62.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.887 0.851 . . . . 0.0 110.548 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -61.34 -52.58 64.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.854 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.56 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -70.33 -57.09 6.1 Favored Pre-proline 0 CA--C 1.53 0.184 0 N-CA-C 110.696 -0.113 . . . . 0.0 110.696 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.477 ' HG2' ' HA ' ' A' ' 14' ' ' ILE . 32.4 Cg_endo -63.18 -31.23 74.98 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.167 1.912 . . . . 0.0 111.925 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HA ' ' HB2' ' A' ' 46' ' ' SER . . . -63.62 -64.9 0.77 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.22 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.2 p -53.62 -31.9 49.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.004 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.504 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.5 mmt -65.64 -52.7 49.81 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.71 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.429 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 0.2 OUTLIER -56.78 -37.63 71.39 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 179.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 27' ' ' SER . 57.6 t -55.29 -57.07 8.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.9 tt0 -66.24 -55.96 13.63 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.937 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 22' ' ' LEU . 54.1 p -53.48 -57.77 9.5 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.917 -0.129 . . . . 0.0 111.299 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.51 -46.62 86.36 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 7.7 m -59.26 -34.7 72.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.057 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 37.1 mtmt -65.39 -49.96 67.31 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.635 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 19.5 m-85 -64.82 -37.31 87.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.29 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 76.49 -13.35 0.93 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.868 -1.515 . . . . 0.0 112.184 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.486 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 92.6 p -67.97 139.89 56.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.483 0.659 . . . . 0.0 112.179 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.73 107.94 12.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.258 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.634 HG22 ' HB3' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -97.84 126.0 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.285 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.724 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 4.7 pt20 -105.87 106.86 17.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.605 ' CB ' ' HB2' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -101.22 121.11 41.28 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.881 -178.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.727 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -96.35 172.96 7.62 Favored 'General case' 0 C--N 1.341 0.217 0 O-C-N 126.211 2.194 . . . . 0.0 109.911 179.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 39' ' ' GLY . 2.1 t80 -146.7 100.92 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.829 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.424 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER 49.6 -59.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 37' ' ' TYR . . . -143.17 37.26 1.51 Allowed Glycine 0 C--N 1.317 -0.515 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -142.65 174.19 10.87 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.727 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -155.19 117.44 4.19 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.081 0.467 . . . . 0.0 111.561 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.9 m -152.37 -176.81 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.971 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -83.51 139.42 32.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.634 ' HB3' HG22 ' A' ' 33' ' ' ILE . 1.5 tp -67.62 55.62 0.06 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.715 0.293 . . . . 0.0 110.709 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -71.73 -4.46 27.72 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.547 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . 81.4 p 38.59 47.5 1.13 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 46' ' ' SER . 38.1 mm -166.43 -95.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.537 0.735 . . . . 0.0 109.217 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 34.1 mmt -68.09 -51.32 47.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.32 -81.35 0.07 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.671 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 46' ' ' SER . 7.2 p -37.55 -43.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 47' ' ' ILE . 1.8 mmt -61.99 -48.86 78.46 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.1 t -53.23 -51.46 62.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.062 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -35.39 80.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.004 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.32 108.36 1.89 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.529 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.8 t -139.27 82.39 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 59' ' ' ALA . . . -102.02 -139.74 10.74 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.454 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 13.8 tttt -73.75 131.88 42.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.582 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 84.6 -5.19 1.0 Allowed 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.7 0.625 . . . . 0.0 111.511 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 56' ' ' GLY . . . -62.72 125.02 22.53 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.722 0.296 . . . . 0.0 111.492 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.98 142.63 27.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.421 HG23 ' HA ' ' A' ' 37' ' ' TYR . 12.7 pt -147.42 172.34 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 6.6 m -150.57 115.15 5.2 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.151 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.6 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -100.46 147.62 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.724 ' HB2' ' HG3' ' A' ' 34' ' ' GLN . 45.3 m-85 -143.09 107.54 4.8 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.899 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.575 ' CB ' HG13 ' A' ' 33' ' ' ILE . . . -93.31 131.08 38.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.116 0.484 . . . . 0.0 111.346 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.54 83.41 2.16 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.96 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -166.72 -154.48 8.4 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.649 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 p -76.28 -55.81 5.22 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.866 0.833 . . . . 0.0 111.893 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.635 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 2.8 m-20 -92.62 40.86 1.06 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.568 0.223 . . . . 0.0 111.224 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 4.9 pt-20 -67.17 -18.77 65.41 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.6 -54.81 3.99 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.89 -34.18 62.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.638 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.542 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -51.74 -62.63 1.5 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.176 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.582 HG12 ' CG ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -49.79 -46.08 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -57.76 -67.92 0.29 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.629 0.252 . . . . 0.0 111.462 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.44 -37.63 67.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.033 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.4 mm -60.85 -39.27 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.463 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -57.0 -54.76 43.06 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -46.05 -41.62 12.32 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 109.945 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.504 HG23 ' HB3' ' A' ' 21' ' ' MET . 3.4 t -65.19 -61.02 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.007 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.482 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 6.0 mt -60.53 -32.93 71.94 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.037 0.446 . . . . 0.0 110.559 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 78' ' ' THR . 5.4 t -61.41 -31.5 71.42 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.279 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 80' ' ' VAL . 13.5 mttt -62.5 -25.91 68.26 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 9.8 pt-20 -64.63 -25.78 68.11 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 120.708 0.29 . . . . 0.0 110.795 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.409 ' HA2' HD11 ' A' ' 9' ' ' ILE . . . -59.48 -14.78 29.31 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pp -54.94 -18.99 5.7 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.095 0.158 . . . . 0.0 111.422 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.4 p -95.92 -93.91 0.2 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.28 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.51 ' HB3' HD12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.402 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.765 0.317 . . . . 0.0 111.394 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.619 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 7.2 mm-40 -97.59 169.62 9.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.712 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -164.34 153.38 13.41 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.018 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -161.94 121.94 2.51 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.008 0.432 . . . . 0.0 112.009 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.7 p -89.73 153.56 20.6 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.765 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 92.2 m-85 -142.2 -176.88 4.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.697 0.76 . . . . 0.0 112.76 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 7' ' ' THR . 5.5 t -149.18 87.43 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.136 -1.393 . . . . 0.0 107.913 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.456 HG23 HD13 ' A' ' 8' ' ' ILE . 36.0 mt -73.87 169.06 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.751 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 1.9 pp -140.11 -26.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.833 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -69.15 82.16 0.34 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.235 0.54 . . . . 0.0 110.502 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.511 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 1.2 pm0 -56.96 -7.91 0.54 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.76 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.7 m -78.7 -30.18 45.88 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.55 -164.66 18.94 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.758 -0.735 . . . . 0.0 113.219 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.412 HG23 ' HB2' ' A' ' 18' ' ' PRO . 23.4 mt -77.02 86.94 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.736 0.303 . . . . 0.0 110.67 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -69.98 -163.98 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.88 -32.95 68.19 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.443 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -74.22 -61.06 1.3 Allowed Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 29.6 Cg_endo -62.56 -31.24 79.96 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.327 2.018 . . . . 0.0 112.613 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.45 -63.19 1.25 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.085 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.6 m -52.72 -33.18 46.65 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.683 0.278 . . . . 0.0 110.719 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -55.61 17.46 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.696 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.3 -38.97 74.8 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.316 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 63.9 t -53.84 -57.89 4.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.1 tt0 -66.84 -55.47 14.64 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.412 ' O ' ' CD2' ' A' ' 29' ' ' PHE . 76.7 p -53.35 -59.44 4.57 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.039 0.212 . . . . 0.0 111.385 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.6 -48.04 82.28 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 122.944 0.152 . . . . 0.0 111.039 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.8 t -60.53 -31.2 70.29 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.649 0.261 . . . . 0.0 111.298 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -68.11 -50.43 54.83 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.591 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 10.6 m-85 -64.92 -42.58 94.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.911 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.32 -11.72 0.78 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.241 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.437 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 99.8 p -68.05 145.37 54.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.453 0.644 . . . . 0.0 112.45 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.95 108.94 15.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.209 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.581 HG13 ' CB ' ' A' ' 65' ' ' ALA . 0.6 OUTLIER -98.6 123.21 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.175 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.691 ' CG ' ' HB2' ' A' ' 64' ' ' TYR . 4.5 pt20 -98.56 106.05 18.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 5.5 tt -98.69 115.66 29.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.485 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.76 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -94.65 172.82 7.94 Favored 'General case' 0 C--N 1.34 0.179 0 O-C-N 126.07 2.106 . . . . 0.0 111.653 -179.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -126.17 165.27 19.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.637 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.453 ' HB3' ' HG3' ' A' ' 60' ' ' GLU . 1.3 p-10 -53.33 -14.1 0.67 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.49 49.4 0.48 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.05 178.65 1.72 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.704 0.287 . . . . 0.0 111.006 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.76 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -159.77 115.59 2.45 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.367 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.9 m -153.34 -175.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.05 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.231 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -85.21 141.18 30.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -65.31 52.7 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 121.907 0.86 . . . . 0.0 111.552 177.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -63.35 -34.47 77.78 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.701 ' HA ' ' HB ' ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.77 -50.62 0.7 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.283 0.563 . . . . 0.0 111.92 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.84 -22.93 7.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.108 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.52 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -169.45 -39.98 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.974 -178.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.91 -56.06 27.18 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.879 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.701 ' HB ' ' HA ' ' A' ' 46' ' ' SER . 5.3 t -69.08 -45.95 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.657 0.228 . . . . 0.0 111.332 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.52 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -60.23 -36.92 78.82 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.721 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.0 t -60.27 -51.72 68.33 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.041 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -64.75 -11.33 35.17 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.92 119.65 0.1 OUTLIER Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.803 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.0 t -117.03 63.88 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.996 0.427 . . . . 0.0 111.378 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 11' ' ' GLU . . . -80.92 -166.78 36.32 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.057 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -75.86 125.63 29.45 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.606 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 89.01 7.05 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.879 0.737 . . . . 0.0 111.089 -178.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.63 117.73 5.69 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-O 120.513 0.197 . . . . 0.0 111.133 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -94.29 142.44 27.41 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.1 pt -143.11 175.12 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.766 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 m -151.67 104.87 3.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.702 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.536 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 0.7 OUTLIER -96.49 151.01 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.712 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 22.7 m-85 -146.45 110.98 5.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.515 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.581 ' CB ' HG13 ' A' ' 33' ' ' ILE . . . -93.48 127.62 39.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.24 0.543 . . . . 0.0 111.187 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.89 89.15 3.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.756 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -174.02 -153.68 10.05 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.601 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.6 p -75.59 -58.08 3.5 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.714 0.757 . . . . 0.0 111.767 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.574 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 3.2 m-20 -91.87 42.7 1.11 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.865 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.595 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 5.9 pt-20 -67.45 -22.26 65.51 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.619 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -89.05 -48.64 7.27 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.06 -37.66 64.41 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.591 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.68 -57.04 12.23 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.715 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.8 mm -49.61 -49.06 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.93 -67.48 0.36 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.79 -34.16 67.37 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.537 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.4 ' O ' ' HB ' ' A' ' 80' ' ' VAL . 9.6 mm -62.29 -37.43 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -58.49 -51.86 68.07 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -47.88 -40.55 21.98 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 123.607 0.567 . . . . 0.0 110.004 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 77' ' ' ILE . 2.5 t -62.09 -57.42 12.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.08 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.461 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -62.55 -36.54 82.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.96 0.409 . . . . 0.0 110.076 178.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 78' ' ' THR . 2.2 t -60.34 -29.77 69.1 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.858 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.417 ' HD3' ' HG2' ' A' ' 17' ' ' ARG . 10.4 ttmt -62.43 -25.19 67.83 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.572 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 81' ' ' LEU . 7.0 pt-20 -61.39 -31.03 70.93 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.78 0.324 . . . . 0.0 110.34 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.36 -18.17 42.13 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.066 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.18 -25.57 61.72 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.538 0.169 . . . . 0.0 110.99 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.3 p -101.75 -98.24 0.27 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.872 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 117.981 -1.009 . . . . 0.0 112.209 179.916 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 ttm . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.703 0.287 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.598 ' CD ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -96.11 163.58 13.05 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.308 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.622 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.9 OUTLIER -153.66 152.5 30.9 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -159.55 165.57 32.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.297 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.5 p -153.87 141.07 19.51 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.82 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.29 -161.98 1.3 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.7 m -153.98 106.88 2.88 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.599 HG22 ' HA2' ' A' ' 85' ' ' GLY . 1.7 mt -102.18 -171.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.736 -176.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 1.0 OUTLIER -144.93 10.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 11.0 t70 -73.63 83.97 1.57 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.12 -23.92 2.43 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.794 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -82.82 -36.97 25.07 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.406 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . 73.31 95.38 0.1 OUTLIER Glycine 0 C--N 1.344 0.995 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.911 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 31.0 mm 67.84 125.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.897 0.379 . . . . 0.0 111.32 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -167.99 128.11 1.33 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.72 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 18' ' ' PRO . . . 43.95 -161.8 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 119.144 -0.455 . . . . 0.0 111.325 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.603 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER 15.51 -77.01 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.603 ' CD ' ' HB3' ' A' ' 17' ' ' ARG . 10.1 Cg_endo -50.34 -42.48 47.67 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.594 2.863 . . . . 0.0 113.509 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.35 -63.97 1.11 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.419 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.5 m -54.82 -31.75 59.59 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.448 ' HB3' HG23 ' A' ' 80' ' ' VAL . 27.7 mtm -64.93 -51.85 59.6 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.692 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 46' ' ' SER . 0.5 OUTLIER -56.65 -36.98 70.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.082 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.62 -60.59 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -66.47 -51.17 59.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.399 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.7 m -51.93 -60.24 3.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.275 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.412 ' HB3' HD22 ' A' ' 22' ' ' LEU . . . -61.9 -48.24 81.35 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.949 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.0 t -58.56 -28.79 65.85 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.542 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -66.13 -49.8 66.21 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.657 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 14.1 m-85 -64.62 -40.94 96.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.998 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.43 -9.44 1.4 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.434 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.0 p -66.72 154.7 40.02 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.64 140.64 46.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 5.1 tt -146.96 114.1 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.181 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.644 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 17.9 pm0 -104.35 128.86 52.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.456 0.646 . . . . 0.0 110.37 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 44' ' ' LEU . 5.8 tt -113.97 121.94 45.43 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.71 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -100.56 177.83 4.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 125.733 1.896 . . . . 0.0 111.494 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -128.02 162.83 25.91 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.868 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -55.43 -12.49 1.11 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.531 179.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.7 46.92 0.51 Allowed Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.41 -177.68 1.05 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.757 0.313 . . . . 0.0 110.919 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.71 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 4.9 tmtm? -159.05 122.79 3.84 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 m -152.24 -174.75 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.025 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -84.11 145.09 28.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.589 ' HA ' ' HB3' ' A' ' 35' ' ' LEU . 1.3 tt -67.66 58.55 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.497 ' HB2' ' HA3' ' A' ' 49' ' ' GLY . 4.5 mtpm? -69.31 -49.44 55.78 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.525 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER 73.78 -54.1 0.68 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.352 -178.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.18 -25.58 13.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.289 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.558 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -169.78 -39.02 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -178.053 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -48.68 -56.03 10.32 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.139 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.525 ' CG2' ' HA ' ' A' ' 46' ' ' SER . 32.0 m -68.57 -50.25 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.558 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -60.22 -40.95 91.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.3 p -58.43 -48.39 80.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.941 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.09 -34.56 78.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.921 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.79 126.22 3.08 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.975 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 51' ' ' MET . 2.9 t -129.13 84.16 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.571 0.224 . . . . 0.0 110.953 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.47 176.86 48.44 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 4.7 tttm -71.95 131.08 42.46 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 85.07 12.06 0.26 Allowed 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.671 0.607 . . . . 0.0 110.467 -178.546 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.97 121.59 12.2 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.321 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 2.8 tt0 -93.9 143.39 26.38 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.2 pt -146.14 172.82 3.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 4' ' ' GLN . 4.4 m -148.13 109.47 4.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.858 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.57 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 1.3 mp -96.16 142.04 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.707 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.644 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 84.0 m-85 -132.24 116.21 16.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.784 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 70' ' ' GLU . . . -101.8 127.78 48.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.023 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -133.25 103.95 6.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.005 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.56 -155.53 26.54 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.765 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.2 p -69.18 -61.09 1.94 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 117.282 0.541 . . . . 0.0 111.659 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.657 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.9 m-20 -92.2 37.92 0.99 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.544 0.211 . . . . 0.0 111.252 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.459 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . 10.1 pt-20 -65.03 -22.45 66.98 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.35 -55.07 3.96 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.29 -34.6 66.62 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.461 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -50.28 -58.88 4.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.24 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.598 HG12 ' CD ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -43.48 -51.02 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 123.218 0.324 . . . . 0.0 111.872 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -54.71 -68.7 0.16 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.83 71.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.454 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.1 mm -62.09 -38.64 81.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.652 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -57.31 -57.68 11.56 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.269 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -44.16 -41.94 6.04 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.576 0.547 . . . . 0.0 110.288 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 21' ' ' MET . 3.8 t -62.91 -63.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.67 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.24 -26.52 68.42 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.066 0.46 . . . . 0.0 110.763 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 78' ' ' THR . 6.7 t -65.08 -33.59 76.4 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.976 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.459 ' HD3' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -60.19 -49.29 78.22 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.488 179.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 2.7 pt-20 -63.76 -28.12 69.66 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.312 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.599 ' HA2' HG22 ' A' ' 8' ' ' ILE . . . -65.42 -19.97 67.17 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.361 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.574 ' HG ' ' N ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -70.74 -46.01 63.79 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.574 ' N ' ' HG ' ' A' ' 86' ' ' LEU . 7.5 m 48.97 -80.22 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.628 0.771 . . . . 0.0 113.077 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.47 ' HG2' HD11 ' A' ' 86' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.881 -1.057 . . . . 0.0 112.218 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptp . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.638 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 2.4 mm-40 -95.3 165.34 12.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.703 0.287 . . . . 0.0 110.812 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.713 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 2.2 pt20 -163.65 156.38 18.12 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -163.15 118.95 1.76 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.032 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 60.3 p -89.31 152.34 21.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.918 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 59.4 m-85 -142.96 -179.89 6.63 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.899 0.857 . . . . 0.0 112.877 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 7' ' ' THR . 9.7 t -152.88 96.47 2.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.022 -1.444 . . . . 0.0 107.976 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.738 HG22 ' H ' ' A' ' 9' ' ' ILE . 1.7 mt -96.29 -168.97 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.043 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.738 ' H ' HG22 ' A' ' 8' ' ' ILE . 2.7 pp -145.86 15.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 122.314 0.246 . . . . 0.0 111.612 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -75.86 80.98 2.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.625 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -52.4 -22.39 4.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.478 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -37.98 23.21 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.11 -166.25 19.97 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.757 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.672 HD12 HG11 ' A' ' 50' ' ' VAL . 60.5 mt -69.42 81.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.006 0.432 . . . . 0.0 110.815 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.537 ' CE1' ' HB3' ' A' ' 17' ' ' ARG . 14.3 p80 -70.78 -162.16 0.06 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.261 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.51 -28.72 67.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.592 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 31.1 ttp180 -74.94 -62.0 0.95 Allowed Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.665 ' HB2' HG23 ' A' ' 14' ' ' ILE . 36.0 Cg_endo -64.49 -33.34 57.44 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.306 2.004 . . . . 0.0 112.888 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -62.9 -63.21 1.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.883 -0.144 . . . . 0.0 111.062 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.1 m -54.29 -31.85 54.89 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.698 0.285 . . . . 0.0 110.719 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.744 ' HB3' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -64.27 -54.57 31.18 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.596 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.558 HD22 HD13 ' A' ' 44' ' ' LEU . 1.2 mt -58.74 -35.7 73.14 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 19' ' ' ALA . 62.6 t -54.45 -62.24 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.92 -51.51 61.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.747 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.504 HG22 ' HE2' ' A' ' 29' ' ' PHE . 97.0 m -52.73 -61.37 2.33 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.105 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.31 -47.75 84.67 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.102 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.2 p -59.82 -29.02 67.96 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' THR . 3.7 mtpm? -63.43 -54.28 39.02 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.672 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 28.3 m-85 -65.65 -37.68 87.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.125 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 84.07 -20.26 0.32 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.533 -1.667 . . . . 0.0 112.275 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 68' ' ' SER . 81.6 p -67.73 143.19 56.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.475 0.655 . . . . 0.0 112.399 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.34 114.84 18.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.521 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.776 HG21 HD21 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -100.89 114.28 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.851 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.702 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 14.9 pm0 -90.3 107.19 18.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 122.089 0.947 . . . . 0.0 109.318 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.651 HD13 ' HB3' ' A' ' 44' ' ' LEU . 4.5 tt -97.09 114.09 25.72 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.777 -1.556 . . . . 0.0 108.831 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.779 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -92.96 174.77 7.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 125.936 2.022 . . . . 0.0 111.641 -179.102 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 28.9 t80 -133.22 165.05 25.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.714 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.506 ' HB3' ' CG ' ' A' ' 60' ' ' GLU . 1.2 p-10 -53.22 -14.74 0.74 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.642 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.32 49.27 0.5 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.32 172.52 3.21 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.515 0.197 . . . . 0.0 110.675 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.779 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -160.29 109.65 1.75 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -155.02 -178.18 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.262 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . 4.9 t30 -83.77 136.94 33.96 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.776 HD21 HG21 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -68.81 58.08 0.09 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.076 0.398 . . . . 0.0 111.051 177.555 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' A' ' 43' ' ' ASN . 1.4 ttmt -65.78 -14.9 62.26 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.665 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.7 OUTLIER 69.3 -49.01 0.6 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.1 mt -52.77 -26.26 10.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.382 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.81 -39.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.86 -52.92 24.13 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.479 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.672 HG11 HD12 ' A' ' 14' ' ' ILE . 15.2 m -67.06 -35.89 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.932 0.366 . . . . 0.0 110.728 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 63.9 mtt -59.87 -48.04 83.32 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.668 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 p -57.68 -51.48 69.36 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.975 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -67.26 -19.19 65.47 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.03 102.41 0.01 OUTLIER Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.951 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 t -100.79 56.84 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.841 0.353 . . . . 0.0 111.106 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.35 -160.46 8.56 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.763 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 1.7 tttm -73.95 134.91 43.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER 76.9 9.61 2.78 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.542 0.526 . . . . 0.0 110.691 -178.631 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.16 119.61 8.73 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.506 ' CG ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -95.4 135.85 36.5 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.468 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.414 ' CD1' HD22 ' A' ' 81' ' ' LEU . 5.8 pt -138.71 172.88 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.394 0.616 . . . . 0.0 112.385 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.711 HG22 ' CE1' ' A' ' 64' ' ' TYR . 7.2 m -151.71 102.54 2.86 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.285 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.844 ' N ' HD13 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -94.0 149.14 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.315 -177.053 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.713 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 38.2 m-85 -146.82 114.19 6.3 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.297 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.647 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -95.38 126.38 40.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.812 0.339 . . . . 0.0 110.579 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -139.88 92.47 2.56 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.925 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.97 -80.01 0.04 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.439 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 31' ' ' SER . 0.2 OUTLIER -143.52 -68.74 0.33 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.254 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 5.5 m-20 -89.86 51.53 2.09 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -69.92 -23.76 63.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.968 -178.029 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.638 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -86.84 -53.26 5.01 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.604 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.05 -36.69 60.88 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.672 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.86 -54.96 31.31 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.897 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.6 mm -43.31 -51.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.928 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -57.59 -68.88 0.2 Allowed 'General case' 0 C--O 1.239 0.538 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.05 -33.17 68.72 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.723 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.1 mm -62.88 -38.37 81.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.74 -60.23 4.01 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -42.0 -41.04 2.4 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.625 0.578 . . . . 0.0 110.47 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 21' ' ' MET . 7.9 t -65.65 -63.46 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.027 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.414 HD22 ' CD1' ' A' ' 61' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 110.969 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ttt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.732 0.301 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.62 ' CD ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -94.04 164.21 13.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.425 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.583 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -160.94 152.26 19.06 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.329 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.07 133.18 5.87 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.771 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 3.0 t -89.97 157.66 17.74 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.944 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.628 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 4.9 m-85 -138.16 176.38 8.75 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.86 0.838 . . . . 0.0 112.251 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.4 m -145.8 75.52 1.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.492 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.645 HG21 ' CG1' ' A' ' 55' ' ' VAL . 48.2 mt -65.29 163.33 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.489 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.737 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 2.1 pp -136.04 -26.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.761 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 13' ' ' GLY . 10.2 t0 -68.09 87.59 0.27 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.452 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -47.85 -27.54 2.14 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.35 -38.01 27.35 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 10' ' ' ASP . . . 88.56 -114.02 4.17 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.937 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.64 HD11 ' HA ' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -75.88 152.59 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.071 0.462 . . . . 0.0 111.855 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.56 ' CE1' ' HD3' ' A' ' 18' ' ' PRO . 24.9 p80 -170.54 -153.53 0.1 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.967 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.87 79.52 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.531 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -78.89 -55.18 0.99 Allowed Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.56 ' HD3' ' CE1' ' A' ' 15' ' ' HIS . 12.3 Cg_exo -62.69 -41.72 29.63 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.623 2.215 . . . . 0.0 113.122 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.73 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -58.08 -64.4 0.93 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -53.93 -33.23 56.13 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.776 0.322 . . . . 0.0 111.086 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.935 ' HB3' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -66.31 -62.47 1.46 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.513 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.506 HD13 ' HB3' ' A' ' 46' ' ' SER . 0.9 OUTLIER -58.67 -37.03 75.14 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 19' ' ' ALA . 70.7 t -53.51 -60.04 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.1 tt0 -66.49 -52.91 40.94 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.761 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.44 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 94.9 m -52.45 -58.93 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.464 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.45 -48.29 80.31 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.31 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -59.72 -28.36 67.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.726 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -66.11 -52.9 44.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.652 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 13.9 m-85 -66.68 -41.81 87.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.31 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 74.8 -7.28 1.76 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.53 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.6 p -66.13 152.35 44.94 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -73.95 140.22 45.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.821 HG23 ' HB3' ' A' ' 44' ' ' LEU . 3.4 tt -142.59 124.24 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-O 121.137 0.494 . . . . 0.0 111.455 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.696 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 9.8 pt20 -112.0 123.33 50.02 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-O 121.436 0.636 . . . . 0.0 110.217 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.737 HD12 HD12 ' A' ' 44' ' ' LEU . 2.1 tt -109.77 123.12 48.98 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.483 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.753 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -103.14 176.41 5.16 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 125.763 1.914 . . . . 0.0 111.585 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -127.16 162.65 25.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.567 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.47 -10.8 1.03 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.72 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.76 45.5 0.57 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.09 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.84 -177.71 0.65 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.661 0.267 . . . . 0.0 110.984 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.753 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 1.2 tmtp? -158.9 124.8 4.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.336 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.504 ' CG2' HD11 ' A' ' 53' ' ' LEU . 21.9 m -153.45 -173.74 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.269 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -85.75 143.76 28.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.821 ' HB3' HG23 ' A' ' 33' ' ' ILE . 1.1 tt -69.25 57.53 0.11 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -69.64 -38.86 77.31 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.698 ' HA ' HG22 ' A' ' 50' ' ' VAL . 2.5 p 70.9 -50.49 0.68 Allowed 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.724 0.64 . . . . 0.0 112.119 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.5 HD13 ' CD1' ' A' ' 14' ' ' ILE . 46.7 mm -53.44 -25.95 11.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.168 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.434 ' HA ' ' HB2' ' A' ' 51' ' ' MET . 14.4 mtp -166.64 -39.27 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.669 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.66 -52.09 26.0 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.979 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.698 HG22 ' HA ' ' A' ' 46' ' ' SER . 6.7 m -72.91 -37.98 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.592 0.196 . . . . 0.0 110.54 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.434 ' HB2' ' HA ' ' A' ' 48' ' ' MET . 0.6 OUTLIER -56.84 -53.19 60.67 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.308 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.5 p -58.02 -37.56 74.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.361 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.504 HD11 ' CG2' ' A' ' 42' ' ' VAL . 6.2 mt -60.9 -30.81 70.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.409 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.76 -42.57 1.87 Allowed Glycine 0 C--N 1.339 0.716 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.265 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 50' ' ' VAL . 72.4 t 35.9 63.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 11' ' ' GLU . . . -86.94 -172.52 48.37 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.109 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.737 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 5.9 tttt -76.11 126.28 30.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 86.45 11.19 0.19 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.885 0.741 . . . . 0.0 110.916 -178.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.92 121.56 13.27 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 120.736 0.303 . . . . 0.0 111.693 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.16 135.99 33.26 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.803 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.821 HD12 HD11 ' A' ' 63' ' ' ILE . 45.1 pt -147.0 176.64 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.14 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.577 ' C ' HD13 ' A' ' 63' ' ' ILE . 14.6 m -152.57 109.9 3.55 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.002 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.821 HD11 HD12 ' A' ' 61' ' ' ILE . 1.1 mm -94.25 154.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.481 -178.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.696 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 57.7 m-85 -141.16 117.61 10.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.539 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.3 129.89 46.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.872 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -134.5 96.05 3.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.138 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.49 -154.47 17.81 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.746 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.0 p -71.95 -59.2 2.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.158 0.479 . . . . 0.0 111.724 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.652 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.6 m-20 -93.47 36.59 1.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.423 0.154 . . . . 0.0 111.407 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.69 -22.36 66.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.91 -56.67 3.29 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.74 -30.34 65.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.738 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -50.18 -63.11 1.22 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.548 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.62 HG12 ' CD ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -43.75 -43.38 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.568 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -58.4 -71.72 0.11 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.778 0.323 . . . . 0.0 111.368 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.04 -33.36 67.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.503 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.16 -38.71 80.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.983 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 -56.12 25.9 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -47.23 -42.71 20.88 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.148 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.935 HG22 ' HB3' ' A' ' 21' ' ' MET . 7.8 t -65.76 -63.38 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.461 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 120.856 0.36 . . . . 0.0 110.421 179.548 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.813 0.339 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.646 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mm-40 -95.67 162.48 13.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.388 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.735 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.6 OUTLIER -166.2 152.93 9.39 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -164.83 121.91 1.57 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.629 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 p -89.65 150.71 22.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.807 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 41.8 m-85 -142.5 176.57 8.92 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.569 0.699 . . . . 0.0 111.815 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 7' ' ' THR . 14.8 t -153.48 111.96 3.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.173 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.5 HD13 ' O ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -132.92 175.3 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -176.453 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.45 ' H ' HG22 ' A' ' 8' ' ' ILE . 2.1 pp -95.28 15.17 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.124 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -69.48 78.04 0.4 Allowed 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.212 0.53 . . . . 0.0 111.545 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.463 ' HG2' ' CB ' ' A' ' 57' ' ' LYS . 1.1 tm-20 -52.24 -32.08 35.21 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.901 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.0 p -82.43 -35.28 27.74 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.98 -86.28 1.25 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.278 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.528 HG23 ' HB2' ' A' ' 18' ' ' PRO . 4.3 mp -137.39 71.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.21 0.528 . . . . 0.0 110.309 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.451 ' N ' ' HG2' ' A' ' 18' ' ' PRO . 11.2 p80 -69.78 -156.23 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.641 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.1 -33.28 71.9 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.554 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 1.3 ttp85 -73.73 -63.5 0.93 Allowed Pre-proline 0 N--CA 1.467 0.382 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.519 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.554 ' CD ' ' HB3' ' A' ' 17' ' ' ARG . 21.4 Cg_endo -60.42 -29.71 89.32 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.505 2.137 . . . . 0.0 112.719 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.607 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -62.5 -64.56 0.89 Allowed 'General case' 0 C--N 1.339 0.132 0 CA-C-N 116.857 -0.156 . . . . 0.0 110.812 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 m -53.73 -32.16 51.05 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 110.604 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -55.43 20.43 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.395 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.632 HD22 HD13 ' A' ' 44' ' ' LEU . 1.3 mt -58.41 -34.17 70.47 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.115 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 19' ' ' ALA . 67.3 t -55.44 -64.57 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -64.93 -44.12 90.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 123.194 0.309 . . . . 0.0 111.672 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.454 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 52.0 m -56.33 -61.32 2.48 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.594 0.235 . . . . 0.0 110.409 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.76 98.0 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.469 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -58.42 -32.95 69.14 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.232 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 25' ' ' THR . 24.9 mtmm -63.55 -52.68 60.01 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.609 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 43.4 m-85 -66.68 -35.54 80.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.667 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 82.5 -20.84 0.33 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.868 -1.515 . . . . 0.0 111.502 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.429 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 88.7 p -68.7 132.33 46.68 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.725 0.774 . . . . 0.0 112.219 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.24 115.44 19.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.686 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.876 HG21 HD21 ' A' ' 44' ' ' LEU . 2.9 mt -97.48 123.62 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.464 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.752 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 2.7 pt20 -94.76 104.15 16.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.574 ' HB2' HD23 ' A' ' 44' ' ' LEU . 5.5 tt -99.44 119.37 37.88 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.029 -1.441 . . . . 0.0 110.176 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.76 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -93.98 169.6 10.16 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 126.023 2.077 . . . . 0.0 110.466 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.968 ' HB3' HD22 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -145.52 97.6 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.509 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 49.93 -59.5 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 37' ' ' TYR . . . -138.62 33.05 2.25 Favored Glycine 0 C--N 1.318 -0.468 0 C-N-CA 121.816 -0.23 . . . . 0.0 112.738 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.464 ' HB3' HD21 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -138.33 171.04 14.97 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.76 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 1.2 tmtm? -156.56 109.88 2.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.934 0.397 . . . . 0.0 111.736 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.4 m -153.78 173.07 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.084 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -81.89 131.89 35.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.876 HD21 HG21 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -67.66 56.81 0.06 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.858 0.361 . . . . 0.0 110.987 177.571 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' O ' HD12 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -66.89 -17.71 65.03 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.558 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.727 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.95 -47.64 0.67 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 45' ' ' LYS . 3.2 mt -52.82 -26.44 10.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.329 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.511 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 13.0 mtp -167.79 -37.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.19 60.06 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.182 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.727 HG22 ' HA ' ' A' ' 46' ' ' SER . 24.8 m -69.29 -50.2 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.511 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -59.0 -41.36 87.46 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.614 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.4 t -57.9 -41.3 82.32 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.216 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.968 HD22 ' HB3' ' A' ' 37' ' ' TYR . 38.7 mt -64.58 -52.57 56.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.821 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.64 -49.03 0.92 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.417 -0.421 . . . . 0.0 113.14 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t 36.49 79.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.437 ' C ' ' HA ' ' A' ' 11' ' ' GLU . . . -76.47 -163.36 15.94 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.902 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.601 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 7.3 tttt -74.34 134.86 42.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.601 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER 76.69 9.29 2.97 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.519 0.512 . . . . 0.0 110.41 -178.502 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.18 136.79 58.1 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 152.21 20.62 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.528 HD11 HD22 ' A' ' 81' ' ' LEU . 12.5 pt -145.66 172.7 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.093 0.473 . . . . 0.0 111.924 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.751 HG22 ' CE1' ' A' ' 64' ' ' TYR . 5.6 m -149.21 103.28 3.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.446 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.867 ' N ' HD13 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -96.64 145.06 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.612 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.752 ' HB2' ' HG3' ' A' ' 34' ' ' GLN . 11.2 m-85 -145.53 111.33 5.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.052 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.704 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -91.13 133.51 35.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.329 0.585 . . . . 0.0 111.767 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -130.88 101.24 5.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.79 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . 174.57 -158.94 27.52 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.7 p -71.53 -60.79 2.05 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.27 1.035 . . . . 0.0 111.133 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.609 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 9.7 m-20 -91.48 42.92 1.12 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.57 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -66.28 -22.47 66.3 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.974 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.646 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -88.29 -46.77 8.93 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.12 -40.21 64.03 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.55 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -54.99 -54.55 41.5 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.441 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 mm -48.43 -47.49 14.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.502 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -55.52 -70.96 0.09 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.78 -37.26 73.39 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.1 mm -60.85 -41.75 89.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.529 0.204 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 79' ' ' ASP . 14.6 m -60.59 -63.59 1.25 Allowed 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.456 ' C ' ' O ' ' A' ' 78' ' ' THR . 45.8 m-20 -34.39 -43.82 0.17 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.034 0.445 . . . . 0.0 110.142 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.1 t -66.68 -66.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.114 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.528 HD22 HD11 ' A' ' 61' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.194 0.521 . . . . 0.0 110.644 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.568 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mm-40 -99.02 159.21 15.12 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.461 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.725 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -159.58 156.69 28.47 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 2.7 mm100 -162.25 164.63 27.53 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.422 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.457 ' HB3' HG23 ' A' ' 62' ' ' THR . 46.2 p -153.66 139.5 18.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.906 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -144.7 -177.59 5.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.396 0.617 . . . . 0.0 111.392 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 t -153.19 116.83 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.576 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.555 HG22 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -134.98 177.5 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -176.678 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.555 ' H ' HG22 ' A' ' 8' ' ' ILE . 17.3 pt -94.07 16.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.747 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -68.58 73.97 0.25 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.329 0.585 . . . . 0.0 111.642 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 57' ' ' LYS . 2.9 tt0 -59.38 -25.26 64.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.048 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -80.01 -33.67 39.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.51 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . 48.66 81.43 0.05 OUTLIER Glycine 0 C--N 1.341 0.836 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.894 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 25.5 mm 71.82 127.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.802 0.334 . . . . 0.0 111.031 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 10.7 p80 -166.76 -119.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.314 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 18' ' ' PRO . . . -69.32 -167.13 0.11 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 118.777 -0.63 . . . . 0.0 109.881 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.667 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 12.29 -73.03 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.667 ' CD ' ' HB3' ' A' ' 17' ' ' ARG . 4.5 Cg_exo -40.31 -45.97 4.26 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.67 2.913 . . . . 0.0 113.212 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 15' ' ' HIS . . . -64.25 -56.22 16.1 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 121.258 -0.177 . . . . 0.0 111.146 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.2 m -50.84 -34.29 27.23 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.921 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 mmm -62.93 -50.45 70.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.291 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -35.61 70.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.852 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.68 -59.06 2.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -66.18 -50.93 62.21 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.301 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.694 HG22 ' HE2' ' A' ' 29' ' ' PHE . 84.8 m -52.69 -60.46 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.47 89.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.579 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.5 t -59.48 -29.4 67.8 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.375 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 25' ' ' THR . 3.5 mtpm? -63.98 -51.46 64.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.694 ' HE2' HG22 ' A' ' 25' ' ' THR . 30.3 m-85 -64.59 -39.66 94.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.746 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 76.5 -14.21 0.84 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.27 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.8 p -68.31 144.91 54.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.384 0.611 . . . . 0.0 112.383 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.48 110.19 13.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.734 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.732 HG23 HG23 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -101.27 119.9 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.46 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.686 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 15.8 pm0 -101.03 113.11 25.8 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.105 HD13 HD13 ' A' ' 44' ' ' LEU . 1.5 tt -103.47 120.83 41.6 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.585 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.779 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.6 OUTLIER -94.87 175.99 6.43 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 126.136 2.147 . . . . 0.0 111.251 -179.78 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -128.53 166.72 18.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.241 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.43 ' CA ' ' HG3' ' A' ' 60' ' ' GLU . 7.6 t-20 -46.62 -21.02 0.15 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.23 55.55 0.39 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.86 -179.7 1.22 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.631 0.253 . . . . 0.0 110.999 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.779 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -158.89 118.81 3.13 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.446 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.401 ' CG2' HD23 ' A' ' 53' ' ' LEU . 21.3 m -153.26 -173.68 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.976 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -86.45 144.39 27.31 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.105 HD13 HD13 ' A' ' 35' ' ' LEU . 6.8 tp -68.81 59.09 0.09 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -67.78 -32.05 72.36 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.472 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.7 OUTLIER 69.59 -52.28 0.61 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.423 0.63 . . . . 0.0 112.183 -179.471 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.8 mt -53.31 -26.2 11.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.213 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.9 mtp -167.56 -39.19 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.628 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -48.22 -47.51 27.32 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.286 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.485 ' HA ' HD21 ' A' ' 53' ' ' LEU . 33.7 m -69.56 -38.71 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.705 0.288 . . . . 0.0 110.899 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.3 mtt -59.63 -47.07 87.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.798 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.4 p -58.71 -48.44 81.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.479 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.485 HD21 ' HA ' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -66.88 -11.07 54.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.44 117.04 0.04 OUTLIER Glycine 0 C--N 1.339 0.746 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.223 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.44 ' HB ' ' HA3' ' A' ' 13' ' ' GLY . 2.5 t -120.2 70.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.754 0.311 . . . . 0.0 111.814 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.25 -167.03 32.94 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.35 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 7.2 tttm -71.82 134.76 46.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.571 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER 76.59 12.8 2.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.553 0.533 . . . . 0.0 111.04 -179.111 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.69 131.92 52.23 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HG3' ' CA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -103.18 144.87 30.75 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.292 179.058 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 pt -146.79 169.09 5.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.714 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.569 HG22 ' CE1' ' A' ' 64' ' ' TYR . 16.9 m -152.44 107.49 3.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.734 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.768 ' CG1' HD12 ' A' ' 35' ' ' LEU . 4.8 mp -96.96 148.09 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.725 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 25.8 m-85 -138.24 114.94 10.62 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.904 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.55 ' HB2' HG13 ' A' ' 33' ' ' ILE . . . -93.46 130.56 39.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.212 0.529 . . . . 0.0 111.459 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -131.48 96.68 4.04 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.751 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.89 -154.77 18.07 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.523 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.4 p -74.63 -60.68 2.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.704 0.752 . . . . 0.0 111.25 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.631 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 5.9 m-20 -91.52 41.22 1.06 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.897 0.38 . . . . 0.0 110.573 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.427 ' HG3' ' CG ' ' A' ' 2' ' ' GLU . 15.0 pt-20 -66.2 -28.52 68.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.974 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.568 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -85.78 -44.02 12.84 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.89 -40.89 67.0 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.612 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -54.68 -54.39 42.38 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.105 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.7 mm -49.6 -49.85 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.961 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -54.78 -69.04 0.14 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.62 -38.07 68.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.607 0.242 . . . . 0.0 111.35 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 73' ' ' ALA . 14.4 mm -61.33 -37.71 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.638 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -62.05 2.14 Favored 'General case' 0 C--O 1.207 -1.164 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -39.56 -43.87 1.37 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.594 0.559 . . . . 0.0 110.436 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.5 t -63.74 -64.64 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.448 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.512 HD23 HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.374 0 CA-C-O 121.011 0.434 . . . . 0.0 110.651 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptp . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.741 ' OE1' ' HB3' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -98.05 164.51 12.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.761 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -157.49 160.19 38.01 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.542 ' HG3' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -160.82 123.09 3.14 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.173 179.423 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 p -94.07 156.59 16.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.692 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -144.48 177.53 8.59 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.654 0.74 . . . . 0.0 111.992 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.6 ' O ' HD13 ' A' ' 8' ' ' ILE . 14.6 t -160.43 104.1 1.42 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.469 -1.242 . . . . 0.0 107.918 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER -142.69 -175.74 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.036 -175.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.723 HG22 ' HA ' ' A' ' 57' ' ' LYS . 14.7 pt -136.89 -41.35 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 t70 44.89 27.7 0.29 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.771 0.26 . . . . 0.0 111.634 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.411 ' OE2' HD12 ' A' ' 9' ' ' ILE . 19.2 mm-40 33.5 34.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.451 0.7 . . . . 0.0 112.741 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER 175.94 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.922 179.236 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.74 -56.93 0.97 Allowed Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.488 HD13 HG23 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -141.11 174.25 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.105 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -171.64 -59.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -174.95 -35.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.457 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -72.13 -56.73 4.21 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 -179.399 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 36.9 Cg_endo -65.29 -33.49 48.26 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.292 1.995 . . . . 0.0 112.149 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.61 ' HA ' ' HB2' ' A' ' 46' ' ' SER . . . -62.73 -65.0 0.75 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.084 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.1 p -55.29 -28.91 56.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.282 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.789 ' HB3' HG22 ' A' ' 80' ' ' VAL . 1.4 mtt -63.16 -55.59 23.85 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.797 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.497 HD22 ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -58.91 -34.57 71.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.075 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 19' ' ' ALA . 73.8 t -54.55 -57.28 6.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.64 -55.97 14.67 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.517 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 29.4 p -52.89 -57.5 10.05 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.547 0.202 . . . . 0.0 111.547 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.14 -47.72 84.91 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.822 -0.172 . . . . 0.0 110.979 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 23.5 m -60.28 -30.97 69.8 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.784 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' ' 25' ' ' THR . 4.9 mtmp? -63.76 -51.38 65.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 14.2 m-85 -64.58 -37.49 87.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.984 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 80.84 -15.5 0.73 Allowed 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.582 -1.644 . . . . 0.0 112.681 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.443 ' HB3' ' H ' ' A' ' 68' ' ' SER . 83.4 p -66.09 145.6 55.65 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.416 0.626 . . . . 0.0 112.263 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.04 109.11 13.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.098 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.848 ' CG1' ' HB2' ' A' ' 65' ' ' ALA . 1.3 mt -99.53 125.15 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.909 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.665 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -103.77 113.45 26.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.643 0.735 . . . . 0.0 109.258 178.304 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.023 HD13 HD13 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -101.34 114.12 27.83 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.935 -179.617 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.536 ' HG3' ' HG2' ' A' ' 41' ' ' LYS . 1.5 tt0 -91.72 173.65 7.76 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 126.262 2.226 . . . . 0.0 110.772 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.427 ' CG ' ' HB2' ' A' ' 53' ' ' LEU . 32.3 t80 -132.35 163.57 28.41 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.084 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.626 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 6.6 t-20 -51.65 -15.48 0.47 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -156.68 50.12 0.44 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.197 -0.525 . . . . 0.0 111.826 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -178.88 -178.51 0.55 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.666 0.27 . . . . 0.0 110.906 -179.353 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 1.7 tmtt? -157.83 120.84 3.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.448 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.4 m -151.43 -175.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.512 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.25 140.87 29.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.023 HD13 HD13 ' A' ' 35' ' ' LEU . 1.6 tp -69.65 56.83 0.13 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.593 0.235 . . . . 0.0 110.582 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.509 ' O ' HD12 ' A' ' 47' ' ' ILE . 3.9 tptp -73.16 9.56 1.2 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.61 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . 89.8 p 39.64 34.24 0.15 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 46' ' ' SER . 2.2 mp -166.16 -84.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.54 ' N ' HG22 ' A' ' 47' ' ' ILE . 3.4 tpp -63.98 -37.27 86.82 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -82.43 0.1 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.475 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.488 HG23 HD13 ' A' ' 14' ' ' ILE . 3.1 m -40.0 -42.06 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.0 mtt -59.07 -50.11 75.32 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.509 0.195 . . . . 0.0 111.233 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.4 t -56.47 -52.64 63.94 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.226 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.427 ' HB2' ' CG ' ' A' ' 37' ' ' TYR . 0.6 OUTLIER -67.31 -18.01 65.0 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.59 101.3 0.05 OUTLIER Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.55 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.442 ' CG2' ' HB ' ' A' ' 50' ' ' VAL . 19.5 t -90.98 75.99 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.939 0.4 . . . . 0.0 111.22 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.12 -161.99 37.12 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.375 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.723 ' HA ' HG22 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -72.63 127.43 32.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 82.33 18.24 0.34 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.698 0.624 . . . . 0.0 110.42 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.88 115.27 2.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.299 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.626 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 2.1 tt0 -96.83 139.63 32.58 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.753 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.82 170.11 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.154 0.502 . . . . 0.0 111.812 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.562 ' C ' HD13 ' A' ' 63' ' ' ILE . 7.0 m -152.55 107.0 3.16 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.928 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.847 ' CD1' HD12 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -94.99 146.59 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.761 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 40.8 m-85 -145.49 108.82 4.63 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.468 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.848 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -98.0 133.54 42.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.838 0.351 . . . . 0.0 110.559 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.82 78.17 1.66 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.569 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -147.76 -89.7 0.08 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.702 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.443 ' H ' ' HB3' ' A' ' 31' ' ' SER . 11.3 p -132.39 -65.65 0.72 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.918 0.359 . . . . 0.0 111.285 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.462 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.4 m-20 -89.69 41.19 1.03 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.867 0.365 . . . . 0.0 110.639 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -24.28 66.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.055 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.28 -53.21 5.92 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -32.91 66.13 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.989 0.423 . . . . 0.0 109.876 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -49.09 -56.49 8.94 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.992 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.58 HD11 ' HG2' ' A' ' 2' ' ' GLU . 15.1 mm -42.64 -55.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.83 -67.62 0.25 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.78 68.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.47 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.92 -37.76 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.558 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -56.32 23.57 Favored 'General case' 0 C--O 1.209 -1.055 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -45.6 -41.07 9.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.089 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.789 HG22 ' HB3' ' A' ' 21' ' ' MET . 6.2 t -65.26 -62.97 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.181 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.973 0.416 . . . . 0.0 110.617 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ttt . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.735 0.302 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.605 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 3.1 mm-40 -95.28 164.58 12.78 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.525 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.7 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 2.3 pt20 -161.78 152.77 18.05 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.777 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.494 ' HB3' ' CE1' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -160.87 122.61 3.03 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.986 0.422 . . . . 0.0 111.967 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.7 p -90.71 155.06 19.1 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.994 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 4' ' ' GLN . 87.4 m-85 -143.45 -179.92 6.72 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 122.009 0.909 . . . . 0.0 112.814 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 7' ' ' THR . 11.8 t -152.06 95.8 2.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.606 -1.633 . . . . 0.0 106.833 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.622 HG22 ' H ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -93.4 179.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.721 -175.781 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.622 ' H ' HG22 ' A' ' 8' ' ' ILE . 1.6 pp -148.5 27.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.665 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.34 78.13 1.01 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.98 0.419 . . . . 0.0 110.343 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.645 ' HG3' ' HB2' ' A' ' 57' ' ' LYS . 1.8 mp0 -54.06 -22.72 11.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.788 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -41.27 37.85 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.75 85.97 0.09 OUTLIER Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.773 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.429 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER 69.17 145.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.134 0.492 . . . . 0.0 111.795 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -171.56 -63.65 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.605 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.678 ' C ' ' HD2' ' A' ' 18' ' ' PRO . . . -178.06 163.51 1.74 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.799 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.538 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 98.51 -60.49 0.0 OUTLIER Pre-proline 0 C--N 1.364 1.229 0 CA-C-N 118.934 0.788 . . . . 0.0 112.743 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.678 ' HD2' ' C ' ' A' ' 16' ' ' ALA . 56.5 Cg_endo -70.65 -27.77 21.79 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.804 1.669 . . . . 0.0 112.471 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.615 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.47 -65.61 0.66 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.695 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.6 m -55.02 -32.98 62.25 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.704 0.288 . . . . 0.0 110.51 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.564 ' HE3' HG22 ' A' ' 80' ' ' VAL . 21.1 mtm -64.83 -53.78 41.37 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.408 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.769 HD11 ' CD2' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -57.98 -37.38 74.11 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.19 179.436 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 19' ' ' ALA . 62.3 t -54.1 -60.16 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -49.65 64.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.431 ' O ' ' CD2' ' A' ' 29' ' ' PHE . 73.5 p -58.13 -58.96 6.13 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.389 0.086 . . . . 0.0 111.051 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.59 85.69 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.744 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.5 t -59.37 -33.07 70.73 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -66.49 -51.4 57.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.602 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.613 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 13.9 m-85 -66.33 -40.78 90.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.509 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 78.36 -20.41 0.39 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.593 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.539 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 93.2 p -66.52 140.09 57.97 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.623 0.725 . . . . 0.0 112.415 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.57 112.84 19.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.112 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.696 HG13 ' HB2' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -97.73 121.38 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.677 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.674 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 4.8 pt20 -101.61 107.41 18.67 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.987 HD13 ' HG ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -99.63 116.25 31.31 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.085 -179.364 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.697 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -93.91 172.23 8.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 125.973 2.046 . . . . 0.0 110.736 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.559 ' CD1' HD11 ' A' ' 53' ' ' LEU . 13.0 t80 -125.4 166.82 15.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.092 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.562 ' HB3' ' CG ' ' A' ' 60' ' ' GLU . 0.7 OUTLIER -53.58 -14.98 0.96 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.82 46.69 0.51 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.102 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HE3' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -173.04 -177.36 1.57 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.798 0.333 . . . . 0.0 111.244 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.697 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 3.0 tmtm? -158.12 117.76 3.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.802 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 m -152.3 -172.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.095 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -86.59 142.67 28.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.987 ' HG ' HD13 ' A' ' 35' ' ' LEU . 4.2 tt -68.68 58.45 0.09 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -41.9 71.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.731 ' HA ' HG22 ' A' ' 50' ' ' VAL . 1.0 OUTLIER 71.27 -51.99 0.69 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.425 0.631 . . . . 0.0 111.897 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -53.06 -27.28 13.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.316 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.562 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 12.8 mtp -167.3 -39.07 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.76 -56.1 12.57 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.17 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.731 HG22 ' HA ' ' A' ' 46' ' ' SER . 18.6 m -68.05 -50.26 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.562 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -59.48 -40.14 85.97 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.375 0.131 . . . . 0.0 111.3 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -57.21 -51.54 68.92 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.625 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.559 HD11 ' CD1' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -66.97 -35.09 79.2 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.07 179.561 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.415 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . 128.69 126.52 2.87 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.711 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 51' ' ' MET . 44.1 t -127.1 107.57 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.591 0.234 . . . . 0.0 111.127 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.0 174.09 18.3 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.513 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.645 ' HB2' ' HG3' ' A' ' 11' ' ' GLU . 15.1 tttt -70.06 136.39 50.26 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.582 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 86.2 5.2 0.42 Allowed 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.651 0.594 . . . . 0.0 111.061 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.86 119.13 7.13 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.562 ' CG ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -94.81 145.74 24.67 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.459 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.578 HD13 HD11 ' A' ' 8' ' ' ILE . 5.5 pt -147.48 175.65 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.573 ' C ' HD13 ' A' ' 63' ' ' ILE . 4.2 m -151.86 107.03 3.28 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.767 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.76 ' N ' HD13 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -96.05 152.3 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.114 -177.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.7 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 51.9 m-85 -146.26 110.24 4.95 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.66 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.696 ' HB2' HG13 ' A' ' 33' ' ' ILE . . . -93.47 126.51 38.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.025 0.441 . . . . 0.0 110.705 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -125.8 94.68 4.18 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.109 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.539 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . 179.88 -159.17 23.38 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.067 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.2 p -69.95 -60.97 1.97 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.104 0.952 . . . . 0.0 111.605 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.582 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 4.2 m-20 -91.79 45.26 1.21 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.849 0.357 . . . . 0.0 110.824 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.605 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 9.5 pt-20 -67.1 -22.53 65.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.12 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.568 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -88.63 -45.58 9.74 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -38.64 67.33 Favored 'General case' 0 C--N 1.342 0.281 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.613 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -52.34 -56.88 11.95 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.49 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.0 mm -44.82 -45.64 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.791 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.73 -70.76 0.15 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.86 -32.49 65.88 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.12 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 73' ' ' ALA . 11.0 mm -62.43 -36.55 75.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -51.78 68.36 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -46.11 -42.85 14.25 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.743 0.652 . . . . 0.0 109.923 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.564 HG22 ' HE3' ' A' ' 21' ' ' MET . 2.4 t -61.14 -57.79 10.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.152 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.679 0.276 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.597 ' CG ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -101.5 160.04 14.77 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.601 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.734 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -150.31 149.86 30.69 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.684 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.83 162.43 32.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.366 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.446 ' HB3' HG23 ' A' ' 62' ' ' THR . 30.6 p -154.17 148.16 25.64 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.745 0.307 . . . . 0.0 111.527 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -144.01 -176.9 5.18 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.415 0.626 . . . . 0.0 111.329 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 7' ' ' THR . 15.3 t -153.53 113.31 3.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.76 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.532 HG22 ' H ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER -136.65 -172.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.245 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 58' ' ' ASP . 21.4 pt -137.24 -40.69 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.489 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 12' ' ' THR . 36.3 t70 46.27 22.41 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 10' ' ' ASP . 20.5 mm-40 25.25 41.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.743 0.817 . . . . 0.0 112.325 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.84 HG21 ' HB3' ' A' ' 15' ' ' HIS . 2.8 m -176.4 -37.09 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.833 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.88 -75.06 1.45 Allowed Glycine 0 C--N 1.347 1.186 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.773 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.635 ' CG2' ' HB2' ' A' ' 19' ' ' ALA . 18.2 mm -139.54 81.94 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.848 0.356 . . . . 0.0 110.063 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.84 ' HB3' HG21 ' A' ' 12' ' ' THR . 10.4 p80 -66.27 -52.56 46.38 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.054 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -178.42 -35.39 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.577 ' HD2' ' HG3' ' A' ' 21' ' ' MET . 3.2 tmm_? -71.47 -53.54 7.57 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 10.0 Cg_endo -52.52 -45.18 41.75 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.541 2.161 . . . . 0.0 112.765 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.635 ' HB2' ' CG2' ' A' ' 14' ' ' ILE . . . -64.36 -64.7 0.81 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.2 m -52.9 -32.14 43.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.374 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.577 ' HG3' ' HD2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -66.1 -49.27 68.13 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.972 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.94 HD22 HD22 ' A' ' 44' ' ' LEU . 3.8 mt -55.75 -38.91 70.45 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.919 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.407 ' O ' ' CB ' ' A' ' 27' ' ' SER . 58.3 t -57.45 -65.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.422 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -45.68 84.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.596 HG22 ' HE2' ' A' ' 29' ' ' PHE . 95.0 m -57.15 -62.35 1.82 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.441 0.163 . . . . 0.0 110.783 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.38 -46.49 88.53 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.636 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 33.0 t -59.01 -29.64 67.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.595 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 25' ' ' THR . 17.4 mtmm -64.18 -52.78 57.29 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.696 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 38.4 m-85 -64.52 -36.5 84.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.047 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 82.44 -16.19 0.62 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.216 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.749 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 86.4 p -66.94 135.13 53.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.459 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.97 110.31 9.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.228 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.063 ' CG2' HG23 ' A' ' 63' ' ' ILE . 4.1 mt -98.64 126.59 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.613 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.637 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 3.6 pt20 -98.18 105.44 17.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 6.2 tt -96.63 112.47 24.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.313 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.796 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -95.16 175.84 6.46 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 125.904 2.003 . . . . 0.0 112.471 -178.631 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -129.12 163.12 26.18 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.494 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 0.7 OUTLIER -55.02 -11.36 0.64 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.66 48.18 0.51 Allowed Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.72 -179.19 0.61 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.714 0.292 . . . . 0.0 110.983 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.796 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -159.18 119.94 3.22 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.493 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.4 m -153.34 -172.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.708 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 45' ' ' LYS . 27.3 t-20 -89.26 148.73 23.42 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.94 HD22 HD22 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -62.92 50.97 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 177.128 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 43' ' ' ASN . 4.0 mptt -59.34 -41.23 88.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.64 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.12 -52.17 0.7 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.449 0.643 . . . . 0.0 111.737 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.03 -24.15 14.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.774 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.1 mtm -167.27 -39.29 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.246 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -50.12 -49.32 37.22 Favored Glycine 0 C--N 1.34 0.788 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.113 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.64 HG22 ' HA ' ' A' ' 46' ' ' SER . 16.7 m -71.49 -36.3 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.811 0.305 . . . . 0.0 110.559 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 56.3 mtt -59.72 -46.76 88.12 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.464 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.7 p -58.78 -49.82 76.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.934 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.479 HD21 ' HA ' ' A' ' 50' ' ' VAL . 1.1 pp -66.96 -12.73 60.56 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.31 109.8 0.06 OUTLIER Glycine 0 C--N 1.34 0.762 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.927 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 t -107.12 59.82 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.989 0.424 . . . . 0.0 110.924 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.87 -156.96 24.42 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.788 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 3.7 tttt -74.28 126.13 29.95 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.618 ' H ' HG22 ' A' ' 9' ' ' ILE . 0.2 OUTLIER 85.28 13.38 0.21 Allowed 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.822 0.701 . . . . 0.0 110.69 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.64 117.38 4.87 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.779 0.323 . . . . 0.0 111.425 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 1.5 tt0 -99.88 139.71 35.15 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.639 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.35 167.71 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.768 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 5' ' ' SER . 18.7 m -151.21 114.74 4.87 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.48 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.063 HG23 ' CG2' ' A' ' 33' ' ' ILE . 3.2 mp -99.58 133.6 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.19 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.734 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 50.6 m-85 -129.91 104.24 7.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.362 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.747 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -95.0 132.07 40.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.176 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.45 78.17 1.5 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.055 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.749 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -164.95 20.8 0.12 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.712 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 67' ' ' GLY . 59.5 p 121.96 -81.94 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.256 1.022 . . . . 0.0 111.914 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.696 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 8.0 m-20 -87.2 46.22 1.35 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.439 0.638 . . . . 0.0 109.997 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -70.5 -21.43 62.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.267 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.96 -51.75 6.17 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -34.52 62.54 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.199 178.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.641 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.75 -63.78 1.04 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.171 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.597 HG12 ' CG ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -48.08 -41.51 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -59.1 -69.33 0.2 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.641 0.258 . . . . 0.0 111.234 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.97 67.79 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.472 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.4 mm -60.26 -38.74 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.152 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.78 -57.9 10.45 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -44.47 -39.8 5.07 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.762 0.664 . . . . 0.0 110.525 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.503 HG22 ' SD ' ' A' ' 21' ' ' MET . 3.3 t -64.17 -60.84 2.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.605 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.426 HD23 HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 110.62 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.725 0.298 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.609 ' HG3' ' N ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -100.39 164.07 12.09 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.57 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.713 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -155.41 159.11 39.61 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.473 ' HG3' HG23 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -156.41 174.39 15.48 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.495 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.7 p -153.03 146.85 25.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.005 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -138.45 -175.43 4.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.864 0.84 . . . . 0.0 113.19 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 7' ' ' THR . 6.7 t -150.31 74.8 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.917 -1.492 . . . . 0.0 107.685 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.457 HD12 ' CG1' ' A' ' 55' ' ' VAL . 73.0 mt -51.02 160.04 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 113.764 -1.562 . . . . 0.0 113.298 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 pp -151.09 4.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 4.4 t70 -74.13 15.54 0.31 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 8.1 mp0 72.1 -63.25 0.43 Allowed 'General case' 0 C--O 1.231 0.124 0 C-N-CA 122.915 0.486 . . . . 0.0 110.422 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 m -85.7 -25.5 26.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.58 -81.09 1.38 Allowed Glycine 0 C--N 1.343 0.963 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.735 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.729 HG23 ' O ' ' A' ' 14' ' ' ILE . 1.1 tp -103.98 62.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.887 0.851 . . . . 0.0 110.548 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -61.34 -52.58 64.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.854 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.56 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -70.33 -57.09 6.1 Favored Pre-proline 0 CA--C 1.53 0.184 0 N-CA-C 110.696 -0.113 . . . . 0.0 110.696 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HG2' ' HA ' ' A' ' 14' ' ' ILE . 32.4 Cg_endo -63.18 -31.23 74.98 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.167 1.912 . . . . 0.0 111.925 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.593 ' HB2' HG13 ' A' ' 14' ' ' ILE . . . -63.62 -64.9 0.77 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.22 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.2 p -53.62 -31.9 49.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.004 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.469 ' HB3' HG21 ' A' ' 80' ' ' VAL . 1.5 mmt -65.64 -52.7 49.81 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.71 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.558 HD13 ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -56.78 -37.63 71.39 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 179.326 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 19' ' ' ALA . 57.6 t -55.29 -57.07 8.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.427 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.9 tt0 -66.24 -55.96 13.63 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.937 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.434 ' OG1' ' HA ' ' A' ' 22' ' ' LEU . 54.1 p -53.48 -57.77 9.5 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.917 -0.129 . . . . 0.0 111.299 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.51 -46.62 86.36 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 7.7 m -59.26 -34.7 72.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.057 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 25' ' ' THR . 37.1 mtmt -65.39 -49.96 67.31 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.643 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 19.5 m-85 -64.82 -37.31 87.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.29 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 76.49 -13.35 0.93 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.868 -1.515 . . . . 0.0 112.184 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.483 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 92.6 p -67.97 139.89 56.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.483 0.659 . . . . 0.0 112.179 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.73 107.94 12.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.258 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.684 ' CG1' ' HB2' ' A' ' 65' ' ' ALA . 1.0 OUTLIER -97.84 126.0 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.285 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.754 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 4.7 pt20 -105.87 106.86 17.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.014 HD13 HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -101.22 121.11 41.28 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.881 -178.605 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.743 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -96.35 172.96 7.62 Favored 'General case' 0 C--N 1.341 0.217 0 O-C-N 126.211 2.194 . . . . 0.0 109.911 179.041 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.589 ' O ' ' N ' ' A' ' 39' ' ' GLY . 2.1 t80 -146.7 100.92 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.829 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.424 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER 49.6 -59.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 37' ' ' TYR . . . -143.17 37.26 1.51 Allowed Glycine 0 C--N 1.317 -0.515 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -142.65 174.19 10.87 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.743 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -155.19 117.44 4.19 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.081 0.467 . . . . 0.0 111.561 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.715 HG21 HD21 ' A' ' 53' ' ' LEU . 19.9 m -152.37 -176.81 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.971 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -83.51 139.42 32.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.014 HD13 HD13 ' A' ' 35' ' ' LEU . 1.5 tp -67.62 55.62 0.06 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.715 0.293 . . . . 0.0 110.709 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -71.73 -4.46 27.72 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.558 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . 81.4 p 38.59 47.5 1.13 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 46' ' ' SER . 38.1 mm -166.43 -95.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.537 0.735 . . . . 0.0 109.217 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.481 ' N ' HG22 ' A' ' 47' ' ' ILE . 34.1 mmt -68.09 -51.32 47.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.32 -81.35 0.07 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.671 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.417 HG23 HG21 ' A' ' 55' ' ' VAL . 7.2 p -37.55 -43.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.412 ' N ' HG13 ' A' ' 50' ' ' VAL . 1.8 mmt -61.99 -48.86 78.46 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.1 t -53.23 -51.46 62.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.062 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.715 HD21 HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -66.25 -35.39 80.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.004 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.32 108.36 1.89 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.529 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.491 HG13 ' CB ' ' A' ' 59' ' ' ALA . 57.8 t -139.27 82.39 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.02 -139.74 10.74 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.454 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.602 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 13.8 tttt -73.75 131.88 42.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.602 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 84.6 -5.19 1.0 Allowed 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.7 0.625 . . . . 0.0 111.511 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.491 ' CB ' HG13 ' A' ' 55' ' ' VAL . . . -62.72 125.02 22.53 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.722 0.296 . . . . 0.0 111.492 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.98 142.63 27.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.42 172.34 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.772 ' C ' HD13 ' A' ' 63' ' ' ILE . 6.6 m -150.57 115.15 5.2 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.151 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.872 ' N ' HD13 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -100.46 147.62 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.403 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.754 ' HB2' ' HG3' ' A' ' 34' ' ' GLN . 45.3 m-85 -143.09 107.54 4.8 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.899 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.684 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -93.31 131.08 38.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.116 0.484 . . . . 0.0 111.346 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.54 83.41 2.16 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.96 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.483 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -166.72 -154.48 8.4 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.649 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 p -76.28 -55.81 5.22 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.866 0.833 . . . . 0.0 111.893 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.643 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 2.8 m-20 -92.62 40.86 1.06 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.568 0.223 . . . . 0.0 111.224 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 4.9 pt-20 -67.17 -18.77 65.41 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.6 -54.81 3.99 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.89 -34.18 62.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.638 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.55 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -51.74 -62.63 1.5 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.176 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.592 HG12 ' CG ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -49.79 -46.08 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -57.76 -67.92 0.29 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.629 0.252 . . . . 0.0 111.462 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.44 -37.63 67.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.033 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.4 mm -60.85 -39.27 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.463 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.0 -54.76 43.06 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -46.05 -41.62 12.32 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 109.945 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 21' ' ' MET . 3.4 t -65.19 -61.02 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.007 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.0 mt . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 121.037 0.446 . . . . 0.0 110.559 179.146 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.765 0.317 . . . . 0.0 111.394 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.637 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 7.2 mm-40 -97.59 169.62 9.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.725 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -164.34 153.38 13.41 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.018 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -161.94 121.94 2.51 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.008 0.432 . . . . 0.0 112.009 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.7 p -89.73 153.56 20.6 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.765 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 92.2 m-85 -142.2 -176.88 4.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.697 0.76 . . . . 0.0 112.76 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 7' ' ' THR . 5.5 t -149.18 87.43 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.136 -1.393 . . . . 0.0 107.913 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 9' ' ' ILE . 36.0 mt -73.87 169.06 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.751 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 1.9 pp -140.11 -26.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.833 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -69.15 82.16 0.34 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.235 0.54 . . . . 0.0 110.502 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.506 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 1.2 pm0 -56.96 -7.91 0.54 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.76 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.7 m -78.7 -30.18 45.88 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.55 -164.66 18.94 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.758 -0.735 . . . . 0.0 113.219 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.8 HG23 ' HB2' ' A' ' 18' ' ' PRO . 23.4 mt -77.02 86.94 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.736 0.303 . . . . 0.0 110.67 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -69.98 -163.98 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.88 -32.95 68.19 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.474 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -74.22 -61.06 1.3 Allowed Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.8 ' HB2' HG23 ' A' ' 14' ' ' ILE . 29.6 Cg_endo -62.56 -31.24 79.96 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.327 2.018 . . . . 0.0 112.613 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.578 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.45 -63.19 1.25 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.085 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.6 m -52.72 -33.18 46.65 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.683 0.278 . . . . 0.0 110.719 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -55.61 17.46 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.696 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.49 ' CD2' HD21 ' A' ' 44' ' ' LEU . 1.1 mt -57.3 -38.97 74.8 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.316 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 19' ' ' ALA . 63.9 t -53.84 -57.89 4.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.1 tt0 -66.84 -55.47 14.64 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.413 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 76.7 p -53.35 -59.44 4.57 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.039 0.212 . . . . 0.0 111.385 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.6 -48.04 82.28 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 122.944 0.152 . . . . 0.0 111.039 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.8 t -60.53 -31.2 70.29 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.649 0.261 . . . . 0.0 111.298 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -68.11 -50.43 54.83 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.601 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 10.6 m-85 -64.92 -42.58 94.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.911 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.32 -11.72 0.78 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.241 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.428 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 99.8 p -68.05 145.37 54.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.453 0.644 . . . . 0.0 112.45 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.95 108.94 15.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.209 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.755 HG23 HG22 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -98.6 123.21 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.175 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.707 ' CG ' ' HB2' ' A' ' 64' ' ' TYR . 4.5 pt20 -98.56 106.05 18.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.632 HD22 HG22 ' A' ' 50' ' ' VAL . 5.5 tt -98.69 115.66 29.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.485 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.782 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -94.65 172.82 7.94 Favored 'General case' 0 C--N 1.34 0.179 0 O-C-N 126.07 2.106 . . . . 0.0 111.653 -179.349 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -126.17 165.27 19.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.637 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.49 ' HB3' ' HG3' ' A' ' 60' ' ' GLU . 1.3 p-10 -53.33 -14.1 0.67 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.49 49.4 0.48 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.05 178.65 1.72 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.704 0.287 . . . . 0.0 111.006 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.782 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -159.77 115.59 2.45 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.367 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.9 m -153.34 -175.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.05 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.231 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -85.21 141.18 30.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.818 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -65.31 52.7 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 121.907 0.86 . . . . 0.0 111.552 177.356 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.437 ' HG2' HD12 ' A' ' 47' ' ' ILE . 37.2 tttt -63.35 -34.47 77.78 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.75 ' HA ' ' HB ' ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.77 -50.62 0.7 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.283 0.563 . . . . 0.0 111.92 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.437 HD12 ' HG2' ' A' ' 45' ' ' LYS . 5.9 mt -53.84 -22.93 7.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.108 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.547 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -169.45 -39.98 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.974 -178.215 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.91 -56.06 27.18 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.879 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.75 ' HB ' ' HA ' ' A' ' 46' ' ' SER . 5.3 t -69.08 -45.95 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.657 0.228 . . . . 0.0 111.332 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.547 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -60.23 -36.92 78.82 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.721 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.0 t -60.27 -51.72 68.33 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.041 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -64.75 -11.33 35.17 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.92 119.65 0.1 OUTLIER Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.803 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.457 HG21 ' CG1' ' A' ' 50' ' ' VAL . 20.0 t -117.03 63.88 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.996 0.427 . . . . 0.0 111.378 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 11' ' ' GLU . . . -80.92 -166.78 36.32 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.057 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -75.86 125.63 29.45 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 89.01 7.05 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.879 0.737 . . . . 0.0 111.089 -178.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.63 117.73 5.69 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-O 120.513 0.197 . . . . 0.0 111.133 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.49 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -94.29 142.44 27.41 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.77 HD12 HD11 ' A' ' 63' ' ' ILE . 22.1 pt -143.11 175.12 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.766 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.592 ' C ' HD13 ' A' ' 63' ' ' ILE . 6.0 m -151.67 104.87 3.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.702 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.77 HD11 HD12 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -96.49 151.01 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.725 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 22.7 m-85 -146.45 110.98 5.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.515 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.674 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -93.48 127.62 39.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.24 0.543 . . . . 0.0 111.187 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.89 89.15 3.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.756 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -174.02 -153.68 10.05 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.601 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.6 p -75.59 -58.08 3.5 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.714 0.757 . . . . 0.0 111.767 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.587 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 3.2 m-20 -91.87 42.7 1.11 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.865 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.606 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 5.9 pt-20 -67.45 -22.26 65.51 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.637 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -89.05 -48.64 7.27 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.06 -37.66 64.41 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.601 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.68 -57.04 12.23 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.715 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.8 mm -49.61 -49.06 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.93 -67.48 0.36 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.79 -34.16 67.37 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.537 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' A' ' 80' ' ' VAL . 9.6 mm -62.29 -37.43 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -51.86 68.07 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -47.88 -40.55 21.98 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 123.607 0.567 . . . . 0.0 110.004 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 77' ' ' ILE . 2.5 t -62.09 -57.42 12.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.08 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.444 ' CD2' HG12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 120.96 0.409 . . . . 0.0 110.076 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 ttm . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.703 0.287 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.623 ' CD ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -96.11 163.58 13.05 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.308 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.638 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.9 OUTLIER -153.66 152.5 30.9 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 62' ' ' THR . 2.3 tp60 -159.55 165.57 32.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.297 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.5 p -153.87 141.07 19.51 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.82 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.29 -161.98 1.3 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.7 m -153.98 106.88 2.88 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.66 HG22 ' H ' ' A' ' 9' ' ' ILE . 1.7 mt -102.18 -171.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.736 -176.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.66 ' H ' HG22 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -144.93 10.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.63 83.97 1.57 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.12 -23.92 2.43 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.794 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -82.82 -36.97 25.07 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . 73.31 95.38 0.1 OUTLIER Glycine 0 C--N 1.344 0.995 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.911 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.416 HG13 ' CA ' ' A' ' 46' ' ' SER . 31.0 mm 67.84 125.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.897 0.379 . . . . 0.0 111.32 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -167.99 128.11 1.33 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.72 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 18' ' ' PRO . . . 43.95 -161.8 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 119.144 -0.455 . . . . 0.0 111.325 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.62 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER 15.51 -77.01 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.62 ' CD ' ' HB3' ' A' ' 17' ' ' ARG . 10.1 Cg_endo -50.34 -42.48 47.67 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.594 2.863 . . . . 0.0 113.509 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.35 -63.97 1.11 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.419 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.5 m -54.82 -31.75 59.59 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.579 ' HB3' HG22 ' A' ' 80' ' ' VAL . 27.7 mtm -64.93 -51.85 59.6 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.692 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.67 ' HG ' HG11 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -56.65 -36.98 70.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.082 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.62 -60.59 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -66.47 -51.17 59.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.399 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.528 HG22 ' HE2' ' A' ' 29' ' ' PHE . 70.7 m -51.93 -60.24 3.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.275 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.9 -48.24 81.35 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.949 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.0 t -58.56 -28.79 65.85 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.542 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -66.13 -49.8 66.21 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.671 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 14.1 m-85 -64.62 -40.94 96.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.998 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.43 -9.44 1.4 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.434 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.0 p -66.72 154.7 40.02 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.64 140.64 46.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.916 HD13 HD22 ' A' ' 44' ' ' LEU . 5.1 tt -146.96 114.1 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.181 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.648 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 17.9 pm0 -104.35 128.86 52.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.456 0.646 . . . . 0.0 110.37 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.741 HD12 HD12 ' A' ' 44' ' ' LEU . 5.8 tt -113.97 121.94 45.43 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.733 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -100.56 177.83 4.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 125.733 1.896 . . . . 0.0 111.494 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.498 ' CD1' HD11 ' A' ' 53' ' ' LEU . 12.2 t80 -128.02 162.83 25.91 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.868 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -55.43 -12.49 1.11 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.531 179.644 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.7 46.92 0.51 Allowed Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.41 -177.68 1.05 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.757 0.313 . . . . 0.0 110.919 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.733 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 4.9 tmtm? -159.05 122.79 3.84 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 m -152.24 -174.75 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.025 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 45' ' ' LYS . 7.6 t30 -84.11 145.09 28.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.916 HD22 HD13 ' A' ' 33' ' ' ILE . 1.3 tt -67.66 58.55 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HB2' ' HA3' ' A' ' 49' ' ' GLY . 4.5 mtpm? -69.31 -49.44 55.78 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.658 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER 73.78 -54.1 0.68 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.352 -178.763 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.18 -25.58 13.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.289 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.594 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -169.78 -39.02 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -178.053 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -48.68 -56.03 10.32 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.139 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.739 HG12 HD22 ' A' ' 35' ' ' LEU . 32.0 m -68.57 -50.25 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.594 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -60.22 -40.95 91.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.3 p -58.43 -48.39 80.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.941 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.573 HD23 ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -66.09 -34.56 78.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.921 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.79 126.22 3.08 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.975 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.524 HG23 ' HA ' ' A' ' 51' ' ' MET . 2.9 t -129.13 84.16 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.571 0.224 . . . . 0.0 110.953 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.47 176.86 48.44 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 4.7 tttm -71.95 131.08 42.46 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.603 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 85.07 12.06 0.26 Allowed 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.671 0.607 . . . . 0.0 110.467 -178.546 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.97 121.59 12.2 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.321 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 2.8 tt0 -93.9 143.39 26.38 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.608 HD12 HD11 ' A' ' 63' ' ' ILE . 19.2 pt -146.14 172.82 3.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.49 ' C ' HD12 ' A' ' 63' ' ' ILE . 4.4 m -148.13 109.47 4.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.858 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.782 ' CG2' HD11 ' A' ' 33' ' ' ILE . 1.3 mp -96.16 142.04 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.707 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.648 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 84.0 m-85 -132.24 116.21 16.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.784 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.8 127.78 48.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.023 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -133.25 103.95 6.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.005 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.56 -155.53 26.54 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.765 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.2 p -69.18 -61.09 1.94 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 117.282 0.541 . . . . 0.0 111.659 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.9 m-20 -92.2 37.92 0.99 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.544 0.211 . . . . 0.0 111.252 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.03 -22.45 66.98 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.35 -55.07 3.96 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.29 -34.6 66.62 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.461 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -50.28 -58.88 4.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.24 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.623 HG12 ' CD ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -43.48 -51.02 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 123.218 0.324 . . . . 0.0 111.872 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -54.71 -68.7 0.16 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.83 71.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.454 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 73' ' ' ALA . 13.1 mm -62.09 -38.64 81.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.652 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -57.68 11.56 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -44.16 -41.94 6.04 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.576 0.547 . . . . 0.0 110.288 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.67 HG11 ' HG ' ' A' ' 22' ' ' LEU . 3.8 t -62.91 -63.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.67 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 121.066 0.46 . . . . 0.0 110.763 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptp . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.638 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 2.4 mm-40 -95.3 165.34 12.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.703 0.287 . . . . 0.0 110.812 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.713 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 2.2 pt20 -163.65 156.38 18.12 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -163.15 118.95 1.76 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.032 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 60.3 p -89.31 152.34 21.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.918 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 59.4 m-85 -142.96 -179.89 6.63 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.899 0.857 . . . . 0.0 112.877 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 7' ' ' THR . 9.7 t -152.88 96.47 2.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.022 -1.444 . . . . 0.0 107.976 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.738 HG22 ' H ' ' A' ' 9' ' ' ILE . 1.7 mt -96.29 -168.97 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.043 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.738 ' H ' HG22 ' A' ' 8' ' ' ILE . 2.7 pp -145.86 15.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 122.314 0.246 . . . . 0.0 111.612 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.502 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 12.0 t0 -75.86 80.98 2.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.625 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -52.4 -22.39 4.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.478 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -37.98 23.21 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.11 -166.25 19.97 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.757 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.672 HD12 HG11 ' A' ' 50' ' ' VAL . 60.5 mt -69.42 81.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.006 0.432 . . . . 0.0 110.815 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.537 ' CE1' ' HB3' ' A' ' 17' ' ' ARG . 14.3 p80 -70.78 -162.16 0.06 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.261 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.51 -28.72 67.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.648 ' CZ ' HD21 ' A' ' 86' ' ' LEU . 31.1 ttp180 -74.94 -62.0 0.95 Allowed Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.665 ' HB2' HG23 ' A' ' 14' ' ' ILE . 36.0 Cg_endo -64.49 -33.34 57.44 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.306 2.004 . . . . 0.0 112.888 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -62.9 -63.21 1.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.883 -0.144 . . . . 0.0 111.062 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.1 m -54.29 -31.85 54.89 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.698 0.285 . . . . 0.0 110.719 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.744 ' HB3' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -64.27 -54.57 31.18 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.596 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.558 HD22 HD13 ' A' ' 44' ' ' LEU . 1.2 mt -58.74 -35.7 73.14 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 19' ' ' ALA . 62.6 t -54.45 -62.24 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.92 -51.51 61.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.747 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.504 HG22 ' HE2' ' A' ' 29' ' ' PHE . 97.0 m -52.73 -61.37 2.33 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.105 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.31 -47.75 84.67 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.102 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.2 p -59.82 -29.02 67.96 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' THR . 3.7 mtpm? -63.43 -54.28 39.02 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.672 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 28.3 m-85 -65.65 -37.68 87.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.125 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 84.07 -20.26 0.32 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.533 -1.667 . . . . 0.0 112.275 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 68' ' ' SER . 81.6 p -67.73 143.19 56.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.475 0.655 . . . . 0.0 112.399 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.34 114.84 18.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.521 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.776 HG21 HD21 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -100.89 114.28 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.851 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.702 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 14.9 pm0 -90.3 107.19 18.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 122.089 0.947 . . . . 0.0 109.318 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.651 HD13 ' HB3' ' A' ' 44' ' ' LEU . 4.5 tt -97.09 114.09 25.72 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.777 -1.556 . . . . 0.0 108.831 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.779 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -92.96 174.77 7.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 125.936 2.022 . . . . 0.0 111.641 -179.102 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 28.9 t80 -133.22 165.05 25.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.714 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.506 ' HB3' ' CG ' ' A' ' 60' ' ' GLU . 1.2 p-10 -53.22 -14.74 0.74 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.642 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.32 49.27 0.5 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.32 172.52 3.21 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.515 0.197 . . . . 0.0 110.675 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.779 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -160.29 109.65 1.75 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -155.02 -178.18 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.262 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . 4.9 t30 -83.77 136.94 33.96 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.776 HD21 HG21 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -68.81 58.08 0.09 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.076 0.398 . . . . 0.0 111.051 177.555 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' A' ' 43' ' ' ASN . 1.4 ttmt -65.78 -14.9 62.26 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.665 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.7 OUTLIER 69.3 -49.01 0.6 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.1 mt -52.77 -26.26 10.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.382 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.81 -39.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.86 -52.92 24.13 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.479 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.672 HG11 HD12 ' A' ' 14' ' ' ILE . 15.2 m -67.06 -35.89 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.932 0.366 . . . . 0.0 110.728 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 63.9 mtt -59.87 -48.04 83.32 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.668 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 p -57.68 -51.48 69.36 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.975 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -67.26 -19.19 65.47 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.03 102.41 0.01 OUTLIER Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.951 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 t -100.79 56.84 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.841 0.353 . . . . 0.0 111.106 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.35 -160.46 8.56 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.763 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 1.7 tttm -73.95 134.91 43.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER 76.9 9.61 2.78 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.542 0.526 . . . . 0.0 110.691 -178.631 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.16 119.61 8.73 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.506 ' CG ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -95.4 135.85 36.5 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.468 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' CD1' HD22 ' A' ' 81' ' ' LEU . 5.8 pt -138.71 172.88 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.394 0.616 . . . . 0.0 112.385 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.711 HG22 ' CE1' ' A' ' 64' ' ' TYR . 7.2 m -151.71 102.54 2.86 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.285 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.844 ' N ' HD13 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -94.0 149.14 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.315 -177.053 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.713 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 38.2 m-85 -146.82 114.19 6.3 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.297 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.647 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -95.38 126.38 40.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.812 0.339 . . . . 0.0 110.579 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -139.88 92.47 2.56 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.925 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.97 -80.01 0.04 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.439 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 31' ' ' SER . 0.2 OUTLIER -143.52 -68.74 0.33 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.254 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 5.5 m-20 -89.86 51.53 2.09 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -69.92 -23.76 63.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.968 -178.029 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.638 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -86.84 -53.26 5.01 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.604 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.05 -36.69 60.88 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.672 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.86 -54.96 31.31 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.897 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.6 mm -43.31 -51.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.928 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -57.59 -68.88 0.2 Allowed 'General case' 0 C--O 1.239 0.538 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.05 -33.17 68.72 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.723 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.1 mm -62.88 -38.37 81.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.511 ' O ' ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -57.74 -60.23 4.01 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -42.0 -41.04 2.4 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.625 0.578 . . . . 0.0 110.47 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 21' ' ' MET . 7.9 t -65.65 -63.46 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.027 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -61.96 -28.05 69.27 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 110.969 179.299 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.511 ' HB3' ' O ' ' A' ' 78' ' ' THR . 1.4 p -63.47 -32.02 73.35 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.973 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.818 ' O ' HD23 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -58.45 -28.38 65.25 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.245 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.596 ' CB ' HG21 ' A' ' 8' ' ' ILE . 13.9 mt-10 -60.32 -34.77 74.27 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 122.481 0.312 . . . . 0.0 111.23 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.499 ' O ' HD11 ' A' ' 9' ' ' ILE . . . -73.13 -10.52 78.29 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.904 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.818 HD23 ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -81.89 9.31 8.38 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.993 0.396 . . . . 0.0 111.541 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 52.7 p -96.88 -96.17 0.2 Allowed 'General case' 0 CA--C 1.536 0.411 0 O-C-N 122.391 -0.193 . . . . 0.0 111.481 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.611 ' O ' HD13 ' A' ' 9' ' ' ILE . 27.3 tt0 . . . . . 0 C--O 1.253 1.242 0 CA-C-O 118.877 -0.583 . . . . 0.0 111.41 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ttt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.732 0.301 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.62 ' CD ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -94.04 164.21 13.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.425 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.583 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -160.94 152.26 19.06 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.329 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.07 133.18 5.87 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.771 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 3.0 t -89.97 157.66 17.74 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.944 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.628 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 4.9 m-85 -138.16 176.38 8.75 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.86 0.838 . . . . 0.0 112.251 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.4 m -145.8 75.52 1.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.492 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.645 HG21 ' CG1' ' A' ' 55' ' ' VAL . 48.2 mt -65.29 163.33 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.489 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.943 HD13 ' HB3' ' A' ' 88' ' ' GLU . 2.1 pp -136.04 -26.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.761 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.497 ' HB2' ' HG3' ' A' ' 84' ' ' GLU . 10.2 t0 -68.09 87.59 0.27 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.452 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -47.85 -27.54 2.14 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.35 -38.01 27.35 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 10' ' ' ASP . . . 88.56 -114.02 4.17 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.937 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.64 HD11 ' HA ' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -75.88 152.59 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.071 0.462 . . . . 0.0 111.855 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.56 ' CE1' ' HD3' ' A' ' 18' ' ' PRO . 24.9 p80 -170.54 -153.53 0.1 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.967 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.87 79.52 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.531 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -78.89 -55.18 0.99 Allowed Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.56 ' HD3' ' CE1' ' A' ' 15' ' ' HIS . 12.3 Cg_exo -62.69 -41.72 29.63 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.623 2.215 . . . . 0.0 113.122 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.73 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -58.08 -64.4 0.93 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -53.93 -33.23 56.13 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.776 0.322 . . . . 0.0 111.086 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.935 ' HB3' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -66.31 -62.47 1.46 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.513 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.506 HD13 ' HB3' ' A' ' 46' ' ' SER . 0.9 OUTLIER -58.67 -37.03 75.14 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 19' ' ' ALA . 70.7 t -53.51 -60.04 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.1 tt0 -66.49 -52.91 40.94 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.761 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.44 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 94.9 m -52.45 -58.93 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.464 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.45 -48.29 80.31 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.31 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -59.72 -28.36 67.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.726 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -66.11 -52.9 44.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.652 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 13.9 m-85 -66.68 -41.81 87.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.31 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 74.8 -7.28 1.76 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.53 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.6 p -66.13 152.35 44.94 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -73.95 140.22 45.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.821 HG23 ' HB3' ' A' ' 44' ' ' LEU . 3.4 tt -142.59 124.24 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-O 121.137 0.494 . . . . 0.0 111.455 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.696 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 9.8 pt20 -112.0 123.33 50.02 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-O 121.436 0.636 . . . . 0.0 110.217 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.737 HD12 HD12 ' A' ' 44' ' ' LEU . 2.1 tt -109.77 123.12 48.98 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.483 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.753 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -103.14 176.41 5.16 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 125.763 1.914 . . . . 0.0 111.585 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -127.16 162.65 25.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.567 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.47 -10.8 1.03 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.72 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.76 45.5 0.57 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.09 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.84 -177.71 0.65 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.661 0.267 . . . . 0.0 110.984 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.753 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 1.2 tmtp? -158.9 124.8 4.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.336 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.504 ' CG2' HD11 ' A' ' 53' ' ' LEU . 21.9 m -153.45 -173.74 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.269 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -85.75 143.76 28.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.821 ' HB3' HG23 ' A' ' 33' ' ' ILE . 1.1 tt -69.25 57.53 0.11 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -69.64 -38.86 77.31 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.698 ' HA ' HG22 ' A' ' 50' ' ' VAL . 2.5 p 70.9 -50.49 0.68 Allowed 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.724 0.64 . . . . 0.0 112.119 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.5 HD13 ' CD1' ' A' ' 14' ' ' ILE . 46.7 mm -53.44 -25.95 11.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.168 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.434 ' HA ' ' HB2' ' A' ' 51' ' ' MET . 14.4 mtp -166.64 -39.27 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.669 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.66 -52.09 26.0 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.979 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.698 HG22 ' HA ' ' A' ' 46' ' ' SER . 6.7 m -72.91 -37.98 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.592 0.196 . . . . 0.0 110.54 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.434 ' HB2' ' HA ' ' A' ' 48' ' ' MET . 0.6 OUTLIER -56.84 -53.19 60.67 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.308 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.5 p -58.02 -37.56 74.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.361 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.504 HD11 ' CG2' ' A' ' 42' ' ' VAL . 6.2 mt -60.9 -30.81 70.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.409 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.76 -42.57 1.87 Allowed Glycine 0 C--N 1.339 0.716 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.265 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 50' ' ' VAL . 72.4 t 35.9 63.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 11' ' ' GLU . . . -86.94 -172.52 48.37 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.109 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.737 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 5.9 tttt -76.11 126.28 30.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 86.45 11.19 0.19 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.885 0.741 . . . . 0.0 110.916 -178.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.92 121.56 13.27 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 120.736 0.303 . . . . 0.0 111.693 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.16 135.99 33.26 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.803 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.821 HD12 HD11 ' A' ' 63' ' ' ILE . 45.1 pt -147.0 176.64 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.14 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.577 ' C ' HD13 ' A' ' 63' ' ' ILE . 14.6 m -152.57 109.9 3.55 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.002 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.821 HD11 HD12 ' A' ' 61' ' ' ILE . 1.1 mm -94.25 154.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.481 -178.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.696 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 57.7 m-85 -141.16 117.61 10.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.539 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.3 129.89 46.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.872 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -134.5 96.05 3.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.138 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.49 -154.47 17.81 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.746 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.0 p -71.95 -59.2 2.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.158 0.479 . . . . 0.0 111.724 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.652 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.6 m-20 -93.47 36.59 1.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.423 0.154 . . . . 0.0 111.407 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.69 -22.36 66.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.91 -56.67 3.29 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.74 -30.34 65.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.738 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -50.18 -63.11 1.22 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.548 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.62 HG12 ' CD ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -43.75 -43.38 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.568 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -58.4 -71.72 0.11 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.778 0.323 . . . . 0.0 111.368 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.04 -33.36 67.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.503 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.16 -38.71 80.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.983 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 82' ' ' SER . 0.2 OUTLIER -57.34 -56.12 25.9 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -47.23 -42.71 20.88 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.148 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.935 HG22 ' HB3' ' A' ' 21' ' ' MET . 7.8 t -65.76 -63.38 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.461 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.486 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 6.9 mt -59.38 -39.37 83.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.856 0.36 . . . . 0.0 110.421 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 78' ' ' THR . 4.4 t -60.73 -26.87 67.5 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.52 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.641 ' O ' HD23 ' A' ' 86' ' ' LEU . 19.3 tptp -59.71 -32.82 70.88 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.416 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.497 ' HG3' ' HB2' ' A' ' 10' ' ' ASP . 9.2 pt-20 -63.75 -25.17 68.07 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.725 0.297 . . . . 0.0 110.472 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.743 ' HA2' HD11 ' A' ' 9' ' ' ILE . . . -63.11 -11.22 37.71 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.001 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 83' ' ' LYS . 2.3 pp -66.92 -3.41 6.94 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.0 p -94.46 -94.26 0.17 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 119.542 -0.266 . . . . 0.0 111.648 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.943 ' HB3' HD13 ' A' ' 9' ' ' ILE . 5.9 pt-20 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 117.836 -1.078 . . . . 0.0 111.78 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.813 0.339 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.646 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mm-40 -95.67 162.48 13.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.388 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.735 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.6 OUTLIER -166.2 152.93 9.39 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -164.83 121.91 1.57 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.629 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 p -89.65 150.71 22.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.807 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 41.8 m-85 -142.5 176.57 8.92 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.569 0.699 . . . . 0.0 111.815 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 7' ' ' THR . 14.8 t -153.48 111.96 3.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.173 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.515 HG21 ' N ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER -132.92 175.3 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -176.453 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.45 ' H ' HG22 ' A' ' 8' ' ' ILE . 2.1 pp -95.28 15.17 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.124 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.722 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 29.3 p-10 -69.48 78.04 0.4 Allowed 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.212 0.53 . . . . 0.0 111.545 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.463 ' HG2' ' CB ' ' A' ' 57' ' ' LYS . 1.1 tm-20 -52.24 -32.08 35.21 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.901 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.0 p -82.43 -35.28 27.74 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.98 -86.28 1.25 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.278 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.528 HG23 ' HB2' ' A' ' 18' ' ' PRO . 4.3 mp -137.39 71.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.21 0.528 . . . . 0.0 110.309 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.451 ' N ' ' HG2' ' A' ' 18' ' ' PRO . 11.2 p80 -69.78 -156.23 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.641 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.1 -33.28 71.9 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.554 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 1.3 ttp85 -73.73 -63.5 0.93 Allowed Pre-proline 0 N--CA 1.467 0.382 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.519 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.628 ' HB3' HD13 ' A' ' 86' ' ' LEU . 21.4 Cg_endo -60.42 -29.71 89.32 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.505 2.137 . . . . 0.0 112.719 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.607 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -62.5 -64.56 0.89 Allowed 'General case' 0 C--N 1.339 0.132 0 CA-C-N 116.857 -0.156 . . . . 0.0 110.812 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 m -53.73 -32.16 51.05 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 110.604 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -55.43 20.43 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.395 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.632 HD22 HD13 ' A' ' 44' ' ' LEU . 1.3 mt -58.41 -34.17 70.47 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.115 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 19' ' ' ALA . 67.3 t -55.44 -64.57 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -64.93 -44.12 90.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 123.194 0.309 . . . . 0.0 111.672 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.454 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 52.0 m -56.33 -61.32 2.48 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.594 0.235 . . . . 0.0 110.409 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.76 98.0 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.469 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -58.42 -32.95 69.14 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.232 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 25' ' ' THR . 24.9 mtmm -63.55 -52.68 60.01 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.609 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 43.4 m-85 -66.68 -35.54 80.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.667 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 82.5 -20.84 0.33 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.868 -1.515 . . . . 0.0 111.502 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.429 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 88.7 p -68.7 132.33 46.68 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.725 0.774 . . . . 0.0 112.219 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.24 115.44 19.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.686 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.876 HG21 HD21 ' A' ' 44' ' ' LEU . 2.9 mt -97.48 123.62 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.464 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.752 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 2.7 pt20 -94.76 104.15 16.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.574 ' HB2' HD23 ' A' ' 44' ' ' LEU . 5.5 tt -99.44 119.37 37.88 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.029 -1.441 . . . . 0.0 110.176 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.76 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -93.98 169.6 10.16 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 126.023 2.077 . . . . 0.0 110.466 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.968 ' HB3' HD22 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -145.52 97.6 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.509 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 49.93 -59.5 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 37' ' ' TYR . . . -138.62 33.05 2.25 Favored Glycine 0 C--N 1.318 -0.468 0 C-N-CA 121.816 -0.23 . . . . 0.0 112.738 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.464 ' HB3' HD21 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -138.33 171.04 14.97 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.76 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 1.2 tmtm? -156.56 109.88 2.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.934 0.397 . . . . 0.0 111.736 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.4 m -153.78 173.07 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.084 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -81.89 131.89 35.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.876 HD21 HG21 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -67.66 56.81 0.06 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.858 0.361 . . . . 0.0 110.987 177.571 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' O ' HD12 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -66.89 -17.71 65.03 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.558 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.727 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.95 -47.64 0.67 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 45' ' ' LYS . 3.2 mt -52.82 -26.44 10.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.329 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.511 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 13.0 mtp -167.79 -37.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.19 60.06 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.182 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.727 HG22 ' HA ' ' A' ' 46' ' ' SER . 24.8 m -69.29 -50.2 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.511 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -59.0 -41.36 87.46 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.614 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.4 t -57.9 -41.3 82.32 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.216 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.968 HD22 ' HB3' ' A' ' 37' ' ' TYR . 38.7 mt -64.58 -52.57 56.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.821 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.64 -49.03 0.92 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.417 -0.421 . . . . 0.0 113.14 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t 36.49 79.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.437 ' C ' ' HA ' ' A' ' 11' ' ' GLU . . . -76.47 -163.36 15.94 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.902 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.601 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 7.3 tttt -74.34 134.86 42.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.601 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER 76.69 9.29 2.97 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.519 0.512 . . . . 0.0 110.41 -178.502 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.18 136.79 58.1 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 152.21 20.62 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.528 HD11 HD22 ' A' ' 81' ' ' LEU . 12.5 pt -145.66 172.7 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.093 0.473 . . . . 0.0 111.924 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.751 HG22 ' CE1' ' A' ' 64' ' ' TYR . 5.6 m -149.21 103.28 3.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.446 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.867 ' N ' HD13 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -96.64 145.06 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.612 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.752 ' HB2' ' HG3' ' A' ' 34' ' ' GLN . 11.2 m-85 -145.53 111.33 5.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.052 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.704 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -91.13 133.51 35.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.329 0.585 . . . . 0.0 111.767 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -130.88 101.24 5.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.79 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . 174.57 -158.94 27.52 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.7 p -71.53 -60.79 2.05 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.27 1.035 . . . . 0.0 111.133 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.609 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 9.7 m-20 -91.48 42.92 1.12 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.57 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -66.28 -22.47 66.3 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.974 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.646 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -88.29 -46.77 8.93 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.12 -40.21 64.03 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.55 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -54.99 -54.55 41.5 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.441 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 mm -48.43 -47.49 14.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.502 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -55.52 -70.96 0.09 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.78 -37.26 73.39 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.1 mm -60.85 -41.75 89.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.529 0.204 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.645 HG22 ' HB2' ' A' ' 82' ' ' SER . 14.6 m -60.59 -63.59 1.25 Allowed 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.456 ' C ' ' O ' ' A' ' 78' ' ' THR . 45.8 m-20 -34.39 -43.82 0.17 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.034 0.445 . . . . 0.0 110.142 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.576 HG12 HD11 ' A' ' 86' ' ' LEU . 9.1 t -66.68 -66.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.114 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.528 HD22 HD11 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -61.84 -40.75 96.38 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.194 0.521 . . . . 0.0 110.644 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.645 ' HB2' HG22 ' A' ' 78' ' ' THR . 0.5 OUTLIER -59.4 -26.26 64.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.626 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -67.07 0.3 Allowed 'General case' 0 C--N 1.349 0.572 0 CA-C-O 120.878 0.371 . . . . 0.0 110.108 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -174.89 37.29 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.95 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.722 ' HA3' ' HB3' ' A' ' 10' ' ' ASP . . . 61.35 21.85 60.39 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' A' ' 18' ' ' PRO . 3.6 mp 59.06 32.16 21.97 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-O 120.524 0.202 . . . . 0.0 111.447 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 10' ' ' ASP . 55.3 p -123.72 -116.99 0.29 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.244 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.423 -0.798 . . . . 0.0 110.988 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.568 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mm-40 -99.02 159.21 15.12 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.461 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.725 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -159.58 156.69 28.47 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 2.7 mm100 -162.25 164.63 27.53 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.422 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.457 ' HB3' HG23 ' A' ' 62' ' ' THR . 46.2 p -153.66 139.5 18.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.906 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -144.7 -177.59 5.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.396 0.617 . . . . 0.0 111.392 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 t -153.19 116.83 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.576 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.591 HD12 ' CA ' ' A' ' 85' ' ' GLY . 0.6 OUTLIER -134.98 177.5 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -176.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.555 ' H ' HG22 ' A' ' 8' ' ' ILE . 17.3 pt -94.07 16.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.747 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.758 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 13.5 p-10 -68.58 73.97 0.25 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.329 0.585 . . . . 0.0 111.642 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 57' ' ' LYS . 2.9 tt0 -59.38 -25.26 64.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.048 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -80.01 -33.67 39.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.51 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . 48.66 81.43 0.05 OUTLIER Glycine 0 C--N 1.341 0.836 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.894 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.571 HD13 HD22 ' A' ' 86' ' ' LEU . 25.5 mm 71.82 127.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.802 0.334 . . . . 0.0 111.031 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 10.7 p80 -166.76 -119.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.314 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 18' ' ' PRO . . . -69.32 -167.13 0.11 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 118.777 -0.63 . . . . 0.0 109.881 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.667 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 12.29 -73.03 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.798 ' CB ' HD23 ' A' ' 86' ' ' LEU . 4.5 Cg_exo -40.31 -45.97 4.26 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.67 2.913 . . . . 0.0 113.212 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 15' ' ' HIS . . . -64.25 -56.22 16.1 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 121.258 -0.177 . . . . 0.0 111.146 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.2 m -50.84 -34.29 27.23 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.921 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 mmm -62.93 -50.45 70.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.291 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -35.61 70.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.852 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.68 -59.06 2.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -66.18 -50.93 62.21 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.301 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.694 HG22 ' HE2' ' A' ' 29' ' ' PHE . 84.8 m -52.69 -60.46 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.47 89.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.579 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.5 t -59.48 -29.4 67.8 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.375 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 25' ' ' THR . 3.5 mtpm? -63.98 -51.46 64.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.694 ' HE2' HG22 ' A' ' 25' ' ' THR . 30.3 m-85 -64.59 -39.66 94.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.746 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 76.5 -14.21 0.84 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.27 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.8 p -68.31 144.91 54.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.384 0.611 . . . . 0.0 112.383 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.48 110.19 13.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.734 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.732 HG23 HG23 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -101.27 119.9 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.46 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.686 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 15.8 pm0 -101.03 113.11 25.8 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.105 HD13 HD13 ' A' ' 44' ' ' LEU . 1.5 tt -103.47 120.83 41.6 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.585 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.779 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.6 OUTLIER -94.87 175.99 6.43 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 126.136 2.147 . . . . 0.0 111.251 -179.78 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -128.53 166.72 18.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.241 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.43 ' CA ' ' HG3' ' A' ' 60' ' ' GLU . 7.6 t-20 -46.62 -21.02 0.15 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.23 55.55 0.39 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.86 -179.7 1.22 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.631 0.253 . . . . 0.0 110.999 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.779 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -158.89 118.81 3.13 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.446 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.401 ' CG2' HD23 ' A' ' 53' ' ' LEU . 21.3 m -153.26 -173.68 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.976 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -86.45 144.39 27.31 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.105 HD13 HD13 ' A' ' 35' ' ' LEU . 6.8 tp -68.81 59.09 0.09 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -67.78 -32.05 72.36 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.472 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.7 OUTLIER 69.59 -52.28 0.61 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.423 0.63 . . . . 0.0 112.183 -179.471 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.8 mt -53.31 -26.2 11.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.213 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.9 mtp -167.56 -39.19 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.628 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -48.22 -47.51 27.32 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.286 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.485 ' HA ' HD21 ' A' ' 53' ' ' LEU . 33.7 m -69.56 -38.71 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.705 0.288 . . . . 0.0 110.899 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.3 mtt -59.63 -47.07 87.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.798 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.4 p -58.71 -48.44 81.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.479 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.485 HD21 ' HA ' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -66.88 -11.07 54.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.44 117.04 0.04 OUTLIER Glycine 0 C--N 1.339 0.746 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.223 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.44 ' HB ' ' HA3' ' A' ' 13' ' ' GLY . 2.5 t -120.2 70.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.754 0.311 . . . . 0.0 111.814 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.25 -167.03 32.94 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.35 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 7.2 tttm -71.82 134.76 46.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.571 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER 76.59 12.8 2.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.553 0.533 . . . . 0.0 111.04 -179.111 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.69 131.92 52.23 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HG3' ' CA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -103.18 144.87 30.75 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.292 179.058 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 pt -146.79 169.09 5.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.714 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.569 HG22 ' CE1' ' A' ' 64' ' ' TYR . 16.9 m -152.44 107.49 3.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.734 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.768 ' CG1' HD12 ' A' ' 35' ' ' LEU . 4.8 mp -96.96 148.09 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.725 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 25.8 m-85 -138.24 114.94 10.62 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.904 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.55 ' HB2' HG13 ' A' ' 33' ' ' ILE . . . -93.46 130.56 39.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.212 0.529 . . . . 0.0 111.459 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -131.48 96.68 4.04 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.751 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.89 -154.77 18.07 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.523 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.4 p -74.63 -60.68 2.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.704 0.752 . . . . 0.0 111.25 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.631 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 5.9 m-20 -91.52 41.22 1.06 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.897 0.38 . . . . 0.0 110.573 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.427 ' HG3' ' CG ' ' A' ' 2' ' ' GLU . 15.0 pt-20 -66.2 -28.52 68.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.974 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.568 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -85.78 -44.02 12.84 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.89 -40.89 67.0 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.612 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -54.68 -54.39 42.38 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.105 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.7 mm -49.6 -49.85 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.961 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -54.78 -69.04 0.14 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.62 -38.07 68.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.607 0.242 . . . . 0.0 111.35 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 73' ' ' ALA . 14.4 mm -61.33 -37.71 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.638 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -58.48 -62.05 2.14 Favored 'General case' 0 C--O 1.207 -1.164 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.194 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -39.56 -43.87 1.37 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.594 0.559 . . . . 0.0 110.436 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.5 t -63.74 -64.64 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.448 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.512 HD23 HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -62.35 -24.36 67.31 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.011 0.434 . . . . 0.0 110.651 179.18 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 78' ' ' THR . 8.8 t -61.44 -31.19 71.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.882 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -55.96 -70.4 0.11 Allowed 'General case' 0 C--N 1.348 0.51 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 2.6 pt-20 -176.93 39.8 0.01 OUTLIER 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.34 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.591 ' CA ' HD12 ' A' ' 8' ' ' ILE . . . 71.68 29.71 67.25 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.774 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.798 HD23 ' CB ' ' A' ' 18' ' ' PRO . 5.8 mp 69.67 52.47 0.43 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.838 0.352 . . . . 0.0 110.068 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 65.03 139.08 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.877 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.758 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.516 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptp . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.741 ' OE1' ' HB3' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -98.05 164.51 12.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.761 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -157.49 160.19 38.01 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.542 ' HG3' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -160.82 123.09 3.14 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.173 179.423 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 p -94.07 156.59 16.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.692 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -144.48 177.53 8.59 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.654 0.74 . . . . 0.0 111.992 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.6 ' O ' HD13 ' A' ' 8' ' ' ILE . 14.6 t -160.43 104.1 1.42 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.469 -1.242 . . . . 0.0 107.918 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER -142.69 -175.74 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.036 -175.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.723 HG22 ' HA ' ' A' ' 57' ' ' LYS . 14.7 pt -136.89 -41.35 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 25.3 t70 44.89 27.7 0.29 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.771 0.26 . . . . 0.0 111.634 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 88' ' ' GLU . 19.2 mm-40 33.5 34.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.451 0.7 . . . . 0.0 112.741 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER 175.94 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.922 179.236 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.74 -56.93 0.97 Allowed Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.488 HD13 HG23 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -141.11 174.25 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.105 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -171.64 -59.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -174.95 -35.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HD2' ' HG2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -72.13 -56.73 4.21 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 -179.399 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 36.9 Cg_endo -65.29 -33.49 48.26 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.292 1.995 . . . . 0.0 112.149 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.61 ' HA ' ' HB2' ' A' ' 46' ' ' SER . . . -62.73 -65.0 0.75 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.084 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.1 p -55.29 -28.91 56.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.282 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.789 ' HB3' HG22 ' A' ' 80' ' ' VAL . 1.4 mtt -63.16 -55.59 23.85 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.797 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.497 HD22 ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -58.91 -34.57 71.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.075 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 19' ' ' ALA . 73.8 t -54.55 -57.28 6.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.64 -55.97 14.67 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.517 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 29.4 p -52.89 -57.5 10.05 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.547 0.202 . . . . 0.0 111.547 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.14 -47.72 84.91 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.822 -0.172 . . . . 0.0 110.979 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 23.5 m -60.28 -30.97 69.8 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.784 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' ' 25' ' ' THR . 4.9 mtmp? -63.76 -51.38 65.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 14.2 m-85 -64.58 -37.49 87.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.984 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 80.84 -15.5 0.73 Allowed 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.582 -1.644 . . . . 0.0 112.681 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.443 ' HB3' ' H ' ' A' ' 68' ' ' SER . 83.4 p -66.09 145.6 55.65 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.416 0.626 . . . . 0.0 112.263 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.04 109.11 13.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.098 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.848 ' CG1' ' HB2' ' A' ' 65' ' ' ALA . 1.3 mt -99.53 125.15 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.909 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.665 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -103.77 113.45 26.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.643 0.735 . . . . 0.0 109.258 178.304 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.023 HD13 HD13 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -101.34 114.12 27.83 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.935 -179.617 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.536 ' HG3' ' HG2' ' A' ' 41' ' ' LYS . 1.5 tt0 -91.72 173.65 7.76 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 126.262 2.226 . . . . 0.0 110.772 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.427 ' CG ' ' HB2' ' A' ' 53' ' ' LEU . 32.3 t80 -132.35 163.57 28.41 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.084 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.626 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 6.6 t-20 -51.65 -15.48 0.47 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -156.68 50.12 0.44 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.197 -0.525 . . . . 0.0 111.826 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -178.88 -178.51 0.55 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.666 0.27 . . . . 0.0 110.906 -179.353 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 1.7 tmtt? -157.83 120.84 3.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.448 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.4 m -151.43 -175.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.512 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.25 140.87 29.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.023 HD13 HD13 ' A' ' 35' ' ' LEU . 1.6 tp -69.65 56.83 0.13 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.593 0.235 . . . . 0.0 110.582 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' O ' HD12 ' A' ' 47' ' ' ILE . 3.9 tptp -73.16 9.56 1.2 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.61 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . 89.8 p 39.64 34.24 0.15 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 46' ' ' SER . 2.2 mp -166.16 -84.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.54 ' N ' HG22 ' A' ' 47' ' ' ILE . 3.4 tpp -63.98 -37.27 86.82 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -82.43 0.1 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.475 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.488 HG23 HD13 ' A' ' 14' ' ' ILE . 3.1 m -40.0 -42.06 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.0 mtt -59.07 -50.11 75.32 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.509 0.195 . . . . 0.0 111.233 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.4 t -56.47 -52.64 63.94 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.226 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.427 ' HB2' ' CG ' ' A' ' 37' ' ' TYR . 0.6 OUTLIER -67.31 -18.01 65.0 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.59 101.3 0.05 OUTLIER Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.55 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.442 ' CG2' ' HB ' ' A' ' 50' ' ' VAL . 19.5 t -90.98 75.99 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.939 0.4 . . . . 0.0 111.22 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.12 -161.99 37.12 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.375 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.723 ' HA ' HG22 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -72.63 127.43 32.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 82.33 18.24 0.34 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.698 0.624 . . . . 0.0 110.42 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.88 115.27 2.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.299 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.626 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 2.1 tt0 -96.83 139.63 32.58 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.753 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.82 170.11 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.154 0.502 . . . . 0.0 111.812 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.562 ' C ' HD13 ' A' ' 63' ' ' ILE . 7.0 m -152.55 107.0 3.16 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.928 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.847 ' CD1' HD12 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -94.99 146.59 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.761 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 40.8 m-85 -145.49 108.82 4.63 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.468 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.848 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -98.0 133.54 42.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.838 0.351 . . . . 0.0 110.559 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.82 78.17 1.66 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.569 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -147.76 -89.7 0.08 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.702 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.443 ' H ' ' HB3' ' A' ' 31' ' ' SER . 11.3 p -132.39 -65.65 0.72 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.918 0.359 . . . . 0.0 111.285 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.462 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.4 m-20 -89.69 41.19 1.03 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.867 0.365 . . . . 0.0 110.639 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -24.28 66.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.055 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.28 -53.21 5.92 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -32.91 66.13 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.989 0.423 . . . . 0.0 109.876 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -49.09 -56.49 8.94 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.992 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.58 HD11 ' HG2' ' A' ' 2' ' ' GLU . 15.1 mm -42.64 -55.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.83 -67.62 0.25 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.78 68.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.47 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.92 -37.76 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.558 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 82' ' ' SER . 0.2 OUTLIER -58.41 -56.32 23.57 Favored 'General case' 0 C--O 1.209 -1.055 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.312 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -45.6 -41.07 9.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.089 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.789 HG22 ' HB3' ' A' ' 21' ' ' MET . 6.2 t -65.26 -62.97 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.181 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.8 -33.95 73.77 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.973 0.416 . . . . 0.0 110.617 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 78' ' ' THR . 5.8 t -61.46 -28.01 68.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.413 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.679 ' O ' HD23 ' A' ' 86' ' ' LEU . 5.1 tptp -59.65 -30.39 68.7 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 121.324 -0.151 . . . . 0.0 111.014 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 2.7 pt-20 -63.83 -26.78 68.78 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.819 0.343 . . . . 0.0 110.427 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.47 -13.06 70.64 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.192 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 83' ' ' LYS . 0.7 OUTLIER -56.69 -27.07 58.21 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 116.754 0.277 . . . . 0.0 110.648 179.068 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.25 -97.23 0.28 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.599 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.519 ' HB2' HD11 ' A' ' 9' ' ' ILE . 4.4 pt-20 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.934 -0.555 . . . . 0.0 112.256 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ttt . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.735 0.302 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.605 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 3.1 mm-40 -95.28 164.58 12.78 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.525 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.7 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 2.3 pt20 -161.78 152.77 18.05 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.777 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.494 ' HB3' ' CE1' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -160.87 122.61 3.03 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.986 0.422 . . . . 0.0 111.967 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.7 p -90.71 155.06 19.1 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.994 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 4' ' ' GLN . 87.4 m-85 -143.45 -179.92 6.72 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 122.009 0.909 . . . . 0.0 112.814 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 7' ' ' THR . 11.8 t -152.06 95.8 2.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.606 -1.633 . . . . 0.0 106.833 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.649 HG23 ' HG2' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -93.4 179.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.721 -175.781 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.743 HD13 ' C ' ' A' ' 88' ' ' GLU . 1.6 pp -148.5 27.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.665 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.34 78.13 1.01 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.98 0.419 . . . . 0.0 110.343 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.645 ' HG3' ' HB2' ' A' ' 57' ' ' LYS . 1.8 mp0 -54.06 -22.72 11.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.788 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -41.27 37.85 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.75 85.97 0.09 OUTLIER Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.773 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.429 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER 69.17 145.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.134 0.492 . . . . 0.0 111.795 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -171.56 -63.65 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.605 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.678 ' C ' ' HD2' ' A' ' 18' ' ' PRO . . . -178.06 163.51 1.74 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.799 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.538 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 98.51 -60.49 0.0 OUTLIER Pre-proline 0 C--N 1.364 1.229 0 CA-C-N 118.934 0.788 . . . . 0.0 112.743 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.678 ' HD2' ' C ' ' A' ' 16' ' ' ALA . 56.5 Cg_endo -70.65 -27.77 21.79 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.804 1.669 . . . . 0.0 112.471 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.615 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.47 -65.61 0.66 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.695 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.6 m -55.02 -32.98 62.25 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.704 0.288 . . . . 0.0 110.51 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.509 ' HE3' ' HA ' ' A' ' 18' ' ' PRO . 21.1 mtm -64.83 -53.78 41.37 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.408 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.769 HD11 ' CD2' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -57.98 -37.38 74.11 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.19 179.436 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 19' ' ' ALA . 62.3 t -54.1 -60.16 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -49.65 64.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.431 ' O ' ' CD2' ' A' ' 29' ' ' PHE . 73.5 p -58.13 -58.96 6.13 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.389 0.086 . . . . 0.0 111.051 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.59 85.69 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.744 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.5 t -59.37 -33.07 70.73 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -66.49 -51.4 57.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.602 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.613 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 13.9 m-85 -66.33 -40.78 90.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.509 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 78.36 -20.41 0.39 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.593 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.539 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 93.2 p -66.52 140.09 57.97 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.623 0.725 . . . . 0.0 112.415 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.57 112.84 19.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.112 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.696 HG13 ' HB2' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -97.73 121.38 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.677 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.674 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 4.8 pt20 -101.61 107.41 18.67 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.987 HD13 ' HG ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -99.63 116.25 31.31 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.085 -179.364 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.697 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -93.91 172.23 8.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 125.973 2.046 . . . . 0.0 110.736 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.559 ' CD1' HD11 ' A' ' 53' ' ' LEU . 13.0 t80 -125.4 166.82 15.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.092 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.562 ' HB3' ' CG ' ' A' ' 60' ' ' GLU . 0.7 OUTLIER -53.58 -14.98 0.96 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.82 46.69 0.51 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.102 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HE3' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -173.04 -177.36 1.57 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.798 0.333 . . . . 0.0 111.244 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.697 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 3.0 tmtm? -158.12 117.76 3.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.802 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 m -152.3 -172.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.095 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -86.59 142.67 28.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.987 ' HG ' HD13 ' A' ' 35' ' ' LEU . 4.2 tt -68.68 58.45 0.09 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -41.9 71.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.731 ' HA ' HG22 ' A' ' 50' ' ' VAL . 1.0 OUTLIER 71.27 -51.99 0.69 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.425 0.631 . . . . 0.0 111.897 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -53.06 -27.28 13.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.316 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.562 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 12.8 mtp -167.3 -39.07 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.76 -56.1 12.57 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.17 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.731 HG22 ' HA ' ' A' ' 46' ' ' SER . 18.6 m -68.05 -50.26 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.562 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -59.48 -40.14 85.97 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.375 0.131 . . . . 0.0 111.3 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -57.21 -51.54 68.92 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.625 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.559 HD11 ' CD1' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -66.97 -35.09 79.2 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.07 179.561 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.415 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . 128.69 126.52 2.87 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.711 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 51' ' ' MET . 44.1 t -127.1 107.57 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.591 0.234 . . . . 0.0 111.127 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.0 174.09 18.3 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.513 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.645 ' HB2' ' HG3' ' A' ' 11' ' ' GLU . 15.1 tttt -70.06 136.39 50.26 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.582 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 86.2 5.2 0.42 Allowed 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.651 0.594 . . . . 0.0 111.061 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.86 119.13 7.13 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.562 ' CG ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -94.81 145.74 24.67 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.459 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.578 HD13 HD11 ' A' ' 8' ' ' ILE . 5.5 pt -147.48 175.65 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.573 ' C ' HD13 ' A' ' 63' ' ' ILE . 4.2 m -151.86 107.03 3.28 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.767 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.76 ' N ' HD13 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -96.05 152.3 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.114 -177.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.7 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 51.9 m-85 -146.26 110.24 4.95 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.66 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.696 ' HB2' HG13 ' A' ' 33' ' ' ILE . . . -93.47 126.51 38.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.025 0.441 . . . . 0.0 110.705 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -125.8 94.68 4.18 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.109 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.539 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . 179.88 -159.17 23.38 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.067 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.2 p -69.95 -60.97 1.97 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.104 0.952 . . . . 0.0 111.605 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.582 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 4.2 m-20 -91.79 45.26 1.21 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.849 0.357 . . . . 0.0 110.824 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.605 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 9.5 pt-20 -67.1 -22.53 65.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.12 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.568 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -88.63 -45.58 9.74 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -38.64 67.33 Favored 'General case' 0 C--N 1.342 0.281 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.613 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -52.34 -56.88 11.95 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.49 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.0 mm -44.82 -45.64 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.791 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.73 -70.76 0.15 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.86 -32.49 65.88 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.12 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 73' ' ' ALA . 11.0 mm -62.43 -36.55 75.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -58.39 -51.78 68.36 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.096 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -46.11 -42.85 14.25 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.743 0.652 . . . . 0.0 109.923 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.472 HG22 ' HE3' ' A' ' 21' ' ' MET . 2.4 t -61.14 -57.79 10.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.152 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.419 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -62.17 -30.41 71.04 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 178.314 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 78' ' ' THR . 4.5 t -61.71 -30.91 71.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.912 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.558 ' O ' HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -63.26 -23.45 67.43 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.667 178.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.649 ' HG2' HG23 ' A' ' 8' ' ' ILE . 2.2 pp20? -59.79 -31.39 69.65 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.626 0.37 . . . . 0.0 110.457 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.87 -16.02 7.21 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.23 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 83' ' ' LYS . 2.8 pp -63.53 -7.79 7.89 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 53.2 p -97.46 -103.82 0.19 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 121.349 -0.14 . . . . 0.0 111.097 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.743 ' C ' HD13 ' A' ' 9' ' ' ILE . 2.1 tp10 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.995 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.679 0.276 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.597 ' CG ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -101.5 160.04 14.77 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.601 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.734 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -150.31 149.86 30.69 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.684 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.83 162.43 32.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.366 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.446 ' HB3' HG23 ' A' ' 62' ' ' THR . 30.6 p -154.17 148.16 25.64 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.745 0.307 . . . . 0.0 111.527 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -144.01 -176.9 5.18 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.415 0.626 . . . . 0.0 111.329 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 7' ' ' THR . 15.3 t -153.53 113.31 3.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.76 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.532 HG22 ' H ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER -136.65 -172.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.245 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 58' ' ' ASP . 21.4 pt -137.24 -40.69 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.489 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.507 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 36.3 t70 46.27 22.41 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.538 ' HG2' ' HA ' ' A' ' 88' ' ' GLU . 20.5 mm-40 25.25 41.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.743 0.817 . . . . 0.0 112.325 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.84 HG21 ' HB3' ' A' ' 15' ' ' HIS . 2.8 m -176.4 -37.09 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.833 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.88 -75.06 1.45 Allowed Glycine 0 C--N 1.347 1.186 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.773 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.635 ' CG2' ' HB2' ' A' ' 19' ' ' ALA . 18.2 mm -139.54 81.94 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.848 0.356 . . . . 0.0 110.063 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.84 ' HB3' HG21 ' A' ' 12' ' ' THR . 10.4 p80 -66.27 -52.56 46.38 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.054 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -178.42 -35.39 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.577 ' HD2' ' HG3' ' A' ' 21' ' ' MET . 3.2 tmm_? -71.47 -53.54 7.57 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 10.0 Cg_endo -52.52 -45.18 41.75 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.541 2.161 . . . . 0.0 112.765 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.635 ' HB2' ' CG2' ' A' ' 14' ' ' ILE . . . -64.36 -64.7 0.81 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.2 m -52.9 -32.14 43.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.374 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.577 ' HG3' ' HD2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -66.1 -49.27 68.13 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.972 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.94 HD22 HD22 ' A' ' 44' ' ' LEU . 3.8 mt -55.75 -38.91 70.45 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.919 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.407 ' O ' ' CB ' ' A' ' 27' ' ' SER . 58.3 t -57.45 -65.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.422 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -45.68 84.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.596 HG22 ' HE2' ' A' ' 29' ' ' PHE . 95.0 m -57.15 -62.35 1.82 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.441 0.163 . . . . 0.0 110.783 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.38 -46.49 88.53 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.636 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 33.0 t -59.01 -29.64 67.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.595 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 25' ' ' THR . 17.4 mtmm -64.18 -52.78 57.29 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.696 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 38.4 m-85 -64.52 -36.5 84.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.047 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 82.44 -16.19 0.62 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.216 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.749 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 86.4 p -66.94 135.13 53.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.459 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.97 110.31 9.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.228 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.063 ' CG2' HG23 ' A' ' 63' ' ' ILE . 4.1 mt -98.64 126.59 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.613 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.637 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 3.6 pt20 -98.18 105.44 17.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 6.2 tt -96.63 112.47 24.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.313 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.796 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -95.16 175.84 6.46 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 125.904 2.003 . . . . 0.0 112.471 -178.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -129.12 163.12 26.18 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.494 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 0.7 OUTLIER -55.02 -11.36 0.64 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.66 48.18 0.51 Allowed Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.72 -179.19 0.61 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.714 0.292 . . . . 0.0 110.983 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.796 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -159.18 119.94 3.22 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.493 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.4 m -153.34 -172.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.708 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 45' ' ' LYS . 27.3 t-20 -89.26 148.73 23.42 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.94 HD22 HD22 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -62.92 50.97 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 177.128 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 43' ' ' ASN . 4.0 mptt -59.34 -41.23 88.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.64 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.12 -52.17 0.7 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.449 0.643 . . . . 0.0 111.737 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.03 -24.15 14.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.774 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.1 mtm -167.27 -39.29 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.246 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -50.12 -49.32 37.22 Favored Glycine 0 C--N 1.34 0.788 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.113 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.64 HG22 ' HA ' ' A' ' 46' ' ' SER . 16.7 m -71.49 -36.3 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.811 0.305 . . . . 0.0 110.559 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 56.3 mtt -59.72 -46.76 88.12 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.464 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.7 p -58.78 -49.82 76.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.934 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.479 HD21 ' HA ' ' A' ' 50' ' ' VAL . 1.1 pp -66.96 -12.73 60.56 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.31 109.8 0.06 OUTLIER Glycine 0 C--N 1.34 0.762 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.927 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 t -107.12 59.82 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.989 0.424 . . . . 0.0 110.924 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.87 -156.96 24.42 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.788 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 3.7 tttt -74.28 126.13 29.95 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.618 ' H ' HG22 ' A' ' 9' ' ' ILE . 0.2 OUTLIER 85.28 13.38 0.21 Allowed 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.822 0.701 . . . . 0.0 110.69 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.64 117.38 4.87 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.779 0.323 . . . . 0.0 111.425 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 1.5 tt0 -99.88 139.71 35.15 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.639 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.35 167.71 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.768 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 5' ' ' SER . 18.7 m -151.21 114.74 4.87 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.48 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.063 HG23 ' CG2' ' A' ' 33' ' ' ILE . 3.2 mp -99.58 133.6 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.19 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.734 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 50.6 m-85 -129.91 104.24 7.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.362 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.747 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -95.0 132.07 40.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.176 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.45 78.17 1.5 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.055 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.749 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -164.95 20.8 0.12 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.712 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 67' ' ' GLY . 59.5 p 121.96 -81.94 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.256 1.022 . . . . 0.0 111.914 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.696 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 8.0 m-20 -87.2 46.22 1.35 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.439 0.638 . . . . 0.0 109.997 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -70.5 -21.43 62.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.267 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.96 -51.75 6.17 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -34.52 62.54 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.199 178.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.641 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.75 -63.78 1.04 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.171 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.597 HG12 ' CG ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -48.08 -41.51 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -59.1 -69.33 0.2 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.641 0.258 . . . . 0.0 111.234 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.97 67.79 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.472 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.4 mm -60.26 -38.74 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.152 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.459 ' O ' ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -56.78 -57.9 10.45 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.854 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -44.47 -39.8 5.07 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.762 0.664 . . . . 0.0 110.525 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.503 HG22 ' SD ' ' A' ' 21' ' ' MET . 3.3 t -64.17 -60.84 2.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.605 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.426 HD23 HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -63.09 -32.24 73.57 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 110.62 178.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 78' ' ' THR . 1.2 p -62.45 -34.02 75.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.636 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.554 ' O ' HD23 ' A' ' 86' ' ' LEU . 2.5 tptp -63.01 -27.8 69.66 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.217 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 6.9 mm-40 -62.01 -28.91 69.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.096 0.559 . . . . 0.0 110.756 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.41 ' HA2' ' HG2' ' A' ' 88' ' ' GLU . . . -63.88 -18.42 62.02 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.038 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -56.17 -29.9 61.47 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.612 0.244 . . . . 0.0 110.623 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.9 p -104.61 -98.97 0.32 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.475 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' ' 11' ' ' GLU . 3.8 pt-20 . . . . . 0 C--O 1.253 1.259 0 CA-C-O 118.957 -0.544 . . . . 0.0 112.145 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.725 0.298 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.609 ' HG3' ' N ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -100.39 164.07 12.09 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.57 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.713 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -155.41 159.11 39.61 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.473 ' HG3' HG23 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -156.41 174.39 15.48 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.495 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.7 p -153.03 146.85 25.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.005 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -138.45 -175.43 4.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.864 0.84 . . . . 0.0 113.19 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 7' ' ' THR . 6.7 t -150.31 74.8 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.917 -1.492 . . . . 0.0 107.685 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.457 HD12 ' CG1' ' A' ' 55' ' ' VAL . 73.0 mt -51.02 160.04 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 113.764 -1.562 . . . . 0.0 113.298 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.756 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.7 pp -151.09 4.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 4.4 t70 -74.13 15.54 0.31 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 8.1 mp0 72.1 -63.25 0.43 Allowed 'General case' 0 C--O 1.231 0.124 0 C-N-CA 122.915 0.486 . . . . 0.0 110.422 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 m -85.7 -25.5 26.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.58 -81.09 1.38 Allowed Glycine 0 C--N 1.343 0.963 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.735 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.729 HG23 ' O ' ' A' ' 14' ' ' ILE . 1.1 tp -103.98 62.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.887 0.851 . . . . 0.0 110.548 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -61.34 -52.58 64.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.854 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.56 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -70.33 -57.09 6.1 Favored Pre-proline 0 CA--C 1.53 0.184 0 N-CA-C 110.696 -0.113 . . . . 0.0 110.696 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HG2' ' HA ' ' A' ' 14' ' ' ILE . 32.4 Cg_endo -63.18 -31.23 74.98 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.167 1.912 . . . . 0.0 111.925 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.593 ' HB2' HG13 ' A' ' 14' ' ' ILE . . . -63.62 -64.9 0.77 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.22 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.2 p -53.62 -31.9 49.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.004 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.469 ' HB3' HG21 ' A' ' 80' ' ' VAL . 1.5 mmt -65.64 -52.7 49.81 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.71 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.558 HD13 ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -56.78 -37.63 71.39 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 179.326 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 19' ' ' ALA . 57.6 t -55.29 -57.07 8.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.427 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.9 tt0 -66.24 -55.96 13.63 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.937 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.434 ' OG1' ' HA ' ' A' ' 22' ' ' LEU . 54.1 p -53.48 -57.77 9.5 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.917 -0.129 . . . . 0.0 111.299 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.51 -46.62 86.36 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 7.7 m -59.26 -34.7 72.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.057 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 25' ' ' THR . 37.1 mtmt -65.39 -49.96 67.31 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.643 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 19.5 m-85 -64.82 -37.31 87.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.29 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 76.49 -13.35 0.93 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.868 -1.515 . . . . 0.0 112.184 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.483 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 92.6 p -67.97 139.89 56.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.483 0.659 . . . . 0.0 112.179 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.73 107.94 12.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.258 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.684 ' CG1' ' HB2' ' A' ' 65' ' ' ALA . 1.0 OUTLIER -97.84 126.0 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.285 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.754 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 4.7 pt20 -105.87 106.86 17.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.014 HD13 HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -101.22 121.11 41.28 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.881 -178.605 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.743 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -96.35 172.96 7.62 Favored 'General case' 0 C--N 1.341 0.217 0 O-C-N 126.211 2.194 . . . . 0.0 109.911 179.041 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.589 ' O ' ' N ' ' A' ' 39' ' ' GLY . 2.1 t80 -146.7 100.92 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.829 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.424 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER 49.6 -59.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 37' ' ' TYR . . . -143.17 37.26 1.51 Allowed Glycine 0 C--N 1.317 -0.515 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -142.65 174.19 10.87 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.743 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -155.19 117.44 4.19 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.081 0.467 . . . . 0.0 111.561 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.715 HG21 HD21 ' A' ' 53' ' ' LEU . 19.9 m -152.37 -176.81 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.971 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -83.51 139.42 32.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.014 HD13 HD13 ' A' ' 35' ' ' LEU . 1.5 tp -67.62 55.62 0.06 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.715 0.293 . . . . 0.0 110.709 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -71.73 -4.46 27.72 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.558 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . 81.4 p 38.59 47.5 1.13 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 46' ' ' SER . 38.1 mm -166.43 -95.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.537 0.735 . . . . 0.0 109.217 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.481 ' N ' HG22 ' A' ' 47' ' ' ILE . 34.1 mmt -68.09 -51.32 47.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.32 -81.35 0.07 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.671 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.417 HG23 HG21 ' A' ' 55' ' ' VAL . 7.2 p -37.55 -43.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.412 ' N ' HG13 ' A' ' 50' ' ' VAL . 1.8 mmt -61.99 -48.86 78.46 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.1 t -53.23 -51.46 62.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.062 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.715 HD21 HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -66.25 -35.39 80.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.004 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.32 108.36 1.89 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.529 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.491 HG13 ' CB ' ' A' ' 59' ' ' ALA . 57.8 t -139.27 82.39 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.02 -139.74 10.74 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.454 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.602 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 13.8 tttt -73.75 131.88 42.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.602 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 84.6 -5.19 1.0 Allowed 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.7 0.625 . . . . 0.0 111.511 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.491 ' CB ' HG13 ' A' ' 55' ' ' VAL . . . -62.72 125.02 22.53 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.722 0.296 . . . . 0.0 111.492 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.98 142.63 27.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.42 172.34 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.772 ' C ' HD13 ' A' ' 63' ' ' ILE . 6.6 m -150.57 115.15 5.2 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.151 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.872 ' N ' HD13 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -100.46 147.62 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.403 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.754 ' HB2' ' HG3' ' A' ' 34' ' ' GLN . 45.3 m-85 -143.09 107.54 4.8 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.899 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.684 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -93.31 131.08 38.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.116 0.484 . . . . 0.0 111.346 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.54 83.41 2.16 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.96 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.483 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -166.72 -154.48 8.4 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.649 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 p -76.28 -55.81 5.22 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.866 0.833 . . . . 0.0 111.893 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.643 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 2.8 m-20 -92.62 40.86 1.06 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.568 0.223 . . . . 0.0 111.224 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 4.9 pt-20 -67.17 -18.77 65.41 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.6 -54.81 3.99 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.89 -34.18 62.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.638 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.55 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -51.74 -62.63 1.5 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.176 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.592 HG12 ' CG ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -49.79 -46.08 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -57.76 -67.92 0.29 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.629 0.252 . . . . 0.0 111.462 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.44 -37.63 67.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.033 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.4 mm -60.85 -39.27 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.463 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 82' ' ' SER . 0.2 OUTLIER -57.0 -54.76 43.06 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -46.05 -41.62 12.32 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 109.945 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 21' ' ' MET . 3.4 t -65.19 -61.02 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.007 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 6.0 mt -60.53 -32.93 71.94 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.037 0.446 . . . . 0.0 110.559 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 78' ' ' THR . 5.4 t -61.41 -31.5 71.42 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.279 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.688 ' O ' HD23 ' A' ' 86' ' ' LEU . 13.5 mttt -62.5 -25.91 68.26 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 9.8 pt-20 -64.63 -25.78 68.11 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 120.708 0.29 . . . . 0.0 110.795 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.756 ' HA2' HD11 ' A' ' 9' ' ' ILE . . . -59.48 -14.78 29.31 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 83' ' ' LYS . 1.4 pp -54.94 -18.99 5.7 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.095 0.158 . . . . 0.0 111.422 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.4 p -95.92 -93.91 0.2 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.28 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.555 ' HB3' HD13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.402 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.765 0.317 . . . . 0.0 111.394 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.637 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 7.2 mm-40 -97.59 169.62 9.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.725 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -164.34 153.38 13.41 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.018 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -161.94 121.94 2.51 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.008 0.432 . . . . 0.0 112.009 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.7 p -89.73 153.56 20.6 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.765 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 92.2 m-85 -142.2 -176.88 4.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.697 0.76 . . . . 0.0 112.76 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 7' ' ' THR . 5.5 t -149.18 87.43 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.136 -1.393 . . . . 0.0 107.913 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 9' ' ' ILE . 36.0 mt -73.87 169.06 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.751 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 1.9 pp -140.11 -26.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.833 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -69.15 82.16 0.34 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.235 0.54 . . . . 0.0 110.502 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.506 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 1.2 pm0 -56.96 -7.91 0.54 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.76 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.7 m -78.7 -30.18 45.88 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.55 -164.66 18.94 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.758 -0.735 . . . . 0.0 113.219 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.8 HG23 ' HB2' ' A' ' 18' ' ' PRO . 23.4 mt -77.02 86.94 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.736 0.303 . . . . 0.0 110.67 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -69.98 -163.98 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.88 -32.95 68.19 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.474 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -74.22 -61.06 1.3 Allowed Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.8 ' HB2' HG23 ' A' ' 14' ' ' ILE . 29.6 Cg_endo -62.56 -31.24 79.96 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.327 2.018 . . . . 0.0 112.613 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.578 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.45 -63.19 1.25 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.085 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.6 m -52.72 -33.18 46.65 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.683 0.278 . . . . 0.0 110.719 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -55.61 17.46 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.696 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.49 ' CD2' HD21 ' A' ' 44' ' ' LEU . 1.1 mt -57.3 -38.97 74.8 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.316 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 19' ' ' ALA . 63.9 t -53.84 -57.89 4.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.1 tt0 -66.84 -55.47 14.64 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.413 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 76.7 p -53.35 -59.44 4.57 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.039 0.212 . . . . 0.0 111.385 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.6 -48.04 82.28 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 122.944 0.152 . . . . 0.0 111.039 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.8 t -60.53 -31.2 70.29 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.649 0.261 . . . . 0.0 111.298 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -68.11 -50.43 54.83 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.601 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 10.6 m-85 -64.92 -42.58 94.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.911 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.32 -11.72 0.78 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.241 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.428 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 99.8 p -68.05 145.37 54.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.453 0.644 . . . . 0.0 112.45 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.95 108.94 15.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.209 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.755 HG23 HG22 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -98.6 123.21 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.175 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.707 ' CG ' ' HB2' ' A' ' 64' ' ' TYR . 4.5 pt20 -98.56 106.05 18.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.632 HD22 HG22 ' A' ' 50' ' ' VAL . 5.5 tt -98.69 115.66 29.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.485 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.782 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -94.65 172.82 7.94 Favored 'General case' 0 C--N 1.34 0.179 0 O-C-N 126.07 2.106 . . . . 0.0 111.653 -179.349 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -126.17 165.27 19.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.637 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.49 ' HB3' ' HG3' ' A' ' 60' ' ' GLU . 1.3 p-10 -53.33 -14.1 0.67 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.49 49.4 0.48 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.05 178.65 1.72 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.704 0.287 . . . . 0.0 111.006 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.782 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -159.77 115.59 2.45 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.367 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.9 m -153.34 -175.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.05 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.231 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -85.21 141.18 30.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.818 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -65.31 52.7 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 121.907 0.86 . . . . 0.0 111.552 177.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.437 ' HG2' HD12 ' A' ' 47' ' ' ILE . 37.2 tttt -63.35 -34.47 77.78 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.75 ' HA ' ' HB ' ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.77 -50.62 0.7 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.283 0.563 . . . . 0.0 111.92 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.437 HD12 ' HG2' ' A' ' 45' ' ' LYS . 5.9 mt -53.84 -22.93 7.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.108 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.547 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -169.45 -39.98 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.974 -178.215 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.91 -56.06 27.18 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.879 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.75 ' HB ' ' HA ' ' A' ' 46' ' ' SER . 5.3 t -69.08 -45.95 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.657 0.228 . . . . 0.0 111.332 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.547 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -60.23 -36.92 78.82 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.721 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.0 t -60.27 -51.72 68.33 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.041 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -64.75 -11.33 35.17 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.92 119.65 0.1 OUTLIER Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.803 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.457 HG21 ' CG1' ' A' ' 50' ' ' VAL . 20.0 t -117.03 63.88 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.996 0.427 . . . . 0.0 111.378 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 11' ' ' GLU . . . -80.92 -166.78 36.32 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.057 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -75.86 125.63 29.45 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 89.01 7.05 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.879 0.737 . . . . 0.0 111.089 -178.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.63 117.73 5.69 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-O 120.513 0.197 . . . . 0.0 111.133 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.49 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -94.29 142.44 27.41 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.77 HD12 HD11 ' A' ' 63' ' ' ILE . 22.1 pt -143.11 175.12 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.766 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.592 ' C ' HD13 ' A' ' 63' ' ' ILE . 6.0 m -151.67 104.87 3.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.702 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.77 HD11 HD12 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -96.49 151.01 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.725 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 22.7 m-85 -146.45 110.98 5.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.515 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.674 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -93.48 127.62 39.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.24 0.543 . . . . 0.0 111.187 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.89 89.15 3.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.756 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -174.02 -153.68 10.05 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.601 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.6 p -75.59 -58.08 3.5 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.714 0.757 . . . . 0.0 111.767 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.587 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 3.2 m-20 -91.87 42.7 1.11 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.865 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.606 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 5.9 pt-20 -67.45 -22.26 65.51 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.637 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -89.05 -48.64 7.27 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.06 -37.66 64.41 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.601 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.68 -57.04 12.23 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.715 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.8 mm -49.61 -49.06 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.93 -67.48 0.36 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.79 -34.16 67.37 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.537 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' A' ' 80' ' ' VAL . 9.6 mm -62.29 -37.43 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -51.86 68.07 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -47.88 -40.55 21.98 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 123.607 0.567 . . . . 0.0 110.004 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 77' ' ' ILE . 2.5 t -62.09 -57.42 12.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.08 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.451 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -62.55 -36.54 82.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.96 0.409 . . . . 0.0 110.076 178.433 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 t -60.34 -29.77 69.1 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.858 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.651 ' O ' HD23 ' A' ' 86' ' ' LEU . 10.4 ttmt -62.43 -25.19 67.83 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.572 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 81' ' ' LEU . 7.0 pt-20 -61.39 -31.03 70.93 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.78 0.324 . . . . 0.0 110.34 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.36 -18.17 42.13 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.066 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 83' ' ' LYS . 0.7 OUTLIER -58.18 -25.57 61.72 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.538 0.169 . . . . 0.0 110.99 179.112 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.3 p -101.75 -98.24 0.27 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.872 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 117.981 -1.009 . . . . 0.0 112.209 179.916 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 ttm . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.703 0.287 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.623 ' CD ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -96.11 163.58 13.05 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.308 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.638 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.9 OUTLIER -153.66 152.5 30.9 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 62' ' ' THR . 2.3 tp60 -159.55 165.57 32.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.297 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.5 p -153.87 141.07 19.51 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.82 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.29 -161.98 1.3 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.7 m -153.98 106.88 2.88 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.753 HG22 ' HA2' ' A' ' 85' ' ' GLY . 1.7 mt -102.18 -171.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.736 -176.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.66 ' H ' HG22 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -144.93 10.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 11.0 t70 -73.63 83.97 1.57 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.12 -23.92 2.43 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.794 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -82.82 -36.97 25.07 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . 73.31 95.38 0.1 OUTLIER Glycine 0 C--N 1.344 0.995 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.911 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.416 HG13 ' CA ' ' A' ' 46' ' ' SER . 31.0 mm 67.84 125.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.897 0.379 . . . . 0.0 111.32 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -167.99 128.11 1.33 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.72 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 18' ' ' PRO . . . 43.95 -161.8 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 119.144 -0.455 . . . . 0.0 111.325 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.62 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER 15.51 -77.01 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.62 ' CD ' ' HB3' ' A' ' 17' ' ' ARG . 10.1 Cg_endo -50.34 -42.48 47.67 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.594 2.863 . . . . 0.0 113.509 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.35 -63.97 1.11 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.419 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.5 m -54.82 -31.75 59.59 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.579 ' HB3' HG22 ' A' ' 80' ' ' VAL . 27.7 mtm -64.93 -51.85 59.6 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.692 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.67 ' HG ' HG11 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -56.65 -36.98 70.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.082 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.62 -60.59 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -66.47 -51.17 59.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.399 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.528 HG22 ' HE2' ' A' ' 29' ' ' PHE . 70.7 m -51.93 -60.24 3.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.275 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.9 -48.24 81.35 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.949 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.0 t -58.56 -28.79 65.85 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.542 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -66.13 -49.8 66.21 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.671 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 14.1 m-85 -64.62 -40.94 96.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.998 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.43 -9.44 1.4 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.434 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.0 p -66.72 154.7 40.02 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.64 140.64 46.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.916 HD13 HD22 ' A' ' 44' ' ' LEU . 5.1 tt -146.96 114.1 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.181 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.648 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 17.9 pm0 -104.35 128.86 52.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.456 0.646 . . . . 0.0 110.37 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.741 HD12 HD12 ' A' ' 44' ' ' LEU . 5.8 tt -113.97 121.94 45.43 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.733 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -100.56 177.83 4.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 125.733 1.896 . . . . 0.0 111.494 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.498 ' CD1' HD11 ' A' ' 53' ' ' LEU . 12.2 t80 -128.02 162.83 25.91 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.868 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -55.43 -12.49 1.11 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.531 179.644 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.7 46.92 0.51 Allowed Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.41 -177.68 1.05 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.757 0.313 . . . . 0.0 110.919 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.733 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 4.9 tmtm? -159.05 122.79 3.84 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 m -152.24 -174.75 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.025 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 45' ' ' LYS . 7.6 t30 -84.11 145.09 28.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.916 HD22 HD13 ' A' ' 33' ' ' ILE . 1.3 tt -67.66 58.55 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HB2' ' HA3' ' A' ' 49' ' ' GLY . 4.5 mtpm? -69.31 -49.44 55.78 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.658 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER 73.78 -54.1 0.68 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.352 -178.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.18 -25.58 13.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.289 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.594 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -169.78 -39.02 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -178.053 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -48.68 -56.03 10.32 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.139 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.739 HG12 HD22 ' A' ' 35' ' ' LEU . 32.0 m -68.57 -50.25 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.594 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -60.22 -40.95 91.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.3 p -58.43 -48.39 80.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.941 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.573 HD23 ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -66.09 -34.56 78.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.921 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.79 126.22 3.08 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.975 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.524 HG23 ' HA ' ' A' ' 51' ' ' MET . 2.9 t -129.13 84.16 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.571 0.224 . . . . 0.0 110.953 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.47 176.86 48.44 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 4.7 tttm -71.95 131.08 42.46 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.603 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 85.07 12.06 0.26 Allowed 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.671 0.607 . . . . 0.0 110.467 -178.546 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.97 121.59 12.2 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.321 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 2.8 tt0 -93.9 143.39 26.38 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.608 HD12 HD11 ' A' ' 63' ' ' ILE . 19.2 pt -146.14 172.82 3.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.49 ' C ' HD12 ' A' ' 63' ' ' ILE . 4.4 m -148.13 109.47 4.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.858 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.782 ' CG2' HD11 ' A' ' 33' ' ' ILE . 1.3 mp -96.16 142.04 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.707 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.648 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 84.0 m-85 -132.24 116.21 16.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.784 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.8 127.78 48.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.023 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -133.25 103.95 6.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.005 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.56 -155.53 26.54 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.765 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.2 p -69.18 -61.09 1.94 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 117.282 0.541 . . . . 0.0 111.659 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.9 m-20 -92.2 37.92 0.99 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.544 0.211 . . . . 0.0 111.252 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.03 -22.45 66.98 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.35 -55.07 3.96 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.29 -34.6 66.62 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.461 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -50.28 -58.88 4.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.24 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.623 HG12 ' CD ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -43.48 -51.02 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 123.218 0.324 . . . . 0.0 111.872 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -54.71 -68.7 0.16 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.83 71.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.454 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 73' ' ' ALA . 13.1 mm -62.09 -38.64 81.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.652 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -57.31 -57.68 11.56 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.269 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -44.16 -41.94 6.04 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.576 0.547 . . . . 0.0 110.288 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.67 HG11 ' HG ' ' A' ' 22' ' ' LEU . 3.8 t -62.91 -63.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.67 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.24 -26.52 68.42 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.066 0.46 . . . . 0.0 110.763 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 78' ' ' THR . 6.7 t -65.08 -33.59 76.4 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.976 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.752 ' O ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -60.19 -49.29 78.22 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.488 179.118 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 2.7 pt-20 -63.76 -28.12 69.66 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.312 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.753 ' HA2' HG22 ' A' ' 8' ' ' ILE . . . -65.42 -19.97 67.17 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.361 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.758 HD12 ' HG2' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -70.74 -46.01 63.79 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.594 ' N ' ' HG ' ' A' ' 86' ' ' LEU . 7.5 m 48.97 -80.22 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.628 0.771 . . . . 0.0 113.077 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.758 ' HG2' HD12 ' A' ' 86' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.881 -1.057 . . . . 0.0 112.218 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptp . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.638 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 2.4 mm-40 -95.3 165.34 12.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.703 0.287 . . . . 0.0 110.812 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.713 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 2.2 pt20 -163.65 156.38 18.12 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -163.15 118.95 1.76 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.032 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 60.3 p -89.31 152.34 21.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.918 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 59.4 m-85 -142.96 -179.89 6.63 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.899 0.857 . . . . 0.0 112.877 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 7' ' ' THR . 9.7 t -152.88 96.47 2.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.022 -1.444 . . . . 0.0 107.976 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.738 HG22 ' H ' ' A' ' 9' ' ' ILE . 1.7 mt -96.29 -168.97 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.043 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.738 ' H ' HG22 ' A' ' 8' ' ' ILE . 2.7 pp -145.86 15.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 122.314 0.246 . . . . 0.0 111.612 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -75.86 80.98 2.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.625 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -52.4 -22.39 4.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.478 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -37.98 23.21 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.11 -166.25 19.97 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.757 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.672 HD12 HG11 ' A' ' 50' ' ' VAL . 60.5 mt -69.42 81.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.006 0.432 . . . . 0.0 110.815 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.537 ' CE1' ' HB3' ' A' ' 17' ' ' ARG . 14.3 p80 -70.78 -162.16 0.06 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.261 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.51 -28.72 67.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.592 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 31.1 ttp180 -74.94 -62.0 0.95 Allowed Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.665 ' HB2' HG23 ' A' ' 14' ' ' ILE . 36.0 Cg_endo -64.49 -33.34 57.44 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.306 2.004 . . . . 0.0 112.888 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -62.9 -63.21 1.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.883 -0.144 . . . . 0.0 111.062 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.1 m -54.29 -31.85 54.89 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.698 0.285 . . . . 0.0 110.719 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.744 ' HB3' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -64.27 -54.57 31.18 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.596 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.558 HD22 HD13 ' A' ' 44' ' ' LEU . 1.2 mt -58.74 -35.7 73.14 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 19' ' ' ALA . 62.6 t -54.45 -62.24 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.92 -51.51 61.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.747 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.504 HG22 ' HE2' ' A' ' 29' ' ' PHE . 97.0 m -52.73 -61.37 2.33 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.105 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.31 -47.75 84.67 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.102 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.2 p -59.82 -29.02 67.96 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' THR . 3.7 mtpm? -63.43 -54.28 39.02 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.672 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 28.3 m-85 -65.65 -37.68 87.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.125 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 84.07 -20.26 0.32 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.533 -1.667 . . . . 0.0 112.275 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 68' ' ' SER . 81.6 p -67.73 143.19 56.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.475 0.655 . . . . 0.0 112.399 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.34 114.84 18.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.521 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.776 HG21 HD21 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -100.89 114.28 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.851 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.702 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 14.9 pm0 -90.3 107.19 18.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 122.089 0.947 . . . . 0.0 109.318 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.651 HD13 ' HB3' ' A' ' 44' ' ' LEU . 4.5 tt -97.09 114.09 25.72 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.777 -1.556 . . . . 0.0 108.831 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.779 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -92.96 174.77 7.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 125.936 2.022 . . . . 0.0 111.641 -179.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 28.9 t80 -133.22 165.05 25.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.714 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.506 ' HB3' ' CG ' ' A' ' 60' ' ' GLU . 1.2 p-10 -53.22 -14.74 0.74 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.642 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.32 49.27 0.5 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.32 172.52 3.21 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.515 0.197 . . . . 0.0 110.675 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.779 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -160.29 109.65 1.75 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -155.02 -178.18 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.262 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . 4.9 t30 -83.77 136.94 33.96 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.776 HD21 HG21 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -68.81 58.08 0.09 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.076 0.398 . . . . 0.0 111.051 177.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' A' ' 43' ' ' ASN . 1.4 ttmt -65.78 -14.9 62.26 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.665 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.7 OUTLIER 69.3 -49.01 0.6 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.1 mt -52.77 -26.26 10.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.382 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.81 -39.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.86 -52.92 24.13 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.479 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.672 HG11 HD12 ' A' ' 14' ' ' ILE . 15.2 m -67.06 -35.89 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.932 0.366 . . . . 0.0 110.728 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 63.9 mtt -59.87 -48.04 83.32 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.668 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 p -57.68 -51.48 69.36 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.975 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -67.26 -19.19 65.47 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.03 102.41 0.01 OUTLIER Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.951 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 t -100.79 56.84 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.841 0.353 . . . . 0.0 111.106 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.35 -160.46 8.56 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.763 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 1.7 tttm -73.95 134.91 43.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER 76.9 9.61 2.78 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.542 0.526 . . . . 0.0 110.691 -178.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.16 119.61 8.73 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.506 ' CG ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -95.4 135.85 36.5 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.414 ' CD1' HD22 ' A' ' 81' ' ' LEU . 5.8 pt -138.71 172.88 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.394 0.616 . . . . 0.0 112.385 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.711 HG22 ' CE1' ' A' ' 64' ' ' TYR . 7.2 m -151.71 102.54 2.86 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.285 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.844 ' N ' HD13 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -94.0 149.14 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.315 -177.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.713 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 38.2 m-85 -146.82 114.19 6.3 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.297 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.647 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -95.38 126.38 40.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.812 0.339 . . . . 0.0 110.579 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -139.88 92.47 2.56 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.925 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.97 -80.01 0.04 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.439 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 31' ' ' SER . 0.2 OUTLIER -143.52 -68.74 0.33 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 5.5 m-20 -89.86 51.53 2.09 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -69.92 -23.76 63.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.968 -178.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.638 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -86.84 -53.26 5.01 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.604 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.05 -36.69 60.88 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.672 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.86 -54.96 31.31 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.897 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.6 mm -43.31 -51.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.928 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -57.59 -68.88 0.2 Allowed 'General case' 0 C--O 1.239 0.538 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.05 -33.17 68.72 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.723 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.1 mm -62.88 -38.37 81.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.74 -60.23 4.01 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -42.0 -41.04 2.4 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.625 0.578 . . . . 0.0 110.47 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 21' ' ' MET . 7.9 t -65.65 -63.46 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.027 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.414 HD22 ' CD1' ' A' ' 61' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 110.969 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ttt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.732 0.301 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.62 ' CD ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -94.04 164.21 13.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.425 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.583 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -160.94 152.26 19.06 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.329 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.07 133.18 5.87 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.771 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 3.0 t -89.97 157.66 17.74 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.944 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.628 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 4.9 m-85 -138.16 176.38 8.75 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.86 0.838 . . . . 0.0 112.251 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.4 m -145.8 75.52 1.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.492 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.645 HG21 ' CG1' ' A' ' 55' ' ' VAL . 48.2 mt -65.29 163.33 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.489 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.737 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 2.1 pp -136.04 -26.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.761 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 13' ' ' GLY . 10.2 t0 -68.09 87.59 0.27 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.452 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -47.85 -27.54 2.14 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.35 -38.01 27.35 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 10' ' ' ASP . . . 88.56 -114.02 4.17 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.937 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.64 HD11 ' HA ' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -75.88 152.59 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.071 0.462 . . . . 0.0 111.855 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.56 ' CE1' ' HD3' ' A' ' 18' ' ' PRO . 24.9 p80 -170.54 -153.53 0.1 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.967 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.87 79.52 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.531 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -78.89 -55.18 0.99 Allowed Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.56 ' HD3' ' CE1' ' A' ' 15' ' ' HIS . 12.3 Cg_exo -62.69 -41.72 29.63 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.623 2.215 . . . . 0.0 113.122 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.73 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -58.08 -64.4 0.93 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -53.93 -33.23 56.13 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.776 0.322 . . . . 0.0 111.086 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.935 ' HB3' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -66.31 -62.47 1.46 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.513 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.506 HD13 ' HB3' ' A' ' 46' ' ' SER . 0.9 OUTLIER -58.67 -37.03 75.14 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 19' ' ' ALA . 70.7 t -53.51 -60.04 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.1 tt0 -66.49 -52.91 40.94 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.761 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.44 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 94.9 m -52.45 -58.93 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.464 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.45 -48.29 80.31 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.31 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -59.72 -28.36 67.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.726 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -66.11 -52.9 44.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.652 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 13.9 m-85 -66.68 -41.81 87.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.31 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 74.8 -7.28 1.76 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.53 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.6 p -66.13 152.35 44.94 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -73.95 140.22 45.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.821 HG23 ' HB3' ' A' ' 44' ' ' LEU . 3.4 tt -142.59 124.24 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-O 121.137 0.494 . . . . 0.0 111.455 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.696 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 9.8 pt20 -112.0 123.33 50.02 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-O 121.436 0.636 . . . . 0.0 110.217 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.737 HD12 HD12 ' A' ' 44' ' ' LEU . 2.1 tt -109.77 123.12 48.98 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.483 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.753 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -103.14 176.41 5.16 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 125.763 1.914 . . . . 0.0 111.585 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -127.16 162.65 25.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.567 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.47 -10.8 1.03 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.72 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.76 45.5 0.57 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.09 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.84 -177.71 0.65 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.661 0.267 . . . . 0.0 110.984 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.753 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 1.2 tmtp? -158.9 124.8 4.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.336 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.504 ' CG2' HD11 ' A' ' 53' ' ' LEU . 21.9 m -153.45 -173.74 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.269 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -85.75 143.76 28.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.821 ' HB3' HG23 ' A' ' 33' ' ' ILE . 1.1 tt -69.25 57.53 0.11 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -69.64 -38.86 77.31 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.698 ' HA ' HG22 ' A' ' 50' ' ' VAL . 2.5 p 70.9 -50.49 0.68 Allowed 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.724 0.64 . . . . 0.0 112.119 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.5 HD13 ' CD1' ' A' ' 14' ' ' ILE . 46.7 mm -53.44 -25.95 11.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.168 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.434 ' HA ' ' HB2' ' A' ' 51' ' ' MET . 14.4 mtp -166.64 -39.27 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.669 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.66 -52.09 26.0 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.979 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.698 HG22 ' HA ' ' A' ' 46' ' ' SER . 6.7 m -72.91 -37.98 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.592 0.196 . . . . 0.0 110.54 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.434 ' HB2' ' HA ' ' A' ' 48' ' ' MET . 0.6 OUTLIER -56.84 -53.19 60.67 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.308 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.5 p -58.02 -37.56 74.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.361 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.504 HD11 ' CG2' ' A' ' 42' ' ' VAL . 6.2 mt -60.9 -30.81 70.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.409 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.76 -42.57 1.87 Allowed Glycine 0 C--N 1.339 0.716 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.265 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 50' ' ' VAL . 72.4 t 35.9 63.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 11' ' ' GLU . . . -86.94 -172.52 48.37 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.109 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.737 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 5.9 tttt -76.11 126.28 30.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 86.45 11.19 0.19 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.885 0.741 . . . . 0.0 110.916 -178.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.92 121.56 13.27 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 120.736 0.303 . . . . 0.0 111.693 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.16 135.99 33.26 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.803 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.821 HD12 HD11 ' A' ' 63' ' ' ILE . 45.1 pt -147.0 176.64 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.14 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.577 ' C ' HD13 ' A' ' 63' ' ' ILE . 14.6 m -152.57 109.9 3.55 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.002 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.821 HD11 HD12 ' A' ' 61' ' ' ILE . 1.1 mm -94.25 154.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.481 -178.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.696 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 57.7 m-85 -141.16 117.61 10.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.539 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.3 129.89 46.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.872 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -134.5 96.05 3.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.138 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.49 -154.47 17.81 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.746 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.0 p -71.95 -59.2 2.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.158 0.479 . . . . 0.0 111.724 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.652 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.6 m-20 -93.47 36.59 1.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.423 0.154 . . . . 0.0 111.407 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.69 -22.36 66.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.91 -56.67 3.29 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.74 -30.34 65.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.738 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -50.18 -63.11 1.22 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.548 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.62 HG12 ' CD ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -43.75 -43.38 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -58.4 -71.72 0.11 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.778 0.323 . . . . 0.0 111.368 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.04 -33.36 67.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.503 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.16 -38.71 80.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.983 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 -56.12 25.9 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -47.23 -42.71 20.88 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.148 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.935 HG22 ' HB3' ' A' ' 21' ' ' MET . 7.8 t -65.76 -63.38 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.461 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 120.856 0.36 . . . . 0.0 110.421 179.548 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.813 0.339 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.646 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mm-40 -95.67 162.48 13.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.388 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.735 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.6 OUTLIER -166.2 152.93 9.39 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -164.83 121.91 1.57 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.629 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 p -89.65 150.71 22.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.807 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 41.8 m-85 -142.5 176.57 8.92 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.569 0.699 . . . . 0.0 111.815 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 7' ' ' THR . 14.8 t -153.48 111.96 3.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.173 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.5 HD13 ' O ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -132.92 175.3 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -176.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.45 ' H ' HG22 ' A' ' 8' ' ' ILE . 2.1 pp -95.28 15.17 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.124 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -69.48 78.04 0.4 Allowed 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.212 0.53 . . . . 0.0 111.545 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.463 ' HG2' ' CB ' ' A' ' 57' ' ' LYS . 1.1 tm-20 -52.24 -32.08 35.21 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.901 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.0 p -82.43 -35.28 27.74 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.98 -86.28 1.25 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.278 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.528 HG23 ' HB2' ' A' ' 18' ' ' PRO . 4.3 mp -137.39 71.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.21 0.528 . . . . 0.0 110.309 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.451 ' N ' ' HG2' ' A' ' 18' ' ' PRO . 11.2 p80 -69.78 -156.23 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.641 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.1 -33.28 71.9 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.554 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 1.3 ttp85 -73.73 -63.5 0.93 Allowed Pre-proline 0 N--CA 1.467 0.382 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.519 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.554 ' CD ' ' HB3' ' A' ' 17' ' ' ARG . 21.4 Cg_endo -60.42 -29.71 89.32 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.505 2.137 . . . . 0.0 112.719 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.607 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -62.5 -64.56 0.89 Allowed 'General case' 0 C--N 1.339 0.132 0 CA-C-N 116.857 -0.156 . . . . 0.0 110.812 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 m -53.73 -32.16 51.05 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 110.604 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -55.43 20.43 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.395 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.632 HD22 HD13 ' A' ' 44' ' ' LEU . 1.3 mt -58.41 -34.17 70.47 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.115 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 19' ' ' ALA . 67.3 t -55.44 -64.57 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -64.93 -44.12 90.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 123.194 0.309 . . . . 0.0 111.672 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.454 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 52.0 m -56.33 -61.32 2.48 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.594 0.235 . . . . 0.0 110.409 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.76 98.0 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.469 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -58.42 -32.95 69.14 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.232 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 25' ' ' THR . 24.9 mtmm -63.55 -52.68 60.01 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.609 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 43.4 m-85 -66.68 -35.54 80.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.667 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 82.5 -20.84 0.33 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.868 -1.515 . . . . 0.0 111.502 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.429 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 88.7 p -68.7 132.33 46.68 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.725 0.774 . . . . 0.0 112.219 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.24 115.44 19.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.686 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.876 HG21 HD21 ' A' ' 44' ' ' LEU . 2.9 mt -97.48 123.62 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.464 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.752 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 1.4 pt20 -94.76 104.15 16.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.574 ' HB2' HD23 ' A' ' 44' ' ' LEU . 5.5 tt -99.44 119.37 37.88 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.029 -1.441 . . . . 0.0 110.176 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.76 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -93.98 169.6 10.16 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 126.023 2.077 . . . . 0.0 110.466 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.968 ' HB3' HD22 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -145.52 97.6 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.509 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 49.93 -59.5 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 37' ' ' TYR . . . -138.62 33.05 2.25 Favored Glycine 0 C--N 1.318 -0.468 0 C-N-CA 121.816 -0.23 . . . . 0.0 112.738 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.464 ' HB3' HD21 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -138.33 171.04 14.97 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.76 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 1.2 tmtm? -156.56 109.88 2.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.934 0.397 . . . . 0.0 111.736 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.4 m -153.78 173.07 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.084 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -81.89 131.89 35.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.876 HD21 HG21 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -67.66 56.81 0.06 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.858 0.361 . . . . 0.0 110.987 177.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' O ' HD12 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -66.89 -17.71 65.03 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.727 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.95 -47.64 0.67 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 45' ' ' LYS . 3.2 mt -52.82 -26.44 10.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.329 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.511 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 13.0 mtp -167.79 -37.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.19 60.06 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.182 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.727 HG22 ' HA ' ' A' ' 46' ' ' SER . 24.8 m -69.29 -50.2 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.511 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -59.0 -41.36 87.46 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.614 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.4 t -57.9 -41.3 82.32 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.216 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.968 HD22 ' HB3' ' A' ' 37' ' ' TYR . 38.7 mt -64.58 -52.57 56.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.821 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.64 -49.03 0.92 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.417 -0.421 . . . . 0.0 113.14 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t 36.49 79.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.437 ' C ' ' HA ' ' A' ' 11' ' ' GLU . . . -76.47 -163.36 15.94 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.902 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.601 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 7.3 tttt -74.34 134.86 42.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.601 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER 76.69 9.29 2.97 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.519 0.512 . . . . 0.0 110.41 -178.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.18 136.79 58.1 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 152.21 20.62 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.528 HD11 HD22 ' A' ' 81' ' ' LEU . 12.5 pt -145.66 172.7 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.093 0.473 . . . . 0.0 111.924 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.751 HG22 ' CE1' ' A' ' 64' ' ' TYR . 5.6 m -149.21 103.28 3.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.446 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.867 ' N ' HD13 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -96.64 145.06 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.612 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.752 ' HB2' ' HG3' ' A' ' 34' ' ' GLN . 11.2 m-85 -145.53 111.33 5.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.052 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.704 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -91.13 133.51 35.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.329 0.585 . . . . 0.0 111.767 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -130.88 101.24 5.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.79 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . 174.57 -158.94 27.52 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.7 p -71.53 -60.79 2.05 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.27 1.035 . . . . 0.0 111.133 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.609 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 9.7 m-20 -91.48 42.92 1.12 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.57 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -66.28 -22.47 66.3 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.974 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.646 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -88.29 -46.77 8.93 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.12 -40.21 64.03 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.55 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -54.99 -54.55 41.5 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.441 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 mm -48.43 -47.49 14.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.502 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -55.52 -70.96 0.09 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.78 -37.26 73.39 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.1 mm -60.85 -41.75 89.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.529 0.204 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 79' ' ' ASP . 14.6 m -60.59 -63.59 1.25 Allowed 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.456 ' C ' ' O ' ' A' ' 78' ' ' THR . 45.8 m-20 -34.39 -43.82 0.17 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.034 0.445 . . . . 0.0 110.142 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.1 t -66.68 -66.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.114 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.528 HD22 HD11 ' A' ' 61' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.194 0.521 . . . . 0.0 110.644 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.568 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mm-40 -99.02 159.21 15.12 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.461 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.725 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -159.58 156.69 28.47 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 2.6 mm-40 -162.25 164.63 27.53 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.422 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.457 ' HB3' HG23 ' A' ' 62' ' ' THR . 46.2 p -153.66 139.5 18.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.906 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -144.7 -177.59 5.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.396 0.617 . . . . 0.0 111.392 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 t -153.19 116.83 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.576 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.555 HG22 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -134.98 177.5 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -176.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.555 ' H ' HG22 ' A' ' 8' ' ' ILE . 17.3 pt -94.07 16.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.747 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -68.58 73.97 0.25 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.329 0.585 . . . . 0.0 111.642 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 57' ' ' LYS . 2.9 tt0 -59.38 -25.26 64.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.048 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -80.01 -33.67 39.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.51 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . 48.66 81.43 0.05 OUTLIER Glycine 0 C--N 1.341 0.836 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.894 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 25.5 mm 71.82 127.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.802 0.334 . . . . 0.0 111.031 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 10.7 p80 -166.76 -119.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.314 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 18' ' ' PRO . . . -69.32 -167.13 0.11 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 118.777 -0.63 . . . . 0.0 109.881 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.667 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 12.29 -73.03 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.667 ' CD ' ' HB3' ' A' ' 17' ' ' ARG . 4.5 Cg_exo -40.31 -45.97 4.26 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.67 2.913 . . . . 0.0 113.212 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 15' ' ' HIS . . . -64.25 -56.22 16.1 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 121.258 -0.177 . . . . 0.0 111.146 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.2 m -50.84 -34.29 27.23 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.921 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 mmm -62.93 -50.45 70.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.291 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -35.61 70.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.852 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.68 -59.06 2.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -66.18 -50.93 62.21 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.301 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.694 HG22 ' HE2' ' A' ' 29' ' ' PHE . 84.8 m -52.69 -60.46 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.47 89.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.579 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.5 t -59.48 -29.4 67.8 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.375 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 25' ' ' THR . 3.5 mtpm? -63.98 -51.46 64.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.694 ' HE2' HG22 ' A' ' 25' ' ' THR . 30.3 m-85 -64.59 -39.66 94.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.746 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 76.5 -14.21 0.84 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.27 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.8 p -68.31 144.91 54.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.384 0.611 . . . . 0.0 112.383 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.48 110.19 13.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.734 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.732 HG23 HG23 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -101.27 119.9 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.46 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.686 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 15.8 pm0 -101.03 113.11 25.8 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.105 HD13 HD13 ' A' ' 44' ' ' LEU . 1.5 tt -103.47 120.83 41.6 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.585 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.779 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.6 OUTLIER -94.87 175.99 6.43 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 126.136 2.147 . . . . 0.0 111.251 -179.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -128.53 166.72 18.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.241 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.43 ' CA ' ' HG3' ' A' ' 60' ' ' GLU . 7.6 t-20 -46.62 -21.02 0.15 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.23 55.55 0.39 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.86 -179.7 1.22 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.631 0.253 . . . . 0.0 110.999 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.779 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -158.89 118.81 3.13 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.446 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.401 ' CG2' HD23 ' A' ' 53' ' ' LEU . 21.3 m -153.26 -173.68 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.976 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -86.45 144.39 27.31 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.105 HD13 HD13 ' A' ' 35' ' ' LEU . 6.8 tp -68.81 59.09 0.09 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -67.78 -32.05 72.36 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.472 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.7 OUTLIER 69.59 -52.28 0.61 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.423 0.63 . . . . 0.0 112.183 -179.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.8 mt -53.31 -26.2 11.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.213 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.9 mtp -167.56 -39.19 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.628 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -48.22 -47.51 27.32 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.286 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.485 ' HA ' HD21 ' A' ' 53' ' ' LEU . 33.7 m -69.56 -38.71 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.705 0.288 . . . . 0.0 110.899 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.3 mtt -59.63 -47.07 87.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.798 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.4 p -58.71 -48.44 81.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.479 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.485 HD21 ' HA ' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -66.88 -11.07 54.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.44 117.04 0.04 OUTLIER Glycine 0 C--N 1.339 0.746 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.223 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.44 ' HB ' ' HA3' ' A' ' 13' ' ' GLY . 2.5 t -120.2 70.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.754 0.311 . . . . 0.0 111.814 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.25 -167.03 32.94 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.35 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 7.2 tttm -71.82 134.76 46.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.571 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER 76.59 12.8 2.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.553 0.533 . . . . 0.0 111.04 -179.111 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.69 131.92 52.23 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HG3' ' CA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -103.18 144.87 30.75 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.292 179.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 pt -146.79 169.09 5.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.714 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.569 HG22 ' CE1' ' A' ' 64' ' ' TYR . 16.9 m -152.44 107.49 3.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.734 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.768 ' CG1' HD12 ' A' ' 35' ' ' LEU . 4.8 mp -96.96 148.09 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.725 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 25.8 m-85 -138.24 114.94 10.62 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.904 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.55 ' HB2' HG13 ' A' ' 33' ' ' ILE . . . -93.46 130.56 39.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.212 0.529 . . . . 0.0 111.459 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -131.48 96.68 4.04 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.751 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.89 -154.77 18.07 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.523 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.4 p -74.63 -60.68 2.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.704 0.752 . . . . 0.0 111.25 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.631 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 5.9 m-20 -91.52 41.22 1.06 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.897 0.38 . . . . 0.0 110.573 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.427 ' HG3' ' CG ' ' A' ' 2' ' ' GLU . 15.0 pt-20 -66.2 -28.52 68.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.974 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.568 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -85.78 -44.02 12.84 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.89 -40.89 67.0 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.612 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -54.68 -54.39 42.38 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.105 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.7 mm -49.6 -49.85 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.961 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -54.78 -69.04 0.14 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.62 -38.07 68.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.607 0.242 . . . . 0.0 111.35 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 73' ' ' ALA . 14.4 mm -61.33 -37.71 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.638 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -62.05 2.14 Favored 'General case' 0 C--O 1.207 -1.164 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -39.56 -43.87 1.37 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.594 0.559 . . . . 0.0 110.436 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.5 t -63.74 -64.64 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.448 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.512 HD23 HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.374 0 CA-C-O 121.011 0.434 . . . . 0.0 110.651 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptp . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.741 ' OE1' ' HB3' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -98.05 164.51 12.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.761 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -157.49 160.19 38.01 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.542 ' HG3' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -160.82 123.09 3.14 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.173 179.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 p -94.07 156.59 16.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.692 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -144.48 177.53 8.59 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.654 0.74 . . . . 0.0 111.992 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.6 ' O ' HD13 ' A' ' 8' ' ' ILE . 14.6 t -160.43 104.1 1.42 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.469 -1.242 . . . . 0.0 107.918 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER -142.69 -175.74 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.036 -175.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.723 HG22 ' HA ' ' A' ' 57' ' ' LYS . 14.7 pt -136.89 -41.35 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 t70 44.89 27.7 0.29 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.771 0.26 . . . . 0.0 111.634 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.411 ' OE2' HD12 ' A' ' 9' ' ' ILE . 19.2 mm-40 33.5 34.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.451 0.7 . . . . 0.0 112.741 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER 175.94 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.922 179.236 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.74 -56.93 0.97 Allowed Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.488 HD13 HG23 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -141.11 174.25 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.105 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -171.64 -59.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -174.95 -35.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.457 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -72.13 -56.73 4.21 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 -179.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 36.9 Cg_endo -65.29 -33.49 48.26 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.292 1.995 . . . . 0.0 112.149 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.61 ' HA ' ' HB2' ' A' ' 46' ' ' SER . . . -62.73 -65.0 0.75 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.084 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.1 p -55.29 -28.91 56.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.282 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.789 ' HB3' HG22 ' A' ' 80' ' ' VAL . 1.4 mtt -63.16 -55.59 23.85 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.797 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.497 HD22 ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -58.91 -34.57 71.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.075 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 19' ' ' ALA . 73.8 t -54.55 -57.28 6.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.64 -55.97 14.67 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.517 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 29.4 p -52.89 -57.5 10.05 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.547 0.202 . . . . 0.0 111.547 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.14 -47.72 84.91 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.822 -0.172 . . . . 0.0 110.979 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 23.5 m -60.28 -30.97 69.8 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.784 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' ' 25' ' ' THR . 4.9 mtmp? -63.76 -51.38 65.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 14.2 m-85 -64.58 -37.49 87.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.984 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 80.84 -15.5 0.73 Allowed 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.582 -1.644 . . . . 0.0 112.681 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.443 ' HB3' ' H ' ' A' ' 68' ' ' SER . 83.4 p -66.09 145.6 55.65 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.416 0.626 . . . . 0.0 112.263 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.04 109.11 13.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.098 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.848 ' CG1' ' HB2' ' A' ' 65' ' ' ALA . 1.3 mt -99.53 125.15 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.909 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.665 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -103.77 113.45 26.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.643 0.735 . . . . 0.0 109.258 178.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.023 HD13 HD13 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -101.34 114.12 27.83 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.935 -179.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.536 ' HG3' ' HG2' ' A' ' 41' ' ' LYS . 1.5 tt0 -91.72 173.65 7.76 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 126.262 2.226 . . . . 0.0 110.772 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.427 ' CG ' ' HB2' ' A' ' 53' ' ' LEU . 32.3 t80 -132.35 163.57 28.41 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.084 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.626 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -51.65 -15.48 0.47 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -156.68 50.12 0.44 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.197 -0.525 . . . . 0.0 111.826 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -178.88 -178.51 0.55 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.666 0.27 . . . . 0.0 110.906 -179.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 1.7 tmtt? -157.83 120.84 3.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.448 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.4 m -151.43 -175.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.512 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.25 140.87 29.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.023 HD13 HD13 ' A' ' 35' ' ' LEU . 1.6 tp -69.65 56.83 0.13 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.593 0.235 . . . . 0.0 110.582 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.509 ' O ' HD12 ' A' ' 47' ' ' ILE . 3.9 tptp -73.16 9.56 1.2 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.61 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . 89.8 p 39.64 34.24 0.15 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 46' ' ' SER . 2.2 mp -166.16 -84.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.54 ' N ' HG22 ' A' ' 47' ' ' ILE . 3.4 tpp -63.98 -37.27 86.82 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -82.43 0.1 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.475 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.488 HG23 HD13 ' A' ' 14' ' ' ILE . 3.1 m -40.0 -42.06 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.0 mtt -59.07 -50.11 75.32 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.509 0.195 . . . . 0.0 111.233 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.4 t -56.47 -52.64 63.94 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.226 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.427 ' HB2' ' CG ' ' A' ' 37' ' ' TYR . 0.6 OUTLIER -67.31 -18.01 65.0 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.59 101.3 0.05 OUTLIER Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.55 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.442 ' CG2' ' HB ' ' A' ' 50' ' ' VAL . 19.5 t -90.98 75.99 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.939 0.4 . . . . 0.0 111.22 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.12 -161.99 37.12 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.375 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.723 ' HA ' HG22 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -72.63 127.43 32.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 82.33 18.24 0.34 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.698 0.624 . . . . 0.0 110.42 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.88 115.27 2.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.299 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.626 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 2.1 tt0 -96.83 139.63 32.58 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.753 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.82 170.11 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.154 0.502 . . . . 0.0 111.812 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.562 ' C ' HD13 ' A' ' 63' ' ' ILE . 7.0 m -152.55 107.0 3.16 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.928 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.847 ' CD1' HD12 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -94.99 146.59 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.761 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 40.8 m-85 -145.49 108.82 4.63 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.468 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.848 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -98.0 133.54 42.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.838 0.351 . . . . 0.0 110.559 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.82 78.17 1.66 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.569 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -147.76 -89.7 0.08 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.702 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.443 ' H ' ' HB3' ' A' ' 31' ' ' SER . 11.3 p -132.39 -65.65 0.72 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.918 0.359 . . . . 0.0 111.285 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.462 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.4 m-20 -89.69 41.19 1.03 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.867 0.365 . . . . 0.0 110.639 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -24.28 66.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.055 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.28 -53.21 5.92 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -32.91 66.13 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.989 0.423 . . . . 0.0 109.876 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -49.09 -56.49 8.94 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.992 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.58 HD11 ' HG2' ' A' ' 2' ' ' GLU . 15.1 mm -42.64 -55.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.83 -67.62 0.25 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.78 68.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.47 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.92 -37.76 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.558 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -56.32 23.57 Favored 'General case' 0 C--O 1.209 -1.055 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -45.6 -41.07 9.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.089 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.789 HG22 ' HB3' ' A' ' 21' ' ' MET . 6.2 t -65.26 -62.97 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.181 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.973 0.416 . . . . 0.0 110.617 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ttt . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.735 0.302 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.605 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 3.1 mm-40 -95.28 164.58 12.78 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.525 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.7 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 2.3 pt20 -161.78 152.77 18.05 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.777 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.494 ' HB3' ' CE1' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -160.87 122.61 3.03 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.986 0.422 . . . . 0.0 111.967 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.7 p -90.71 155.06 19.1 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.994 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 4' ' ' GLN . 87.4 m-85 -143.45 -179.92 6.72 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 122.009 0.909 . . . . 0.0 112.814 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 7' ' ' THR . 11.8 t -152.06 95.8 2.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.606 -1.633 . . . . 0.0 106.833 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.622 HG22 ' H ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -93.4 179.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.721 -175.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.622 ' H ' HG22 ' A' ' 8' ' ' ILE . 1.6 pp -148.5 27.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.665 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.34 78.13 1.01 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.98 0.419 . . . . 0.0 110.343 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.645 ' HG3' ' HB2' ' A' ' 57' ' ' LYS . 1.8 mp0 -54.06 -22.72 11.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.788 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -41.27 37.85 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.75 85.97 0.09 OUTLIER Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.773 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.429 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER 69.17 145.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.134 0.492 . . . . 0.0 111.795 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -171.56 -63.65 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.605 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.678 ' C ' ' HD2' ' A' ' 18' ' ' PRO . . . -178.06 163.51 1.74 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.799 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.538 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 98.51 -60.49 0.0 OUTLIER Pre-proline 0 C--N 1.364 1.229 0 CA-C-N 118.934 0.788 . . . . 0.0 112.743 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.678 ' HD2' ' C ' ' A' ' 16' ' ' ALA . 56.5 Cg_endo -70.65 -27.77 21.79 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.804 1.669 . . . . 0.0 112.471 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.615 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.47 -65.61 0.66 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.695 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.6 m -55.02 -32.98 62.25 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.704 0.288 . . . . 0.0 110.51 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.564 ' HE3' HG22 ' A' ' 80' ' ' VAL . 21.1 mtm -64.83 -53.78 41.37 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.408 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.769 HD11 ' CD2' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -57.98 -37.38 74.11 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.19 179.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 19' ' ' ALA . 62.3 t -54.1 -60.16 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -49.65 64.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.431 ' O ' ' CD2' ' A' ' 29' ' ' PHE . 73.5 p -58.13 -58.96 6.13 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.389 0.086 . . . . 0.0 111.051 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.59 85.69 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.744 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.5 t -59.37 -33.07 70.73 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -66.49 -51.4 57.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.602 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.613 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 13.9 m-85 -66.33 -40.78 90.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.509 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 78.36 -20.41 0.39 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.593 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.539 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 93.2 p -66.52 140.09 57.97 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.623 0.725 . . . . 0.0 112.415 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.57 112.84 19.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.112 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.696 HG13 ' HB2' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -97.73 121.38 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.677 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.674 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 1.8 pt20 -101.61 107.41 18.67 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.987 HD13 ' HG ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -99.63 116.25 31.31 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.085 -179.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.697 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -93.91 172.23 8.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 125.973 2.046 . . . . 0.0 110.736 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.559 ' CD1' HD11 ' A' ' 53' ' ' LEU . 13.0 t80 -125.4 166.82 15.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.092 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.562 ' HB3' ' CG ' ' A' ' 60' ' ' GLU . 0.7 OUTLIER -53.58 -14.98 0.96 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.82 46.69 0.51 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.102 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HE3' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -173.04 -177.36 1.57 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.798 0.333 . . . . 0.0 111.244 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.697 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 3.0 tmtm? -158.12 117.76 3.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.802 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 m -152.3 -172.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.095 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -86.59 142.67 28.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.987 ' HG ' HD13 ' A' ' 35' ' ' LEU . 4.2 tt -68.68 58.45 0.09 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -41.9 71.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.731 ' HA ' HG22 ' A' ' 50' ' ' VAL . 1.0 OUTLIER 71.27 -51.99 0.69 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.425 0.631 . . . . 0.0 111.897 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -53.06 -27.28 13.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.316 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.562 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 12.8 mtp -167.3 -39.07 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.76 -56.1 12.57 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.17 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.731 HG22 ' HA ' ' A' ' 46' ' ' SER . 18.6 m -68.05 -50.26 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.562 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -59.48 -40.14 85.97 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.375 0.131 . . . . 0.0 111.3 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -57.21 -51.54 68.92 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.625 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.559 HD11 ' CD1' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -66.97 -35.09 79.2 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.07 179.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.415 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . 128.69 126.52 2.87 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.711 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 51' ' ' MET . 44.1 t -127.1 107.57 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.591 0.234 . . . . 0.0 111.127 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.0 174.09 18.3 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.513 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.645 ' HB2' ' HG3' ' A' ' 11' ' ' GLU . 15.1 tttt -70.06 136.39 50.26 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.582 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 86.2 5.2 0.42 Allowed 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.651 0.594 . . . . 0.0 111.061 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.86 119.13 7.13 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.562 ' CG ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -94.81 145.74 24.67 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.578 HD13 HD11 ' A' ' 8' ' ' ILE . 5.5 pt -147.48 175.65 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.573 ' C ' HD13 ' A' ' 63' ' ' ILE . 4.2 m -151.86 107.03 3.28 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.767 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.76 ' N ' HD13 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -96.05 152.3 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.114 -177.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.7 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 51.9 m-85 -146.26 110.24 4.95 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.66 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.696 ' HB2' HG13 ' A' ' 33' ' ' ILE . . . -93.47 126.51 38.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.025 0.441 . . . . 0.0 110.705 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -125.8 94.68 4.18 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.109 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.539 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . 179.88 -159.17 23.38 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.067 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.2 p -69.95 -60.97 1.97 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.104 0.952 . . . . 0.0 111.605 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.582 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 4.2 m-20 -91.79 45.26 1.21 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.849 0.357 . . . . 0.0 110.824 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.605 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 9.5 pt-20 -67.1 -22.53 65.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.12 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.568 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -88.63 -45.58 9.74 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -38.64 67.33 Favored 'General case' 0 C--N 1.342 0.281 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.613 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -52.34 -56.88 11.95 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.49 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.0 mm -44.82 -45.64 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.791 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.73 -70.76 0.15 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.86 -32.49 65.88 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.12 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 73' ' ' ALA . 11.0 mm -62.43 -36.55 75.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -51.78 68.36 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -46.11 -42.85 14.25 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.743 0.652 . . . . 0.0 109.923 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.564 HG22 ' HE3' ' A' ' 21' ' ' MET . 2.4 t -61.14 -57.79 10.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.152 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.679 0.276 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.597 ' CG ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -101.5 160.04 14.77 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.601 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.734 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -150.31 149.86 30.69 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.684 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.83 162.43 32.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.366 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.446 ' HB3' HG23 ' A' ' 62' ' ' THR . 30.6 p -154.17 148.16 25.64 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.745 0.307 . . . . 0.0 111.527 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -144.01 -176.9 5.18 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.415 0.626 . . . . 0.0 111.329 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 7' ' ' THR . 15.3 t -153.53 113.31 3.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.76 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.532 HG22 ' H ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER -136.65 -172.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 58' ' ' ASP . 21.4 pt -137.24 -40.69 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.489 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 12' ' ' THR . 36.3 t70 46.27 22.41 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 10' ' ' ASP . 20.5 mm-40 25.25 41.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.743 0.817 . . . . 0.0 112.325 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.84 HG21 ' HB3' ' A' ' 15' ' ' HIS . 2.8 m -176.4 -37.09 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.833 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.88 -75.06 1.45 Allowed Glycine 0 C--N 1.347 1.186 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.773 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.635 ' CG2' ' HB2' ' A' ' 19' ' ' ALA . 18.2 mm -139.54 81.94 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.848 0.356 . . . . 0.0 110.063 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.84 ' HB3' HG21 ' A' ' 12' ' ' THR . 10.4 p80 -66.27 -52.56 46.38 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.054 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -178.42 -35.39 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.577 ' HD2' ' HG3' ' A' ' 21' ' ' MET . 3.2 tmm_? -71.47 -53.54 7.57 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 10.0 Cg_endo -52.52 -45.18 41.75 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.541 2.161 . . . . 0.0 112.765 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.635 ' HB2' ' CG2' ' A' ' 14' ' ' ILE . . . -64.36 -64.7 0.81 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.2 m -52.9 -32.14 43.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.374 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.577 ' HG3' ' HD2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -66.1 -49.27 68.13 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.972 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.94 HD22 HD22 ' A' ' 44' ' ' LEU . 3.8 mt -55.75 -38.91 70.45 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.919 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.407 ' O ' ' CB ' ' A' ' 27' ' ' SER . 58.3 t -57.45 -65.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.422 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -45.68 84.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.596 HG22 ' HE2' ' A' ' 29' ' ' PHE . 95.0 m -57.15 -62.35 1.82 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.441 0.163 . . . . 0.0 110.783 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.38 -46.49 88.53 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.636 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 33.0 t -59.01 -29.64 67.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.595 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 25' ' ' THR . 17.4 mtmm -64.18 -52.78 57.29 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.696 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 38.4 m-85 -64.52 -36.5 84.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.047 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 82.44 -16.19 0.62 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.216 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.749 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 86.4 p -66.94 135.13 53.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.459 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.97 110.31 9.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.228 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.063 ' CG2' HG23 ' A' ' 63' ' ' ILE . 4.1 mt -98.64 126.59 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.613 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.637 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 3.6 pt20 -98.18 105.44 17.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 6.2 tt -96.63 112.47 24.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.313 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.796 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -95.16 175.84 6.46 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 125.904 2.003 . . . . 0.0 112.471 -178.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -129.12 163.12 26.18 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.494 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 0.7 OUTLIER -55.02 -11.36 0.64 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.66 48.18 0.51 Allowed Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.72 -179.19 0.61 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.714 0.292 . . . . 0.0 110.983 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.796 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -159.18 119.94 3.22 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.493 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.4 m -153.34 -172.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.708 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.532 ' ND2' HD12 ' A' ' 44' ' ' LEU . 6.5 t30 -89.26 148.73 23.42 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.94 HD22 HD22 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -62.92 50.97 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 177.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 43' ' ' ASN . 4.0 mptt -59.34 -41.23 88.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.64 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.12 -52.17 0.7 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.449 0.643 . . . . 0.0 111.737 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.03 -24.15 14.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.774 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.1 mtm -167.27 -39.29 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.246 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -50.12 -49.32 37.22 Favored Glycine 0 C--N 1.34 0.788 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.113 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.64 HG22 ' HA ' ' A' ' 46' ' ' SER . 16.7 m -71.49 -36.3 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.811 0.305 . . . . 0.0 110.559 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 56.3 mtt -59.72 -46.76 88.12 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.464 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.7 p -58.78 -49.82 76.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.934 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.479 HD21 ' HA ' ' A' ' 50' ' ' VAL . 1.1 pp -66.96 -12.73 60.56 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.31 109.8 0.06 OUTLIER Glycine 0 C--N 1.34 0.762 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.927 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 t -107.12 59.82 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.989 0.424 . . . . 0.0 110.924 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.87 -156.96 24.42 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.788 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 3.7 tttt -74.28 126.13 29.95 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.618 ' H ' HG22 ' A' ' 9' ' ' ILE . 0.2 OUTLIER 85.28 13.38 0.21 Allowed 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.822 0.701 . . . . 0.0 110.69 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.64 117.38 4.87 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.779 0.323 . . . . 0.0 111.425 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 1.5 tt0 -99.88 139.71 35.15 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.639 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.35 167.71 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.768 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 5' ' ' SER . 18.7 m -151.21 114.74 4.87 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.48 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.063 HG23 ' CG2' ' A' ' 33' ' ' ILE . 3.2 mp -99.58 133.6 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.19 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.734 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 50.6 m-85 -129.91 104.24 7.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.362 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.747 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -95.0 132.07 40.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.176 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.45 78.17 1.5 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.055 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.749 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -164.95 20.8 0.12 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.712 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 67' ' ' GLY . 59.5 p 121.96 -81.94 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.256 1.022 . . . . 0.0 111.914 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.696 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 8.0 m-20 -87.2 46.22 1.35 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.439 0.638 . . . . 0.0 109.997 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -70.5 -21.43 62.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.267 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.96 -51.75 6.17 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -34.52 62.54 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.199 178.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.641 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.75 -63.78 1.04 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.171 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.597 HG12 ' CG ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -48.08 -41.51 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -59.1 -69.33 0.2 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.641 0.258 . . . . 0.0 111.234 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.97 67.79 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.472 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.4 mm -60.26 -38.74 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.152 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.78 -57.9 10.45 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -44.47 -39.8 5.07 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.762 0.664 . . . . 0.0 110.525 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.503 HG22 ' SD ' ' A' ' 21' ' ' MET . 3.3 t -64.17 -60.84 2.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.605 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.426 HD23 HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 110.62 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.725 0.298 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.609 ' HG3' ' N ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -100.39 164.07 12.09 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.57 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.713 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -155.41 159.11 39.61 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.473 ' HG3' HG23 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -156.41 174.39 15.48 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.495 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.7 p -153.03 146.85 25.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.005 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -138.45 -175.43 4.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.864 0.84 . . . . 0.0 113.19 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 7' ' ' THR . 6.7 t -150.31 74.8 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.917 -1.492 . . . . 0.0 107.685 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.457 HD12 ' CG1' ' A' ' 55' ' ' VAL . 73.0 mt -51.02 160.04 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 113.764 -1.562 . . . . 0.0 113.298 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 pp -151.09 4.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 4.4 t70 -74.13 15.54 0.31 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 8.1 mp0 72.1 -63.25 0.43 Allowed 'General case' 0 C--O 1.231 0.124 0 C-N-CA 122.915 0.486 . . . . 0.0 110.422 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 m -85.7 -25.5 26.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.58 -81.09 1.38 Allowed Glycine 0 C--N 1.343 0.963 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.735 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.729 HG23 ' O ' ' A' ' 14' ' ' ILE . 1.1 tp -103.98 62.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.887 0.851 . . . . 0.0 110.548 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -61.34 -52.58 64.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.854 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.56 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -70.33 -57.09 6.1 Favored Pre-proline 0 CA--C 1.53 0.184 0 N-CA-C 110.696 -0.113 . . . . 0.0 110.696 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HG2' ' HA ' ' A' ' 14' ' ' ILE . 32.4 Cg_endo -63.18 -31.23 74.98 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.167 1.912 . . . . 0.0 111.925 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.593 ' HB2' HG13 ' A' ' 14' ' ' ILE . . . -63.62 -64.9 0.77 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.22 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.2 p -53.62 -31.9 49.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.004 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.469 ' HB3' HG21 ' A' ' 80' ' ' VAL . 1.5 mmt -65.64 -52.7 49.81 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.71 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.558 HD13 ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -56.78 -37.63 71.39 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 179.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 19' ' ' ALA . 57.6 t -55.29 -57.07 8.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.427 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.9 tt0 -66.24 -55.96 13.63 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.937 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.434 ' OG1' ' HA ' ' A' ' 22' ' ' LEU . 54.1 p -53.48 -57.77 9.5 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.917 -0.129 . . . . 0.0 111.299 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.51 -46.62 86.36 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 7.7 m -59.26 -34.7 72.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.057 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 25' ' ' THR . 37.1 mtmt -65.39 -49.96 67.31 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.643 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 19.5 m-85 -64.82 -37.31 87.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.29 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 76.49 -13.35 0.93 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.868 -1.515 . . . . 0.0 112.184 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.483 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 92.6 p -67.97 139.89 56.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.483 0.659 . . . . 0.0 112.179 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.73 107.94 12.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.258 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.684 ' CG1' ' HB2' ' A' ' 65' ' ' ALA . 1.0 OUTLIER -97.84 126.0 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.285 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.754 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 4.7 pt20 -105.87 106.86 17.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.014 HD13 HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -101.22 121.11 41.28 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.881 -178.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.743 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -96.35 172.96 7.62 Favored 'General case' 0 C--N 1.341 0.217 0 O-C-N 126.211 2.194 . . . . 0.0 109.911 179.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.589 ' O ' ' N ' ' A' ' 39' ' ' GLY . 2.1 t80 -146.7 100.92 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.829 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.424 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER 49.6 -59.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 37' ' ' TYR . . . -143.17 37.26 1.51 Allowed Glycine 0 C--N 1.317 -0.515 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -142.65 174.19 10.87 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.743 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -155.19 117.44 4.19 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.081 0.467 . . . . 0.0 111.561 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.715 HG21 HD21 ' A' ' 53' ' ' LEU . 19.9 m -152.37 -176.81 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.971 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -83.51 139.42 32.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.014 HD13 HD13 ' A' ' 35' ' ' LEU . 1.5 tp -67.62 55.62 0.06 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.715 0.293 . . . . 0.0 110.709 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -71.73 -4.46 27.72 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.558 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . 81.4 p 38.59 47.5 1.13 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 46' ' ' SER . 38.1 mm -166.43 -95.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.537 0.735 . . . . 0.0 109.217 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.481 ' N ' HG22 ' A' ' 47' ' ' ILE . 34.1 mmt -68.09 -51.32 47.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.32 -81.35 0.07 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.671 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.417 HG23 HG21 ' A' ' 55' ' ' VAL . 7.2 p -37.55 -43.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.412 ' N ' HG13 ' A' ' 50' ' ' VAL . 1.8 mmt -61.99 -48.86 78.46 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.1 t -53.23 -51.46 62.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.062 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.715 HD21 HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -66.25 -35.39 80.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.004 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.32 108.36 1.89 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.529 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.491 HG13 ' CB ' ' A' ' 59' ' ' ALA . 57.8 t -139.27 82.39 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.02 -139.74 10.74 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.454 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.602 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 13.8 tttt -73.75 131.88 42.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.602 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 84.6 -5.19 1.0 Allowed 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.7 0.625 . . . . 0.0 111.511 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.491 ' CB ' HG13 ' A' ' 55' ' ' VAL . . . -62.72 125.02 22.53 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.722 0.296 . . . . 0.0 111.492 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.98 142.63 27.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.42 172.34 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.772 ' C ' HD13 ' A' ' 63' ' ' ILE . 6.6 m -150.57 115.15 5.2 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.151 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.872 ' N ' HD13 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -100.46 147.62 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.754 ' HB2' ' HG3' ' A' ' 34' ' ' GLN . 45.3 m-85 -143.09 107.54 4.8 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.899 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.684 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -93.31 131.08 38.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.116 0.484 . . . . 0.0 111.346 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.54 83.41 2.16 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.96 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.483 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -166.72 -154.48 8.4 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.649 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 p -76.28 -55.81 5.22 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.866 0.833 . . . . 0.0 111.893 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.643 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 2.8 m-20 -92.62 40.86 1.06 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.568 0.223 . . . . 0.0 111.224 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 4.9 pt-20 -67.17 -18.77 65.41 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.6 -54.81 3.99 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.89 -34.18 62.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.638 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.55 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -51.74 -62.63 1.5 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.176 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.592 HG12 ' CG ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -49.79 -46.08 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -57.76 -67.92 0.29 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.629 0.252 . . . . 0.0 111.462 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.44 -37.63 67.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.033 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.4 mm -60.85 -39.27 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.463 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.0 -54.76 43.06 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -46.05 -41.62 12.32 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 109.945 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 21' ' ' MET . 3.4 t -65.19 -61.02 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.007 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.0 mt . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 121.037 0.446 . . . . 0.0 110.559 179.146 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.765 0.317 . . . . 0.0 111.394 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.637 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 7.2 mm-40 -97.59 169.62 9.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.725 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -164.34 153.38 13.41 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.018 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -161.94 121.94 2.51 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.008 0.432 . . . . 0.0 112.009 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.7 p -89.73 153.56 20.6 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.765 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 92.2 m-85 -142.2 -176.88 4.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.697 0.76 . . . . 0.0 112.76 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 7' ' ' THR . 5.5 t -149.18 87.43 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.136 -1.393 . . . . 0.0 107.913 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 9' ' ' ILE . 36.0 mt -73.87 169.06 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.751 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 1.9 pp -140.11 -26.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.833 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -69.15 82.16 0.34 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.235 0.54 . . . . 0.0 110.502 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.506 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 1.2 pm0 -56.96 -7.91 0.54 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.76 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.7 m -78.7 -30.18 45.88 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.55 -164.66 18.94 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.758 -0.735 . . . . 0.0 113.219 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.8 HG23 ' HB2' ' A' ' 18' ' ' PRO . 23.4 mt -77.02 86.94 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.736 0.303 . . . . 0.0 110.67 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -69.98 -163.98 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.88 -32.95 68.19 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.474 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -74.22 -61.06 1.3 Allowed Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.8 ' HB2' HG23 ' A' ' 14' ' ' ILE . 29.6 Cg_endo -62.56 -31.24 79.96 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.327 2.018 . . . . 0.0 112.613 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.578 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.45 -63.19 1.25 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.085 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.6 m -52.72 -33.18 46.65 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.683 0.278 . . . . 0.0 110.719 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -55.61 17.46 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.696 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.49 ' CD2' HD21 ' A' ' 44' ' ' LEU . 1.1 mt -57.3 -38.97 74.8 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.316 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 19' ' ' ALA . 63.9 t -53.84 -57.89 4.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.1 tt0 -66.84 -55.47 14.64 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.413 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 76.7 p -53.35 -59.44 4.57 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.039 0.212 . . . . 0.0 111.385 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.6 -48.04 82.28 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 122.944 0.152 . . . . 0.0 111.039 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.8 t -60.53 -31.2 70.29 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.649 0.261 . . . . 0.0 111.298 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -68.11 -50.43 54.83 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.601 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 10.6 m-85 -64.92 -42.58 94.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.911 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.32 -11.72 0.78 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.241 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.428 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 99.8 p -68.05 145.37 54.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.453 0.644 . . . . 0.0 112.45 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.95 108.94 15.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.209 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.755 HG23 HG22 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -98.6 123.21 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.175 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.707 ' CG ' ' HB2' ' A' ' 64' ' ' TYR . 4.5 pt20 -98.56 106.05 18.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.632 HD22 HG22 ' A' ' 50' ' ' VAL . 5.5 tt -98.69 115.66 29.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.485 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.782 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -94.65 172.82 7.94 Favored 'General case' 0 C--N 1.34 0.179 0 O-C-N 126.07 2.106 . . . . 0.0 111.653 -179.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -126.17 165.27 19.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.637 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.49 ' HB3' ' HG3' ' A' ' 60' ' ' GLU . 1.3 p-10 -53.33 -14.1 0.67 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.49 49.4 0.48 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.05 178.65 1.72 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.704 0.287 . . . . 0.0 111.006 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.782 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -159.77 115.59 2.45 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.367 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.9 m -153.34 -175.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.05 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.231 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -85.21 141.18 30.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.818 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -65.31 52.7 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 121.907 0.86 . . . . 0.0 111.552 177.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.437 ' HG2' HD12 ' A' ' 47' ' ' ILE . 37.2 tttt -63.35 -34.47 77.78 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.75 ' HA ' ' HB ' ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.77 -50.62 0.7 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.283 0.563 . . . . 0.0 111.92 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.437 HD12 ' HG2' ' A' ' 45' ' ' LYS . 5.9 mt -53.84 -22.93 7.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.108 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.547 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -169.45 -39.98 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.974 -178.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.91 -56.06 27.18 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.879 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.75 ' HB ' ' HA ' ' A' ' 46' ' ' SER . 5.3 t -69.08 -45.95 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.657 0.228 . . . . 0.0 111.332 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.547 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -60.23 -36.92 78.82 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.721 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.0 t -60.27 -51.72 68.33 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.041 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -64.75 -11.33 35.17 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.92 119.65 0.1 OUTLIER Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.803 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.457 HG21 ' CG1' ' A' ' 50' ' ' VAL . 20.0 t -117.03 63.88 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.996 0.427 . . . . 0.0 111.378 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 11' ' ' GLU . . . -80.92 -166.78 36.32 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.057 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -75.86 125.63 29.45 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 89.01 7.05 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.879 0.737 . . . . 0.0 111.089 -178.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.63 117.73 5.69 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-O 120.513 0.197 . . . . 0.0 111.133 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.49 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -94.29 142.44 27.41 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.77 HD12 HD11 ' A' ' 63' ' ' ILE . 22.1 pt -143.11 175.12 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.766 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.592 ' C ' HD13 ' A' ' 63' ' ' ILE . 6.0 m -151.67 104.87 3.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.702 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.77 HD11 HD12 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -96.49 151.01 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.725 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 22.7 m-85 -146.45 110.98 5.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.515 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.674 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -93.48 127.62 39.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.24 0.543 . . . . 0.0 111.187 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.89 89.15 3.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.756 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -174.02 -153.68 10.05 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.601 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.6 p -75.59 -58.08 3.5 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.714 0.757 . . . . 0.0 111.767 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.587 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 3.2 m-20 -91.87 42.7 1.11 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.865 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.606 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 5.9 pt-20 -67.45 -22.26 65.51 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.637 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -89.05 -48.64 7.27 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.06 -37.66 64.41 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.601 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.68 -57.04 12.23 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.715 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.8 mm -49.61 -49.06 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.93 -67.48 0.36 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.79 -34.16 67.37 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.537 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' A' ' 80' ' ' VAL . 9.6 mm -62.29 -37.43 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -51.86 68.07 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -47.88 -40.55 21.98 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 123.607 0.567 . . . . 0.0 110.004 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 77' ' ' ILE . 2.5 t -62.09 -57.42 12.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.08 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.444 ' CD2' HG12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 120.96 0.409 . . . . 0.0 110.076 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 ttm . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.703 0.287 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.623 ' CD ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -96.11 163.58 13.05 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.308 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.638 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.9 OUTLIER -153.66 152.5 30.9 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.486 HE21 HG21 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -159.55 165.57 32.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.297 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.5 p -153.87 141.07 19.51 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.82 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.29 -161.98 1.3 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.7 m -153.98 106.88 2.88 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.66 HG22 ' H ' ' A' ' 9' ' ' ILE . 1.7 mt -102.18 -171.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.736 -176.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.66 ' H ' HG22 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -144.93 10.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.63 83.97 1.57 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.12 -23.92 2.43 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.794 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -82.82 -36.97 25.07 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . 73.31 95.38 0.1 OUTLIER Glycine 0 C--N 1.344 0.995 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.911 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.416 HG13 ' CA ' ' A' ' 46' ' ' SER . 31.0 mm 67.84 125.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.897 0.379 . . . . 0.0 111.32 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -167.99 128.11 1.33 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.72 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 18' ' ' PRO . . . 43.95 -161.8 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 119.144 -0.455 . . . . 0.0 111.325 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.62 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER 15.51 -77.01 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.62 ' CD ' ' HB3' ' A' ' 17' ' ' ARG . 10.1 Cg_endo -50.34 -42.48 47.67 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.594 2.863 . . . . 0.0 113.509 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.35 -63.97 1.11 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.419 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.5 m -54.82 -31.75 59.59 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.579 ' HB3' HG22 ' A' ' 80' ' ' VAL . 27.7 mtm -64.93 -51.85 59.6 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.692 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.67 ' HG ' HG11 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -56.65 -36.98 70.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.082 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.62 -60.59 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -66.47 -51.17 59.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.399 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.528 HG22 ' HE2' ' A' ' 29' ' ' PHE . 70.7 m -51.93 -60.24 3.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.275 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.9 -48.24 81.35 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.949 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.0 t -58.56 -28.79 65.85 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.542 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -66.13 -49.8 66.21 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.671 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 14.1 m-85 -64.62 -40.94 96.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.998 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.43 -9.44 1.4 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.434 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.0 p -66.72 154.7 40.02 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.64 140.64 46.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.916 HD13 HD22 ' A' ' 44' ' ' LEU . 5.1 tt -146.96 114.1 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.181 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.648 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 17.9 pm0 -104.35 128.86 52.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.456 0.646 . . . . 0.0 110.37 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.741 HD12 HD12 ' A' ' 44' ' ' LEU . 5.8 tt -113.97 121.94 45.43 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.733 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -100.56 177.83 4.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 125.733 1.896 . . . . 0.0 111.494 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.498 ' CD1' HD11 ' A' ' 53' ' ' LEU . 12.2 t80 -128.02 162.83 25.91 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.868 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -55.43 -12.49 1.11 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.531 179.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.7 46.92 0.51 Allowed Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.41 -177.68 1.05 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.757 0.313 . . . . 0.0 110.919 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.733 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 4.9 tmtm? -159.05 122.79 3.84 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 m -152.24 -174.75 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.025 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 45' ' ' LYS . 7.6 t30 -84.11 145.09 28.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.916 HD22 HD13 ' A' ' 33' ' ' ILE . 1.3 tt -67.66 58.55 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HB2' ' HA3' ' A' ' 49' ' ' GLY . 4.5 mtpm? -69.31 -49.44 55.78 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.658 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER 73.78 -54.1 0.68 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.352 -178.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.18 -25.58 13.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.289 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.594 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -169.78 -39.02 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -178.053 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -48.68 -56.03 10.32 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.139 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.739 HG12 HD22 ' A' ' 35' ' ' LEU . 32.0 m -68.57 -50.25 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.594 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -60.22 -40.95 91.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.3 p -58.43 -48.39 80.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.941 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.573 HD23 ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -66.09 -34.56 78.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.921 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.79 126.22 3.08 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.975 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.524 HG23 ' HA ' ' A' ' 51' ' ' MET . 2.9 t -129.13 84.16 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.571 0.224 . . . . 0.0 110.953 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.47 176.86 48.44 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 4.7 tttm -71.95 131.08 42.46 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.603 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 85.07 12.06 0.26 Allowed 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.671 0.607 . . . . 0.0 110.467 -178.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.97 121.59 12.2 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.321 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 2.8 tt0 -93.9 143.39 26.38 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.608 HD12 HD11 ' A' ' 63' ' ' ILE . 19.2 pt -146.14 172.82 3.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.49 ' C ' HD12 ' A' ' 63' ' ' ILE . 4.4 m -148.13 109.47 4.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.858 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.782 ' CG2' HD11 ' A' ' 33' ' ' ILE . 1.3 mp -96.16 142.04 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.707 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.648 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 84.0 m-85 -132.24 116.21 16.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.784 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.8 127.78 48.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.023 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -133.25 103.95 6.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.005 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.56 -155.53 26.54 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.765 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.2 p -69.18 -61.09 1.94 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 117.282 0.541 . . . . 0.0 111.659 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.9 m-20 -92.2 37.92 0.99 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.544 0.211 . . . . 0.0 111.252 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.03 -22.45 66.98 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.35 -55.07 3.96 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.29 -34.6 66.62 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.461 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -50.28 -58.88 4.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.24 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.623 HG12 ' CD ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -43.48 -51.02 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 123.218 0.324 . . . . 0.0 111.872 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -54.71 -68.7 0.16 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.83 71.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.454 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 73' ' ' ALA . 13.1 mm -62.09 -38.64 81.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.652 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -57.68 11.56 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -44.16 -41.94 6.04 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.576 0.547 . . . . 0.0 110.288 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.67 HG11 ' HG ' ' A' ' 22' ' ' LEU . 3.8 t -62.91 -63.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.67 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 121.066 0.46 . . . . 0.0 110.763 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptp . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.638 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 2.4 mm-40 -95.3 165.34 12.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.703 0.287 . . . . 0.0 110.812 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.713 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 2.2 pt20 -163.65 156.38 18.12 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -163.15 118.95 1.76 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.032 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 60.3 p -89.31 152.34 21.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.918 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 59.4 m-85 -142.96 -179.89 6.63 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.899 0.857 . . . . 0.0 112.877 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 7' ' ' THR . 9.7 t -152.88 96.47 2.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.022 -1.444 . . . . 0.0 107.976 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.738 HG22 ' H ' ' A' ' 9' ' ' ILE . 1.7 mt -96.29 -168.97 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.043 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.738 ' H ' HG22 ' A' ' 8' ' ' ILE . 2.7 pp -145.86 15.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 122.314 0.246 . . . . 0.0 111.612 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.502 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 12.0 t0 -75.86 80.98 2.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.625 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -52.4 -22.39 4.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.478 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -37.98 23.21 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.11 -166.25 19.97 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.757 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.672 HD12 HG11 ' A' ' 50' ' ' VAL . 60.5 mt -69.42 81.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.006 0.432 . . . . 0.0 110.815 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.537 ' CE1' ' HB3' ' A' ' 17' ' ' ARG . 14.3 p80 -70.78 -162.16 0.06 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.261 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.51 -28.72 67.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.648 ' CZ ' HD21 ' A' ' 86' ' ' LEU . 31.1 ttp180 -74.94 -62.0 0.95 Allowed Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.665 ' HB2' HG23 ' A' ' 14' ' ' ILE . 36.0 Cg_endo -64.49 -33.34 57.44 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.306 2.004 . . . . 0.0 112.888 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -62.9 -63.21 1.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.883 -0.144 . . . . 0.0 111.062 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.1 m -54.29 -31.85 54.89 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.698 0.285 . . . . 0.0 110.719 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.744 ' HB3' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -64.27 -54.57 31.18 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.596 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.558 HD22 HD13 ' A' ' 44' ' ' LEU . 1.2 mt -58.74 -35.7 73.14 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 19' ' ' ALA . 62.6 t -54.45 -62.24 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.92 -51.51 61.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.747 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.504 HG22 ' HE2' ' A' ' 29' ' ' PHE . 97.0 m -52.73 -61.37 2.33 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.105 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.31 -47.75 84.67 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.102 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.2 p -59.82 -29.02 67.96 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' THR . 3.7 mtpm? -63.43 -54.28 39.02 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.672 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 28.3 m-85 -65.65 -37.68 87.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.125 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 84.07 -20.26 0.32 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.533 -1.667 . . . . 0.0 112.275 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 68' ' ' SER . 81.6 p -67.73 143.19 56.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.475 0.655 . . . . 0.0 112.399 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.34 114.84 18.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.521 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.776 HG21 HD21 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -100.89 114.28 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.851 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.702 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 14.9 pm0 -90.3 107.19 18.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 122.089 0.947 . . . . 0.0 109.318 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.651 HD13 ' HB3' ' A' ' 44' ' ' LEU . 4.5 tt -97.09 114.09 25.72 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.777 -1.556 . . . . 0.0 108.831 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.779 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -92.96 174.77 7.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 125.936 2.022 . . . . 0.0 111.641 -179.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 28.9 t80 -133.22 165.05 25.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.714 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.506 ' HB3' ' CG ' ' A' ' 60' ' ' GLU . 1.2 p-10 -53.22 -14.74 0.74 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.642 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.32 49.27 0.5 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.32 172.52 3.21 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.515 0.197 . . . . 0.0 110.675 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.779 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -160.29 109.65 1.75 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -155.02 -178.18 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.262 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . 4.9 t30 -83.77 136.94 33.96 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.776 HD21 HG21 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -68.81 58.08 0.09 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.076 0.398 . . . . 0.0 111.051 177.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' A' ' 43' ' ' ASN . 1.4 ttmt -65.78 -14.9 62.26 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.665 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.7 OUTLIER 69.3 -49.01 0.6 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.1 mt -52.77 -26.26 10.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.382 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.81 -39.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.86 -52.92 24.13 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.479 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.672 HG11 HD12 ' A' ' 14' ' ' ILE . 15.2 m -67.06 -35.89 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.932 0.366 . . . . 0.0 110.728 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 63.9 mtt -59.87 -48.04 83.32 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.668 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.0 p -57.68 -51.48 69.36 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.975 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -67.26 -19.19 65.47 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.03 102.41 0.01 OUTLIER Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.951 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 t -100.79 56.84 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.841 0.353 . . . . 0.0 111.106 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.35 -160.46 8.56 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.763 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 1.7 tttm -73.95 134.91 43.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER 76.9 9.61 2.78 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.542 0.526 . . . . 0.0 110.691 -178.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.16 119.61 8.73 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.506 ' CG ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -95.4 135.85 36.5 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' CD1' HD22 ' A' ' 81' ' ' LEU . 5.8 pt -138.71 172.88 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.394 0.616 . . . . 0.0 112.385 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.711 HG22 ' CE1' ' A' ' 64' ' ' TYR . 7.2 m -151.71 102.54 2.86 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.285 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.844 ' N ' HD13 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -94.0 149.14 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.315 -177.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.713 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 38.2 m-85 -146.82 114.19 6.3 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.297 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.647 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -95.38 126.38 40.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.812 0.339 . . . . 0.0 110.579 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -139.88 92.47 2.56 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.925 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.97 -80.01 0.04 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.439 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 31' ' ' SER . 0.2 OUTLIER -143.52 -68.74 0.33 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 5.5 m-20 -89.86 51.53 2.09 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -69.92 -23.76 63.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.968 -178.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.638 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -86.84 -53.26 5.01 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.604 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.05 -36.69 60.88 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.672 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.86 -54.96 31.31 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.897 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.6 mm -43.31 -51.5 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.928 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -57.59 -68.88 0.2 Allowed 'General case' 0 C--O 1.239 0.538 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.05 -33.17 68.72 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.723 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.1 mm -62.88 -38.37 81.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.511 ' O ' ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -57.74 -60.23 4.01 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -42.0 -41.04 2.4 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.625 0.578 . . . . 0.0 110.47 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 21' ' ' MET . 7.9 t -65.65 -63.46 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.027 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -61.96 -28.05 69.27 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 110.969 179.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.511 ' HB3' ' O ' ' A' ' 78' ' ' THR . 1.4 p -63.47 -32.02 73.35 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.973 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.818 ' O ' HD23 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -58.45 -28.38 65.25 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.245 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.596 ' CB ' HG21 ' A' ' 8' ' ' ILE . 13.9 mt-10 -60.32 -34.77 74.27 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 122.481 0.312 . . . . 0.0 111.23 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.499 ' O ' HD11 ' A' ' 9' ' ' ILE . . . -73.13 -10.52 78.29 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.904 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.818 HD23 ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -81.89 9.31 8.38 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.993 0.396 . . . . 0.0 111.541 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 52.7 p -96.88 -96.17 0.2 Allowed 'General case' 0 CA--C 1.536 0.411 0 O-C-N 122.391 -0.193 . . . . 0.0 111.481 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.611 ' O ' HD13 ' A' ' 9' ' ' ILE . 27.3 tt0 . . . . . 0 C--O 1.253 1.242 0 CA-C-O 118.877 -0.583 . . . . 0.0 111.41 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ttt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.732 0.301 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.62 ' CD ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -94.04 164.21 13.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.425 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.583 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -160.94 152.26 19.06 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.329 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.07 133.18 5.87 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.771 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 3.0 t -89.97 157.66 17.74 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.944 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.628 ' HB2' ' CG1' ' A' ' 61' ' ' ILE . 4.9 m-85 -138.16 176.38 8.75 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.86 0.838 . . . . 0.0 112.251 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.4 m -145.8 75.52 1.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.492 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.645 HG21 ' CG1' ' A' ' 55' ' ' VAL . 48.2 mt -65.29 163.33 2.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.489 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.943 HD13 ' HB3' ' A' ' 88' ' ' GLU . 2.1 pp -136.04 -26.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.761 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.497 ' HB2' ' HG3' ' A' ' 84' ' ' GLU . 10.2 t0 -68.09 87.59 0.27 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.452 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -47.85 -27.54 2.14 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.35 -38.01 27.35 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 10' ' ' ASP . . . 88.56 -114.02 4.17 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.937 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.64 HD11 ' HA ' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -75.88 152.59 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.071 0.462 . . . . 0.0 111.855 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.56 ' CE1' ' HD3' ' A' ' 18' ' ' PRO . 24.9 p80 -170.54 -153.53 0.1 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.967 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.87 79.52 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.531 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -78.89 -55.18 0.99 Allowed Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.56 ' HD3' ' CE1' ' A' ' 15' ' ' HIS . 12.3 Cg_exo -62.69 -41.72 29.63 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.623 2.215 . . . . 0.0 113.122 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.73 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -58.08 -64.4 0.93 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -53.93 -33.23 56.13 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.776 0.322 . . . . 0.0 111.086 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.935 ' HB3' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -66.31 -62.47 1.46 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.513 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.506 HD13 ' HB3' ' A' ' 46' ' ' SER . 0.9 OUTLIER -58.67 -37.03 75.14 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 19' ' ' ALA . 70.7 t -53.51 -60.04 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.1 tt0 -66.49 -52.91 40.94 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.761 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.44 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 94.9 m -52.45 -58.93 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.464 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.45 -48.29 80.31 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.31 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -59.72 -28.36 67.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.726 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -66.11 -52.9 44.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.652 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 13.9 m-85 -66.68 -41.81 87.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.31 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 74.8 -7.28 1.76 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.53 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.6 p -66.13 152.35 44.94 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -73.95 140.22 45.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.821 HG23 ' HB3' ' A' ' 44' ' ' LEU . 3.4 tt -142.59 124.24 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-O 121.137 0.494 . . . . 0.0 111.455 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.696 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 9.8 pt20 -112.0 123.33 50.02 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-O 121.436 0.636 . . . . 0.0 110.217 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.737 HD12 HD12 ' A' ' 44' ' ' LEU . 2.1 tt -109.77 123.12 48.98 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.483 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.753 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -103.14 176.41 5.16 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 125.763 1.914 . . . . 0.0 111.585 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -127.16 162.65 25.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.567 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.47 -10.8 1.03 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.72 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.76 45.5 0.57 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.09 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.84 -177.71 0.65 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.661 0.267 . . . . 0.0 110.984 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.753 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 1.2 tmtp? -158.9 124.8 4.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.336 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.504 ' CG2' HD11 ' A' ' 53' ' ' LEU . 21.9 m -153.45 -173.74 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.269 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -85.75 143.76 28.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.821 ' HB3' HG23 ' A' ' 33' ' ' ILE . 1.1 tt -69.25 57.53 0.11 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -69.64 -38.86 77.31 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.698 ' HA ' HG22 ' A' ' 50' ' ' VAL . 2.5 p 70.9 -50.49 0.68 Allowed 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.724 0.64 . . . . 0.0 112.119 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.5 HD13 ' CD1' ' A' ' 14' ' ' ILE . 46.7 mm -53.44 -25.95 11.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.168 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.434 ' HA ' ' HB2' ' A' ' 51' ' ' MET . 14.4 mtp -166.64 -39.27 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.669 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.66 -52.09 26.0 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.979 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.698 HG22 ' HA ' ' A' ' 46' ' ' SER . 6.7 m -72.91 -37.98 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.592 0.196 . . . . 0.0 110.54 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.434 ' HB2' ' HA ' ' A' ' 48' ' ' MET . 0.6 OUTLIER -56.84 -53.19 60.67 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.308 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.5 p -58.02 -37.56 74.56 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.361 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.504 HD11 ' CG2' ' A' ' 42' ' ' VAL . 6.2 mt -60.9 -30.81 70.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.409 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.76 -42.57 1.87 Allowed Glycine 0 C--N 1.339 0.716 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.265 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 50' ' ' VAL . 72.4 t 35.9 63.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 11' ' ' GLU . . . -86.94 -172.52 48.37 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.109 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.737 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 5.9 tttt -76.11 126.28 30.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 86.45 11.19 0.19 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.885 0.741 . . . . 0.0 110.916 -178.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.92 121.56 13.27 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 120.736 0.303 . . . . 0.0 111.693 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.16 135.99 33.26 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.803 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.821 HD12 HD11 ' A' ' 63' ' ' ILE . 45.1 pt -147.0 176.64 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.14 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.577 ' C ' HD13 ' A' ' 63' ' ' ILE . 14.6 m -152.57 109.9 3.55 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.002 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.821 HD11 HD12 ' A' ' 61' ' ' ILE . 1.1 mm -94.25 154.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.481 -178.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.696 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 57.7 m-85 -141.16 117.61 10.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.539 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.3 129.89 46.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.872 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -134.5 96.05 3.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.138 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.49 -154.47 17.81 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.746 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.0 p -71.95 -59.2 2.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.158 0.479 . . . . 0.0 111.724 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.652 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.6 m-20 -93.47 36.59 1.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.423 0.154 . . . . 0.0 111.407 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.69 -22.36 66.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.91 -56.67 3.29 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.74 -30.34 65.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.738 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -50.18 -63.11 1.22 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.548 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.62 HG12 ' CD ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -43.75 -43.38 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -58.4 -71.72 0.11 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.778 0.323 . . . . 0.0 111.368 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.04 -33.36 67.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.503 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.4 mm -61.16 -38.71 80.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.983 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 82' ' ' SER . 0.2 OUTLIER -57.34 -56.12 25.9 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -47.23 -42.71 20.88 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.148 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.935 HG22 ' HB3' ' A' ' 21' ' ' MET . 7.8 t -65.76 -63.38 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.461 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.486 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 6.9 mt -59.38 -39.37 83.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.856 0.36 . . . . 0.0 110.421 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 78' ' ' THR . 4.4 t -60.73 -26.87 67.5 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.52 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.641 ' O ' HD23 ' A' ' 86' ' ' LEU . 19.3 tptp -59.71 -32.82 70.88 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.416 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.497 ' HG3' ' HB2' ' A' ' 10' ' ' ASP . 9.2 pt-20 -63.75 -25.17 68.07 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.725 0.297 . . . . 0.0 110.472 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.743 ' HA2' HD11 ' A' ' 9' ' ' ILE . . . -63.11 -11.22 37.71 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.001 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 83' ' ' LYS . 2.3 pp -66.92 -3.41 6.94 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.0 p -94.46 -94.26 0.17 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 119.542 -0.266 . . . . 0.0 111.648 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.943 ' HB3' HD13 ' A' ' 9' ' ' ILE . 5.9 pt-20 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 117.836 -1.078 . . . . 0.0 111.78 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.813 0.339 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.646 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mm-40 -95.67 162.48 13.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.388 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.735 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.6 OUTLIER -166.2 152.93 9.39 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -164.83 121.91 1.57 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.629 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 p -89.65 150.71 22.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.807 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 41.8 m-85 -142.5 176.57 8.92 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.569 0.699 . . . . 0.0 111.815 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 7' ' ' THR . 14.8 t -153.48 111.96 3.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.173 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.515 HG21 ' N ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER -132.92 175.3 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -176.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.45 ' H ' HG22 ' A' ' 8' ' ' ILE . 2.1 pp -95.28 15.17 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.124 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.722 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 29.3 p-10 -69.48 78.04 0.4 Allowed 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.212 0.53 . . . . 0.0 111.545 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.463 ' HG2' ' CB ' ' A' ' 57' ' ' LYS . 1.1 tm-20 -52.24 -32.08 35.21 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.901 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.0 p -82.43 -35.28 27.74 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.98 -86.28 1.25 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.278 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.528 HG23 ' HB2' ' A' ' 18' ' ' PRO . 4.3 mp -137.39 71.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.21 0.528 . . . . 0.0 110.309 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.451 ' N ' ' HG2' ' A' ' 18' ' ' PRO . 11.2 p80 -69.78 -156.23 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.641 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.1 -33.28 71.9 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.554 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 1.3 ttp85 -73.73 -63.5 0.93 Allowed Pre-proline 0 N--CA 1.467 0.382 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.519 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.628 ' HB3' HD13 ' A' ' 86' ' ' LEU . 21.4 Cg_endo -60.42 -29.71 89.32 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.505 2.137 . . . . 0.0 112.719 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.607 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -62.5 -64.56 0.89 Allowed 'General case' 0 C--N 1.339 0.132 0 CA-C-N 116.857 -0.156 . . . . 0.0 110.812 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 m -53.73 -32.16 51.05 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 110.604 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -55.43 20.43 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.395 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.632 HD22 HD13 ' A' ' 44' ' ' LEU . 1.3 mt -58.41 -34.17 70.47 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.115 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 19' ' ' ALA . 67.3 t -55.44 -64.57 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -64.93 -44.12 90.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 123.194 0.309 . . . . 0.0 111.672 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.454 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 52.0 m -56.33 -61.32 2.48 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.594 0.235 . . . . 0.0 110.409 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.76 98.0 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.469 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -58.42 -32.95 69.14 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.232 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 25' ' ' THR . 24.9 mtmm -63.55 -52.68 60.01 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.609 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 43.4 m-85 -66.68 -35.54 80.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.667 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 82.5 -20.84 0.33 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.868 -1.515 . . . . 0.0 111.502 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.429 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 88.7 p -68.7 132.33 46.68 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.725 0.774 . . . . 0.0 112.219 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.24 115.44 19.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.686 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.876 HG21 HD21 ' A' ' 44' ' ' LEU . 2.9 mt -97.48 123.62 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.464 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.752 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 1.4 pt20 -94.76 104.15 16.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.574 ' HB2' HD23 ' A' ' 44' ' ' LEU . 5.5 tt -99.44 119.37 37.88 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.029 -1.441 . . . . 0.0 110.176 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.76 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -93.98 169.6 10.16 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 126.023 2.077 . . . . 0.0 110.466 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.968 ' HB3' HD22 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -145.52 97.6 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.509 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 49.93 -59.5 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 37' ' ' TYR . . . -138.62 33.05 2.25 Favored Glycine 0 C--N 1.318 -0.468 0 C-N-CA 121.816 -0.23 . . . . 0.0 112.738 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.464 ' HB3' HD21 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -138.33 171.04 14.97 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.76 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 1.2 tmtm? -156.56 109.88 2.64 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.934 0.397 . . . . 0.0 111.736 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.4 m -153.78 173.07 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.084 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -81.89 131.89 35.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.876 HD21 HG21 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -67.66 56.81 0.06 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.858 0.361 . . . . 0.0 110.987 177.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' O ' HD12 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -66.89 -17.71 65.03 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.727 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.95 -47.64 0.67 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 45' ' ' LYS . 3.2 mt -52.82 -26.44 10.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.329 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.511 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 13.0 mtp -167.79 -37.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.19 60.06 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.182 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.727 HG22 ' HA ' ' A' ' 46' ' ' SER . 24.8 m -69.29 -50.2 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.511 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -59.0 -41.36 87.46 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.614 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.4 t -57.9 -41.3 82.32 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.216 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.968 HD22 ' HB3' ' A' ' 37' ' ' TYR . 38.7 mt -64.58 -52.57 56.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.821 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.64 -49.03 0.92 Allowed Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.417 -0.421 . . . . 0.0 113.14 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t 36.49 79.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.437 ' C ' ' HA ' ' A' ' 11' ' ' GLU . . . -76.47 -163.36 15.94 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.902 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.601 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 7.3 tttt -74.34 134.86 42.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.601 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER 76.69 9.29 2.97 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.519 0.512 . . . . 0.0 110.41 -178.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.18 136.79 58.1 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 152.21 20.62 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.528 HD11 HD22 ' A' ' 81' ' ' LEU . 12.5 pt -145.66 172.7 4.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.093 0.473 . . . . 0.0 111.924 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.751 HG22 ' CE1' ' A' ' 64' ' ' TYR . 5.6 m -149.21 103.28 3.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.446 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.867 ' N ' HD13 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -96.64 145.06 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.612 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.752 ' HB2' ' HG3' ' A' ' 34' ' ' GLN . 11.2 m-85 -145.53 111.33 5.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.052 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.704 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -91.13 133.51 35.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.329 0.585 . . . . 0.0 111.767 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -130.88 101.24 5.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.79 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . 174.57 -158.94 27.52 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.7 p -71.53 -60.79 2.05 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.27 1.035 . . . . 0.0 111.133 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.609 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 9.7 m-20 -91.48 42.92 1.12 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.57 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -66.28 -22.47 66.3 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.974 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.646 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -88.29 -46.77 8.93 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.12 -40.21 64.03 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.55 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -54.99 -54.55 41.5 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.441 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 mm -48.43 -47.49 14.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.502 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -55.52 -70.96 0.09 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.78 -37.26 73.39 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.1 mm -60.85 -41.75 89.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.529 0.204 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.645 HG22 ' HB2' ' A' ' 82' ' ' SER . 14.6 m -60.59 -63.59 1.25 Allowed 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.456 ' C ' ' O ' ' A' ' 78' ' ' THR . 45.8 m-20 -34.39 -43.82 0.17 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.034 0.445 . . . . 0.0 110.142 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.576 HG12 HD11 ' A' ' 86' ' ' LEU . 9.1 t -66.68 -66.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.114 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.528 HD22 HD11 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -61.84 -40.75 96.38 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.194 0.521 . . . . 0.0 110.644 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.645 ' HB2' HG22 ' A' ' 78' ' ' THR . 0.5 OUTLIER -59.4 -26.26 64.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.626 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -67.07 0.3 Allowed 'General case' 0 C--N 1.349 0.572 0 CA-C-O 120.878 0.371 . . . . 0.0 110.108 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -174.89 37.29 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.95 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.722 ' HA3' ' HB3' ' A' ' 10' ' ' ASP . . . 61.35 21.85 60.39 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' A' ' 18' ' ' PRO . 3.6 mp 59.06 32.16 21.97 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-O 120.524 0.202 . . . . 0.0 111.447 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 10' ' ' ASP . 55.3 p -123.72 -116.99 0.29 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.244 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.423 -0.798 . . . . 0.0 110.988 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.568 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mm-40 -99.02 159.21 15.12 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.461 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.725 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -159.58 156.69 28.47 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 2.6 mm-40 -162.25 164.63 27.53 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.422 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.457 ' HB3' HG23 ' A' ' 62' ' ' THR . 46.2 p -153.66 139.5 18.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.906 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -144.7 -177.59 5.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.396 0.617 . . . . 0.0 111.392 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 t -153.19 116.83 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.576 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.591 HD12 ' CA ' ' A' ' 85' ' ' GLY . 0.6 OUTLIER -134.98 177.5 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -176.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.555 ' H ' HG22 ' A' ' 8' ' ' ILE . 17.3 pt -94.07 16.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.747 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.758 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 13.5 p-10 -68.58 73.97 0.25 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.329 0.585 . . . . 0.0 111.642 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 57' ' ' LYS . 2.9 tt0 -59.38 -25.26 64.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.048 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -80.01 -33.67 39.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.51 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . 48.66 81.43 0.05 OUTLIER Glycine 0 C--N 1.341 0.836 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.894 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.571 HD13 HD22 ' A' ' 86' ' ' LEU . 25.5 mm 71.82 127.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.802 0.334 . . . . 0.0 111.031 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 10.7 p80 -166.76 -119.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.314 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 18' ' ' PRO . . . -69.32 -167.13 0.11 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 118.777 -0.63 . . . . 0.0 109.881 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.667 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 12.29 -73.03 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.798 ' CB ' HD23 ' A' ' 86' ' ' LEU . 4.5 Cg_exo -40.31 -45.97 4.26 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.67 2.913 . . . . 0.0 113.212 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 15' ' ' HIS . . . -64.25 -56.22 16.1 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 121.258 -0.177 . . . . 0.0 111.146 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.2 m -50.84 -34.29 27.23 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.921 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 mmm -62.93 -50.45 70.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.291 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -35.61 70.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.852 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.68 -59.06 2.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -66.18 -50.93 62.21 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.301 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.694 HG22 ' HE2' ' A' ' 29' ' ' PHE . 84.8 m -52.69 -60.46 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.47 89.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.579 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.5 t -59.48 -29.4 67.8 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.375 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 25' ' ' THR . 3.5 mtpm? -63.98 -51.46 64.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.694 ' HE2' HG22 ' A' ' 25' ' ' THR . 30.3 m-85 -64.59 -39.66 94.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.746 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 76.5 -14.21 0.84 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.27 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.8 p -68.31 144.91 54.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.384 0.611 . . . . 0.0 112.383 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.48 110.19 13.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.734 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.732 HG23 HG23 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -101.27 119.9 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.46 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.686 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 15.8 pm0 -101.03 113.11 25.8 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.105 HD13 HD13 ' A' ' 44' ' ' LEU . 1.5 tt -103.47 120.83 41.6 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.585 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.779 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.6 OUTLIER -94.87 175.99 6.43 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 126.136 2.147 . . . . 0.0 111.251 -179.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -128.53 166.72 18.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.241 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.43 ' CA ' ' HG3' ' A' ' 60' ' ' GLU . 7.6 t-20 -46.62 -21.02 0.15 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.23 55.55 0.39 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.86 -179.7 1.22 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.631 0.253 . . . . 0.0 110.999 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.779 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -158.89 118.81 3.13 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.446 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.401 ' CG2' HD23 ' A' ' 53' ' ' LEU . 21.3 m -153.26 -173.68 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.976 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -86.45 144.39 27.31 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.105 HD13 HD13 ' A' ' 35' ' ' LEU . 6.8 tp -68.81 59.09 0.09 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -67.78 -32.05 72.36 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.472 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.7 OUTLIER 69.59 -52.28 0.61 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.423 0.63 . . . . 0.0 112.183 -179.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.8 mt -53.31 -26.2 11.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.213 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.9 mtp -167.56 -39.19 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.628 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -48.22 -47.51 27.32 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.286 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.485 ' HA ' HD21 ' A' ' 53' ' ' LEU . 33.7 m -69.56 -38.71 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.705 0.288 . . . . 0.0 110.899 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.3 mtt -59.63 -47.07 87.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.798 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.4 p -58.71 -48.44 81.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.479 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.485 HD21 ' HA ' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -66.88 -11.07 54.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.44 117.04 0.04 OUTLIER Glycine 0 C--N 1.339 0.746 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.223 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.44 ' HB ' ' HA3' ' A' ' 13' ' ' GLY . 2.5 t -120.2 70.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.754 0.311 . . . . 0.0 111.814 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.25 -167.03 32.94 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.35 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 7.2 tttm -71.82 134.76 46.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.571 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER 76.59 12.8 2.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.553 0.533 . . . . 0.0 111.04 -179.111 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.69 131.92 52.23 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HG3' ' CA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -103.18 144.87 30.75 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.292 179.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 pt -146.79 169.09 5.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.714 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.569 HG22 ' CE1' ' A' ' 64' ' ' TYR . 16.9 m -152.44 107.49 3.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.734 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.768 ' CG1' HD12 ' A' ' 35' ' ' LEU . 4.8 mp -96.96 148.09 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.725 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 25.8 m-85 -138.24 114.94 10.62 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.904 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.55 ' HB2' HG13 ' A' ' 33' ' ' ILE . . . -93.46 130.56 39.25 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.212 0.529 . . . . 0.0 111.459 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -131.48 96.68 4.04 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.751 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.89 -154.77 18.07 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.523 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.4 p -74.63 -60.68 2.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.704 0.752 . . . . 0.0 111.25 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.631 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 5.9 m-20 -91.52 41.22 1.06 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.897 0.38 . . . . 0.0 110.573 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.427 ' HG3' ' CG ' ' A' ' 2' ' ' GLU . 15.0 pt-20 -66.2 -28.52 68.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.974 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.568 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -85.78 -44.02 12.84 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.89 -40.89 67.0 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.612 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -54.68 -54.39 42.38 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.105 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.7 mm -49.6 -49.85 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.961 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -54.78 -69.04 0.14 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.62 -38.07 68.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.607 0.242 . . . . 0.0 111.35 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 73' ' ' ALA . 14.4 mm -61.33 -37.71 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.638 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -58.48 -62.05 2.14 Favored 'General case' 0 C--O 1.207 -1.164 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -39.56 -43.87 1.37 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.594 0.559 . . . . 0.0 110.436 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.5 t -63.74 -64.64 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.448 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.512 HD23 HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -62.35 -24.36 67.31 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.011 0.434 . . . . 0.0 110.651 179.18 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 78' ' ' THR . 8.8 t -61.44 -31.19 71.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.882 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -55.96 -70.4 0.11 Allowed 'General case' 0 C--N 1.348 0.51 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 2.6 pt-20 -176.93 39.8 0.01 OUTLIER 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.34 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.591 ' CA ' HD12 ' A' ' 8' ' ' ILE . . . 71.68 29.71 67.25 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.774 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.798 HD23 ' CB ' ' A' ' 18' ' ' PRO . 5.8 mp 69.67 52.47 0.43 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.838 0.352 . . . . 0.0 110.068 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 65.03 139.08 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.877 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.758 ' HA ' ' HA ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.516 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptp . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.741 ' OE1' ' HB3' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -98.05 164.51 12.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.761 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -157.49 160.19 38.01 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.542 ' HG3' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -160.82 123.09 3.14 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.173 179.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.0 p -94.07 156.59 16.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.692 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -144.48 177.53 8.59 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.654 0.74 . . . . 0.0 111.992 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.6 ' O ' HD13 ' A' ' 8' ' ' ILE . 14.6 t -160.43 104.1 1.42 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.469 -1.242 . . . . 0.0 107.918 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER -142.69 -175.74 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.036 -175.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.723 HG22 ' HA ' ' A' ' 57' ' ' LYS . 14.7 pt -136.89 -41.35 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 25.3 t70 44.89 27.7 0.29 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.771 0.26 . . . . 0.0 111.634 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 88' ' ' GLU . 19.2 mm-40 33.5 34.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.451 0.7 . . . . 0.0 112.741 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER 175.94 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.922 179.236 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.74 -56.93 0.97 Allowed Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.488 HD13 HG23 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -141.11 174.25 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.105 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -171.64 -59.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -174.95 -35.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HD2' ' HG2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -72.13 -56.73 4.21 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 -179.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 36.9 Cg_endo -65.29 -33.49 48.26 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.292 1.995 . . . . 0.0 112.149 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.61 ' HA ' ' HB2' ' A' ' 46' ' ' SER . . . -62.73 -65.0 0.75 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.084 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.1 p -55.29 -28.91 56.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.282 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.789 ' HB3' HG22 ' A' ' 80' ' ' VAL . 1.4 mtt -63.16 -55.59 23.85 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.797 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.497 HD22 ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -58.91 -34.57 71.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.075 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 19' ' ' ALA . 73.8 t -54.55 -57.28 6.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.64 -55.97 14.67 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.517 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 29.4 p -52.89 -57.5 10.05 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.547 0.202 . . . . 0.0 111.547 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.14 -47.72 84.91 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.822 -0.172 . . . . 0.0 110.979 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 23.5 m -60.28 -30.97 69.8 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.784 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' ' 25' ' ' THR . 4.9 mtmp? -63.76 -51.38 65.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 14.2 m-85 -64.58 -37.49 87.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.984 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 80.84 -15.5 0.73 Allowed 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.582 -1.644 . . . . 0.0 112.681 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.443 ' HB3' ' H ' ' A' ' 68' ' ' SER . 83.4 p -66.09 145.6 55.65 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.416 0.626 . . . . 0.0 112.263 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.04 109.11 13.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.098 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.848 ' CG1' ' HB2' ' A' ' 65' ' ' ALA . 1.3 mt -99.53 125.15 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.909 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.665 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -103.77 113.45 26.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.643 0.735 . . . . 0.0 109.258 178.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.023 HD13 HD13 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -101.34 114.12 27.83 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.935 -179.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.536 ' HG3' ' HG2' ' A' ' 41' ' ' LYS . 1.5 tt0 -91.72 173.65 7.76 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 126.262 2.226 . . . . 0.0 110.772 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.427 ' CG ' ' HB2' ' A' ' 53' ' ' LEU . 32.3 t80 -132.35 163.57 28.41 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.084 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.626 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -51.65 -15.48 0.47 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -156.68 50.12 0.44 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.197 -0.525 . . . . 0.0 111.826 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -178.88 -178.51 0.55 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.666 0.27 . . . . 0.0 110.906 -179.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 1.7 tmtt? -157.83 120.84 3.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.448 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.4 m -151.43 -175.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.512 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.25 140.87 29.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.023 HD13 HD13 ' A' ' 35' ' ' LEU . 1.6 tp -69.65 56.83 0.13 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.593 0.235 . . . . 0.0 110.582 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' O ' HD12 ' A' ' 47' ' ' ILE . 3.9 tptp -73.16 9.56 1.2 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.61 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . 89.8 p 39.64 34.24 0.15 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 46' ' ' SER . 2.2 mp -166.16 -84.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.54 ' N ' HG22 ' A' ' 47' ' ' ILE . 3.4 tpp -63.98 -37.27 86.82 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -82.43 0.1 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.475 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.488 HG23 HD13 ' A' ' 14' ' ' ILE . 3.1 m -40.0 -42.06 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.0 mtt -59.07 -50.11 75.32 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.509 0.195 . . . . 0.0 111.233 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.4 t -56.47 -52.64 63.94 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.226 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.427 ' HB2' ' CG ' ' A' ' 37' ' ' TYR . 0.6 OUTLIER -67.31 -18.01 65.0 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.59 101.3 0.05 OUTLIER Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.55 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.442 ' CG2' ' HB ' ' A' ' 50' ' ' VAL . 19.5 t -90.98 75.99 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.939 0.4 . . . . 0.0 111.22 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.12 -161.99 37.12 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.375 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.723 ' HA ' HG22 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -72.63 127.43 32.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 82.33 18.24 0.34 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.698 0.624 . . . . 0.0 110.42 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.88 115.27 2.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.299 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.626 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 2.1 tt0 -96.83 139.63 32.58 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.753 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.82 170.11 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.154 0.502 . . . . 0.0 111.812 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.562 ' C ' HD13 ' A' ' 63' ' ' ILE . 7.0 m -152.55 107.0 3.16 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.928 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.847 ' CD1' HD12 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -94.99 146.59 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.761 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 40.8 m-85 -145.49 108.82 4.63 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.468 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.848 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -98.0 133.54 42.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.838 0.351 . . . . 0.0 110.559 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.82 78.17 1.66 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.569 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -147.76 -89.7 0.08 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.702 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.443 ' H ' ' HB3' ' A' ' 31' ' ' SER . 11.3 p -132.39 -65.65 0.72 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.918 0.359 . . . . 0.0 111.285 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.462 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.4 m-20 -89.69 41.19 1.03 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.867 0.365 . . . . 0.0 110.639 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -24.28 66.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.055 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.28 -53.21 5.92 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -32.91 66.13 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.989 0.423 . . . . 0.0 109.876 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -49.09 -56.49 8.94 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.992 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.58 HD11 ' HG2' ' A' ' 2' ' ' GLU . 15.1 mm -42.64 -55.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.83 -67.62 0.25 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.78 68.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.47 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.92 -37.76 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.558 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 82' ' ' SER . 0.2 OUTLIER -58.41 -56.32 23.57 Favored 'General case' 0 C--O 1.209 -1.055 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.312 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -45.6 -41.07 9.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.089 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.789 HG22 ' HB3' ' A' ' 21' ' ' MET . 6.2 t -65.26 -62.97 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.181 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.8 -33.95 73.77 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.973 0.416 . . . . 0.0 110.617 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 78' ' ' THR . 5.8 t -61.46 -28.01 68.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.413 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.679 ' O ' HD23 ' A' ' 86' ' ' LEU . 5.1 tptp -59.65 -30.39 68.7 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 121.324 -0.151 . . . . 0.0 111.014 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 2.7 pt-20 -63.83 -26.78 68.78 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.819 0.343 . . . . 0.0 110.427 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.47 -13.06 70.64 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.192 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 83' ' ' LYS . 0.7 OUTLIER -56.69 -27.07 58.21 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 116.754 0.277 . . . . 0.0 110.648 179.068 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.25 -97.23 0.28 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.599 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.519 ' HB2' HD11 ' A' ' 9' ' ' ILE . 4.4 pt-20 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.934 -0.555 . . . . 0.0 112.256 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ttt . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.735 0.302 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.605 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 3.1 mm-40 -95.28 164.58 12.78 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.525 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.7 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 2.3 pt20 -161.78 152.77 18.05 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.777 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.494 ' HB3' ' CE1' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -160.87 122.61 3.03 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.986 0.422 . . . . 0.0 111.967 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.7 p -90.71 155.06 19.1 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.994 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 4' ' ' GLN . 87.4 m-85 -143.45 -179.92 6.72 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 122.009 0.909 . . . . 0.0 112.814 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 7' ' ' THR . 11.8 t -152.06 95.8 2.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.606 -1.633 . . . . 0.0 106.833 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.649 HG23 ' HG2' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -93.4 179.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.721 -175.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.743 HD13 ' C ' ' A' ' 88' ' ' GLU . 1.6 pp -148.5 27.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.665 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.34 78.13 1.01 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.98 0.419 . . . . 0.0 110.343 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.645 ' HG3' ' HB2' ' A' ' 57' ' ' LYS . 1.8 mp0 -54.06 -22.72 11.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.788 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -41.27 37.85 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.75 85.97 0.09 OUTLIER Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.773 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.429 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER 69.17 145.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.134 0.492 . . . . 0.0 111.795 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -171.56 -63.65 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.605 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.678 ' C ' ' HD2' ' A' ' 18' ' ' PRO . . . -178.06 163.51 1.74 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.799 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.538 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER 98.51 -60.49 0.0 OUTLIER Pre-proline 0 C--N 1.364 1.229 0 CA-C-N 118.934 0.788 . . . . 0.0 112.743 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.678 ' HD2' ' C ' ' A' ' 16' ' ' ALA . 56.5 Cg_endo -70.65 -27.77 21.79 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 121.804 1.669 . . . . 0.0 112.471 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.615 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.47 -65.61 0.66 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.695 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.6 m -55.02 -32.98 62.25 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.704 0.288 . . . . 0.0 110.51 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.509 ' HE3' ' HA ' ' A' ' 18' ' ' PRO . 21.1 mtm -64.83 -53.78 41.37 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.408 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.769 HD11 ' CD2' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -57.98 -37.38 74.11 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.19 179.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 19' ' ' ALA . 62.3 t -54.1 -60.16 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -49.65 64.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.431 ' O ' ' CD2' ' A' ' 29' ' ' PHE . 73.5 p -58.13 -58.96 6.13 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.389 0.086 . . . . 0.0 111.051 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.59 85.69 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.744 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.5 t -59.37 -33.07 70.73 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.702 0.287 . . . . 0.0 110.804 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -66.49 -51.4 57.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.602 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.613 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 13.9 m-85 -66.33 -40.78 90.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.509 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 78.36 -20.41 0.39 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.593 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.539 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 93.2 p -66.52 140.09 57.97 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.623 0.725 . . . . 0.0 112.415 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.57 112.84 19.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.112 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.696 HG13 ' HB2' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -97.73 121.38 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.677 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.674 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 1.8 pt20 -101.61 107.41 18.67 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.987 HD13 ' HG ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -99.63 116.25 31.31 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.085 -179.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.697 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -93.91 172.23 8.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 125.973 2.046 . . . . 0.0 110.736 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.559 ' CD1' HD11 ' A' ' 53' ' ' LEU . 13.0 t80 -125.4 166.82 15.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.092 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.562 ' HB3' ' CG ' ' A' ' 60' ' ' GLU . 0.7 OUTLIER -53.58 -14.98 0.96 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.82 46.69 0.51 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.102 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HE3' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -173.04 -177.36 1.57 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.798 0.333 . . . . 0.0 111.244 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.697 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 3.0 tmtm? -158.12 117.76 3.25 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.802 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 m -152.3 -172.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.095 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -86.59 142.67 28.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.987 ' HG ' HD13 ' A' ' 35' ' ' LEU . 4.2 tt -68.68 58.45 0.09 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -41.9 71.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.731 ' HA ' HG22 ' A' ' 50' ' ' VAL . 1.0 OUTLIER 71.27 -51.99 0.69 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.425 0.631 . . . . 0.0 111.897 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -53.06 -27.28 13.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.316 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.562 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 12.8 mtp -167.3 -39.07 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.76 -56.1 12.57 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.17 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.731 HG22 ' HA ' ' A' ' 46' ' ' SER . 18.6 m -68.05 -50.26 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.562 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -59.48 -40.14 85.97 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.375 0.131 . . . . 0.0 111.3 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -57.21 -51.54 68.92 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.625 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.559 HD11 ' CD1' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -66.97 -35.09 79.2 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.07 179.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.415 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . 128.69 126.52 2.87 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.711 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 51' ' ' MET . 44.1 t -127.1 107.57 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.591 0.234 . . . . 0.0 111.127 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.0 174.09 18.3 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.513 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.645 ' HB2' ' HG3' ' A' ' 11' ' ' GLU . 15.1 tttt -70.06 136.39 50.26 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.582 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 86.2 5.2 0.42 Allowed 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.651 0.594 . . . . 0.0 111.061 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.86 119.13 7.13 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.562 ' CG ' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -94.81 145.74 24.67 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.578 HD13 HD11 ' A' ' 8' ' ' ILE . 5.5 pt -147.48 175.65 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.573 ' C ' HD13 ' A' ' 63' ' ' ILE . 4.2 m -151.86 107.03 3.28 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.767 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.76 ' N ' HD13 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -96.05 152.3 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.114 -177.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.7 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 51.9 m-85 -146.26 110.24 4.95 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.66 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.696 ' HB2' HG13 ' A' ' 33' ' ' ILE . . . -93.47 126.51 38.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.025 0.441 . . . . 0.0 110.705 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -125.8 94.68 4.18 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.109 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.539 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . 179.88 -159.17 23.38 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.067 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.2 p -69.95 -60.97 1.97 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.104 0.952 . . . . 0.0 111.605 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.582 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 4.2 m-20 -91.79 45.26 1.21 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.849 0.357 . . . . 0.0 110.824 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.605 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 9.5 pt-20 -67.1 -22.53 65.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.12 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.568 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -88.63 -45.58 9.74 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -38.64 67.33 Favored 'General case' 0 C--N 1.342 0.281 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.613 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -52.34 -56.88 11.95 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.49 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.0 mm -44.82 -45.64 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.791 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.73 -70.76 0.15 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.86 -32.49 65.88 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.12 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 73' ' ' ALA . 11.0 mm -62.43 -36.55 75.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -58.39 -51.78 68.36 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.096 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -46.11 -42.85 14.25 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.743 0.652 . . . . 0.0 109.923 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.472 HG22 ' HE3' ' A' ' 21' ' ' MET . 2.4 t -61.14 -57.79 10.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.152 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.419 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -62.17 -30.41 71.04 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 110.23 178.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 78' ' ' THR . 4.5 t -61.71 -30.91 71.07 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.912 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.558 ' O ' HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -63.26 -23.45 67.43 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.667 178.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.649 ' HG2' HG23 ' A' ' 8' ' ' ILE . 2.2 pp20? -59.79 -31.39 69.65 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.626 0.37 . . . . 0.0 110.457 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.87 -16.02 7.21 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.23 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 83' ' ' LYS . 2.8 pp -63.53 -7.79 7.89 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 53.2 p -97.46 -103.82 0.19 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 121.349 -0.14 . . . . 0.0 111.097 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.743 ' C ' HD13 ' A' ' 9' ' ' ILE . 2.1 tp10 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.995 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.679 0.276 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.597 ' CG ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -101.5 160.04 14.77 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.601 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.734 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -150.31 149.86 30.69 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.684 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.83 162.43 32.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.366 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.446 ' HB3' HG23 ' A' ' 62' ' ' THR . 30.6 p -154.17 148.16 25.64 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.745 0.307 . . . . 0.0 111.527 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -144.01 -176.9 5.18 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.415 0.626 . . . . 0.0 111.329 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 7' ' ' THR . 15.3 t -153.53 113.31 3.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.76 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.532 HG22 ' H ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER -136.65 -172.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 58' ' ' ASP . 21.4 pt -137.24 -40.69 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.489 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.507 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 36.3 t70 46.27 22.41 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.538 ' HG2' ' HA ' ' A' ' 88' ' ' GLU . 20.5 mm-40 25.25 41.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.743 0.817 . . . . 0.0 112.325 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.84 HG21 ' HB3' ' A' ' 15' ' ' HIS . 2.8 m -176.4 -37.09 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.833 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.88 -75.06 1.45 Allowed Glycine 0 C--N 1.347 1.186 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.773 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.635 ' CG2' ' HB2' ' A' ' 19' ' ' ALA . 18.2 mm -139.54 81.94 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.848 0.356 . . . . 0.0 110.063 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.84 ' HB3' HG21 ' A' ' 12' ' ' THR . 10.4 p80 -66.27 -52.56 46.38 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.054 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -178.42 -35.39 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.577 ' HD2' ' HG3' ' A' ' 21' ' ' MET . 3.2 tmm_? -71.47 -53.54 7.57 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 17' ' ' ARG . 10.0 Cg_endo -52.52 -45.18 41.75 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.541 2.161 . . . . 0.0 112.765 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.635 ' HB2' ' CG2' ' A' ' 14' ' ' ILE . . . -64.36 -64.7 0.81 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.2 m -52.9 -32.14 43.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.374 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.577 ' HG3' ' HD2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -66.1 -49.27 68.13 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.972 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.94 HD22 HD22 ' A' ' 44' ' ' LEU . 3.8 mt -55.75 -38.91 70.45 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.919 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.407 ' O ' ' CB ' ' A' ' 27' ' ' SER . 58.3 t -57.45 -65.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.422 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -45.68 84.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.596 HG22 ' HE2' ' A' ' 29' ' ' PHE . 95.0 m -57.15 -62.35 1.82 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.441 0.163 . . . . 0.0 110.783 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.38 -46.49 88.53 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.636 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 33.0 t -59.01 -29.64 67.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.595 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 25' ' ' THR . 17.4 mtmm -64.18 -52.78 57.29 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.696 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 38.4 m-85 -64.52 -36.5 84.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.047 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 82.44 -16.19 0.62 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.216 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.749 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 86.4 p -66.94 135.13 53.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.459 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.97 110.31 9.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.228 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.063 ' CG2' HG23 ' A' ' 63' ' ' ILE . 4.1 mt -98.64 126.59 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.613 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.637 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 3.6 pt20 -98.18 105.44 17.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 6.2 tt -96.63 112.47 24.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.313 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.796 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -95.16 175.84 6.46 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 125.904 2.003 . . . . 0.0 112.471 -178.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -129.12 163.12 26.18 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.494 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 0.7 OUTLIER -55.02 -11.36 0.64 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.66 48.18 0.51 Allowed Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.72 -179.19 0.61 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.714 0.292 . . . . 0.0 110.983 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.796 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -159.18 119.94 3.22 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.493 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.4 m -153.34 -172.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.708 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.532 ' ND2' HD12 ' A' ' 44' ' ' LEU . 6.5 t30 -89.26 148.73 23.42 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.94 HD22 HD22 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -62.92 50.97 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 177.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 43' ' ' ASN . 4.0 mptt -59.34 -41.23 88.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.64 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.12 -52.17 0.7 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.449 0.643 . . . . 0.0 111.737 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.03 -24.15 14.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.774 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.1 mtm -167.27 -39.29 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.246 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -50.12 -49.32 37.22 Favored Glycine 0 C--N 1.34 0.788 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.113 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.64 HG22 ' HA ' ' A' ' 46' ' ' SER . 16.7 m -71.49 -36.3 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.811 0.305 . . . . 0.0 110.559 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 56.3 mtt -59.72 -46.76 88.12 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.464 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.7 p -58.78 -49.82 76.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.934 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.479 HD21 ' HA ' ' A' ' 50' ' ' VAL . 1.1 pp -66.96 -12.73 60.56 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.31 109.8 0.06 OUTLIER Glycine 0 C--N 1.34 0.762 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.927 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 t -107.12 59.82 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.989 0.424 . . . . 0.0 110.924 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.87 -156.96 24.42 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.788 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 3.7 tttt -74.28 126.13 29.95 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.618 ' H ' HG22 ' A' ' 9' ' ' ILE . 0.2 OUTLIER 85.28 13.38 0.21 Allowed 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.822 0.701 . . . . 0.0 110.69 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.64 117.38 4.87 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.779 0.323 . . . . 0.0 111.425 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 1.5 tt0 -99.88 139.71 35.15 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.639 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.35 167.71 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.768 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 5' ' ' SER . 18.7 m -151.21 114.74 4.87 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.48 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.063 HG23 ' CG2' ' A' ' 33' ' ' ILE . 3.2 mp -99.58 133.6 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.19 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.734 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 50.6 m-85 -129.91 104.24 7.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.362 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.747 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -95.0 132.07 40.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.176 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.45 78.17 1.5 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.055 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.749 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -164.95 20.8 0.12 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.712 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 67' ' ' GLY . 59.5 p 121.96 -81.94 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.256 1.022 . . . . 0.0 111.914 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.696 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 8.0 m-20 -87.2 46.22 1.35 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.439 0.638 . . . . 0.0 109.997 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -70.5 -21.43 62.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.267 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.96 -51.75 6.17 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -34.52 62.54 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.199 178.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.641 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.75 -63.78 1.04 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.171 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.597 HG12 ' CG ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -48.08 -41.51 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -59.1 -69.33 0.2 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.641 0.258 . . . . 0.0 111.234 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.97 67.79 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.472 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.4 mm -60.26 -38.74 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.152 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.459 ' O ' ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -56.78 -57.9 10.45 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -44.47 -39.8 5.07 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.762 0.664 . . . . 0.0 110.525 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.503 HG22 ' SD ' ' A' ' 21' ' ' MET . 3.3 t -64.17 -60.84 2.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.605 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.426 HD23 HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -63.09 -32.24 73.57 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 110.62 178.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 78' ' ' THR . 1.2 p -62.45 -34.02 75.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.636 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.554 ' O ' HD23 ' A' ' 86' ' ' LEU . 2.5 tptp -63.01 -27.8 69.66 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.217 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 6.9 mm-40 -62.01 -28.91 69.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.096 0.559 . . . . 0.0 110.756 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.41 ' HA2' ' HG2' ' A' ' 88' ' ' GLU . . . -63.88 -18.42 62.02 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.038 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -56.17 -29.9 61.47 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.612 0.244 . . . . 0.0 110.623 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.9 p -104.61 -98.97 0.32 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.475 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' ' 11' ' ' GLU . 3.8 pt-20 . . . . . 0 C--O 1.253 1.259 0 CA-C-O 118.957 -0.544 . . . . 0.0 112.145 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.725 0.298 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.609 ' HG3' ' N ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -100.39 164.07 12.09 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.57 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.713 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -155.41 159.11 39.61 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.473 ' HG3' HG23 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -156.41 174.39 15.48 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.495 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.7 p -153.03 146.85 25.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.005 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -138.45 -175.43 4.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.864 0.84 . . . . 0.0 113.19 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 7' ' ' THR . 6.7 t -150.31 74.8 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.917 -1.492 . . . . 0.0 107.685 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.457 HD12 ' CG1' ' A' ' 55' ' ' VAL . 73.0 mt -51.02 160.04 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 113.764 -1.562 . . . . 0.0 113.298 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.756 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.7 pp -151.09 4.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 4.4 t70 -74.13 15.54 0.31 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 8.1 mp0 72.1 -63.25 0.43 Allowed 'General case' 0 C--O 1.231 0.124 0 C-N-CA 122.915 0.486 . . . . 0.0 110.422 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 m -85.7 -25.5 26.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.58 -81.09 1.38 Allowed Glycine 0 C--N 1.343 0.963 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.735 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.729 HG23 ' O ' ' A' ' 14' ' ' ILE . 1.1 tp -103.98 62.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.887 0.851 . . . . 0.0 110.548 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -61.34 -52.58 64.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.854 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.56 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -70.33 -57.09 6.1 Favored Pre-proline 0 CA--C 1.53 0.184 0 N-CA-C 110.696 -0.113 . . . . 0.0 110.696 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HG2' ' HA ' ' A' ' 14' ' ' ILE . 32.4 Cg_endo -63.18 -31.23 74.98 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.167 1.912 . . . . 0.0 111.925 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.593 ' HB2' HG13 ' A' ' 14' ' ' ILE . . . -63.62 -64.9 0.77 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.22 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.2 p -53.62 -31.9 49.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.004 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.469 ' HB3' HG21 ' A' ' 80' ' ' VAL . 1.5 mmt -65.64 -52.7 49.81 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.71 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.558 HD13 ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -56.78 -37.63 71.39 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 179.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 19' ' ' ALA . 57.6 t -55.29 -57.07 8.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.427 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.9 tt0 -66.24 -55.96 13.63 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.937 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.434 ' OG1' ' HA ' ' A' ' 22' ' ' LEU . 54.1 p -53.48 -57.77 9.5 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.917 -0.129 . . . . 0.0 111.299 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.51 -46.62 86.36 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 7.7 m -59.26 -34.7 72.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.057 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 25' ' ' THR . 37.1 mtmt -65.39 -49.96 67.31 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.643 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 19.5 m-85 -64.82 -37.31 87.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.29 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 76.49 -13.35 0.93 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.868 -1.515 . . . . 0.0 112.184 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.483 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 92.6 p -67.97 139.89 56.38 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.483 0.659 . . . . 0.0 112.179 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.73 107.94 12.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.258 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.684 ' CG1' ' HB2' ' A' ' 65' ' ' ALA . 1.0 OUTLIER -97.84 126.0 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.285 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.754 ' HG3' ' HB2' ' A' ' 64' ' ' TYR . 4.7 pt20 -105.87 106.86 17.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.014 HD13 HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -101.22 121.11 41.28 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.881 -178.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.743 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -96.35 172.96 7.62 Favored 'General case' 0 C--N 1.341 0.217 0 O-C-N 126.211 2.194 . . . . 0.0 109.911 179.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.589 ' O ' ' N ' ' A' ' 39' ' ' GLY . 2.1 t80 -146.7 100.92 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.829 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.424 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER 49.6 -59.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 37' ' ' TYR . . . -143.17 37.26 1.51 Allowed Glycine 0 C--N 1.317 -0.515 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -142.65 174.19 10.87 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.743 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -155.19 117.44 4.19 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.081 0.467 . . . . 0.0 111.561 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.715 HG21 HD21 ' A' ' 53' ' ' LEU . 19.9 m -152.37 -176.81 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.971 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -83.51 139.42 32.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.014 HD13 HD13 ' A' ' 35' ' ' LEU . 1.5 tp -67.62 55.62 0.06 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.715 0.293 . . . . 0.0 110.709 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -71.73 -4.46 27.72 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.558 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . 81.4 p 38.59 47.5 1.13 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 46' ' ' SER . 38.1 mm -166.43 -95.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.537 0.735 . . . . 0.0 109.217 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.481 ' N ' HG22 ' A' ' 47' ' ' ILE . 34.1 mmt -68.09 -51.32 47.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.32 -81.35 0.07 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.671 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.417 HG23 HG21 ' A' ' 55' ' ' VAL . 7.2 p -37.55 -43.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.412 ' N ' HG13 ' A' ' 50' ' ' VAL . 1.8 mmt -61.99 -48.86 78.46 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.1 t -53.23 -51.46 62.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.062 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.715 HD21 HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -66.25 -35.39 80.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.004 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.32 108.36 1.89 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.529 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.491 HG13 ' CB ' ' A' ' 59' ' ' ALA . 57.8 t -139.27 82.39 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 120.866 0.365 . . . . 0.0 111.134 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.02 -139.74 10.74 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.454 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.602 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 13.8 tttt -73.75 131.88 42.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.602 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 84.6 -5.19 1.0 Allowed 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.7 0.625 . . . . 0.0 111.511 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.491 ' CB ' HG13 ' A' ' 55' ' ' VAL . . . -62.72 125.02 22.53 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.722 0.296 . . . . 0.0 111.492 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.98 142.63 27.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.42 172.34 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.772 ' C ' HD13 ' A' ' 63' ' ' ILE . 6.6 m -150.57 115.15 5.2 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.151 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.872 ' N ' HD13 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -100.46 147.62 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.754 ' HB2' ' HG3' ' A' ' 34' ' ' GLN . 45.3 m-85 -143.09 107.54 4.8 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.899 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.684 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -93.31 131.08 38.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.116 0.484 . . . . 0.0 111.346 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.54 83.41 2.16 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.96 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.483 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -166.72 -154.48 8.4 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.649 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 p -76.28 -55.81 5.22 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.866 0.833 . . . . 0.0 111.893 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.643 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 2.8 m-20 -92.62 40.86 1.06 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.568 0.223 . . . . 0.0 111.224 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 4.9 pt-20 -67.17 -18.77 65.41 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.6 -54.81 3.99 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.89 -34.18 62.79 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.638 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.55 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -51.74 -62.63 1.5 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.176 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.592 HG12 ' CG ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -49.79 -46.08 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -57.76 -67.92 0.29 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.629 0.252 . . . . 0.0 111.462 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.44 -37.63 67.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.033 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.4 mm -60.85 -39.27 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.463 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 82' ' ' SER . 0.2 OUTLIER -57.0 -54.76 43.06 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -46.05 -41.62 12.32 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 109.945 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 21' ' ' MET . 3.4 t -65.19 -61.02 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.007 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 6.0 mt -60.53 -32.93 71.94 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.037 0.446 . . . . 0.0 110.559 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 78' ' ' THR . 5.4 t -61.41 -31.5 71.42 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.279 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.688 ' O ' HD23 ' A' ' 86' ' ' LEU . 13.5 mttt -62.5 -25.91 68.26 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 9.8 pt-20 -64.63 -25.78 68.11 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 120.708 0.29 . . . . 0.0 110.795 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.756 ' HA2' HD11 ' A' ' 9' ' ' ILE . . . -59.48 -14.78 29.31 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 83' ' ' LYS . 1.4 pp -54.94 -18.99 5.7 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.095 0.158 . . . . 0.0 111.422 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.4 p -95.92 -93.91 0.2 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.28 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.555 ' HB3' HD13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.402 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.765 0.317 . . . . 0.0 111.394 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.637 ' HG3' ' HA ' ' A' ' 71' ' ' ALA . 7.2 mm-40 -97.59 169.62 9.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.725 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -164.34 153.38 13.41 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.018 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -161.94 121.94 2.51 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.008 0.432 . . . . 0.0 112.009 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.7 p -89.73 153.56 20.6 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.765 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 4' ' ' GLN . 92.2 m-85 -142.2 -176.88 4.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.697 0.76 . . . . 0.0 112.76 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 7' ' ' THR . 5.5 t -149.18 87.43 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.136 -1.393 . . . . 0.0 107.913 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 9' ' ' ILE . 36.0 mt -73.87 169.06 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.751 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 1.9 pp -140.11 -26.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.833 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -69.15 82.16 0.34 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.235 0.54 . . . . 0.0 110.502 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.506 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 1.2 pm0 -56.96 -7.91 0.54 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.76 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.7 m -78.7 -30.18 45.88 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.55 -164.66 18.94 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.758 -0.735 . . . . 0.0 113.219 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.8 HG23 ' HB2' ' A' ' 18' ' ' PRO . 23.4 mt -77.02 86.94 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.736 0.303 . . . . 0.0 110.67 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -69.98 -163.98 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.88 -32.95 68.19 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.474 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -74.22 -61.06 1.3 Allowed Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.8 ' HB2' HG23 ' A' ' 14' ' ' ILE . 29.6 Cg_endo -62.56 -31.24 79.96 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.327 2.018 . . . . 0.0 112.613 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.578 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.45 -63.19 1.25 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.085 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.6 m -52.72 -33.18 46.65 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.683 0.278 . . . . 0.0 110.719 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -55.61 17.46 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.696 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.49 ' CD2' HD21 ' A' ' 44' ' ' LEU . 1.1 mt -57.3 -38.97 74.8 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.316 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 19' ' ' ALA . 63.9 t -53.84 -57.89 4.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 25' ' ' THR . 1.1 tt0 -66.84 -55.47 14.64 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.413 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 76.7 p -53.35 -59.44 4.57 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.039 0.212 . . . . 0.0 111.385 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.6 -48.04 82.28 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 122.944 0.152 . . . . 0.0 111.039 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.8 t -60.53 -31.2 70.29 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.649 0.261 . . . . 0.0 111.298 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -68.11 -50.43 54.83 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.601 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 10.6 m-85 -64.92 -42.58 94.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.911 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.32 -11.72 0.78 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.241 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.428 ' CB ' ' HA3' ' A' ' 67' ' ' GLY . 99.8 p -68.05 145.37 54.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.453 0.644 . . . . 0.0 112.45 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.95 108.94 15.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.209 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.755 HG23 HG22 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -98.6 123.21 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.175 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.707 ' CG ' ' HB2' ' A' ' 64' ' ' TYR . 4.5 pt20 -98.56 106.05 18.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.632 HD22 HG22 ' A' ' 50' ' ' VAL . 5.5 tt -98.69 115.66 29.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.485 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.782 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -94.65 172.82 7.94 Favored 'General case' 0 C--N 1.34 0.179 0 O-C-N 126.07 2.106 . . . . 0.0 111.653 -179.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -126.17 165.27 19.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.637 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.49 ' HB3' ' HG3' ' A' ' 60' ' ' GLU . 1.3 p-10 -53.33 -14.1 0.67 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.49 49.4 0.48 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.05 178.65 1.72 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.704 0.287 . . . . 0.0 111.006 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.782 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -159.77 115.59 2.45 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.367 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.9 m -153.34 -175.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.05 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.231 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -85.21 141.18 30.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.818 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -65.31 52.7 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 121.907 0.86 . . . . 0.0 111.552 177.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.437 ' HG2' HD12 ' A' ' 47' ' ' ILE . 37.2 tttt -63.35 -34.47 77.78 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.75 ' HA ' ' HB ' ' A' ' 50' ' ' VAL . 0.9 OUTLIER 72.77 -50.62 0.7 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.283 0.563 . . . . 0.0 111.92 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.437 HD12 ' HG2' ' A' ' 45' ' ' LYS . 5.9 mt -53.84 -22.93 7.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.108 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.547 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -169.45 -39.98 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.974 -178.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.91 -56.06 27.18 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.879 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.75 ' HB ' ' HA ' ' A' ' 46' ' ' SER . 5.3 t -69.08 -45.95 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.657 0.228 . . . . 0.0 111.332 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.547 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -60.23 -36.92 78.82 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.721 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.0 t -60.27 -51.72 68.33 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.041 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -64.75 -11.33 35.17 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.92 119.65 0.1 OUTLIER Glycine 0 C--N 1.34 0.777 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.803 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.457 HG21 ' CG1' ' A' ' 50' ' ' VAL . 20.0 t -117.03 63.88 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.996 0.427 . . . . 0.0 111.378 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 11' ' ' GLU . . . -80.92 -166.78 36.32 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.057 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -75.86 125.63 29.45 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 89.01 7.05 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.879 0.737 . . . . 0.0 111.089 -178.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.63 117.73 5.69 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-O 120.513 0.197 . . . . 0.0 111.133 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.49 ' HG3' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -94.29 142.44 27.41 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.77 HD12 HD11 ' A' ' 63' ' ' ILE . 22.1 pt -143.11 175.12 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.766 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.592 ' C ' HD13 ' A' ' 63' ' ' ILE . 6.0 m -151.67 104.87 3.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.702 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.77 HD11 HD12 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -96.49 151.01 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.725 ' CD2' ' HB3' ' A' ' 3' ' ' GLN . 22.7 m-85 -146.45 110.98 5.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.515 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.674 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . . . -93.48 127.62 39.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.24 0.543 . . . . 0.0 111.187 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.89 89.15 3.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.756 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 31' ' ' SER . . . -174.02 -153.68 10.05 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.601 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.6 p -75.59 -58.08 3.5 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.714 0.757 . . . . 0.0 111.767 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.587 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 3.2 m-20 -91.87 42.7 1.11 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.865 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.606 ' HG3' ' HG2' ' A' ' 2' ' ' GLU . 5.9 pt-20 -67.45 -22.26 65.51 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.637 ' HA ' ' HG3' ' A' ' 2' ' ' GLU . . . -89.05 -48.64 7.27 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.06 -37.66 64.41 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.601 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -53.68 -57.04 12.23 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.715 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.8 mm -49.61 -49.06 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.93 -67.48 0.36 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.79 -34.16 67.37 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.537 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' A' ' 80' ' ' VAL . 9.6 mm -62.29 -37.43 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -51.86 68.07 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -47.88 -40.55 21.98 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 123.607 0.567 . . . . 0.0 110.004 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 77' ' ' ILE . 2.5 t -62.09 -57.42 12.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.08 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.451 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -62.55 -36.54 82.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.96 0.409 . . . . 0.0 110.076 178.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 t -60.34 -29.77 69.1 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.858 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.651 ' O ' HD23 ' A' ' 86' ' ' LEU . 10.4 ttmt -62.43 -25.19 67.83 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.572 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 81' ' ' LEU . 7.0 pt-20 -61.39 -31.03 70.93 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.78 0.324 . . . . 0.0 110.34 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.36 -18.17 42.13 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.066 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 83' ' ' LYS . 0.7 OUTLIER -58.18 -25.57 61.72 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.538 0.169 . . . . 0.0 110.99 179.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.3 p -101.75 -98.24 0.27 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.872 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 117.981 -1.009 . . . . 0.0 112.209 179.916 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 ttm . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.703 0.287 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.623 ' CD ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -96.11 163.58 13.05 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.308 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.638 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 0.9 OUTLIER -153.66 152.5 30.9 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.486 HE21 HG21 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -159.55 165.57 32.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.297 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.5 p -153.87 141.07 19.51 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.82 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.29 -161.98 1.3 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.7 m -153.98 106.88 2.88 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.753 HG22 ' HA2' ' A' ' 85' ' ' GLY . 1.7 mt -102.18 -171.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.736 -176.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.66 ' H ' HG22 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -144.93 10.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 11.0 t70 -73.63 83.97 1.57 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.12 -23.92 2.43 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.794 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -82.82 -36.97 25.07 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . 73.31 95.38 0.1 OUTLIER Glycine 0 C--N 1.344 0.995 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.911 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.416 HG13 ' CA ' ' A' ' 46' ' ' SER . 31.0 mm 67.84 125.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.897 0.379 . . . . 0.0 111.32 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -167.99 128.11 1.33 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.72 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 18' ' ' PRO . . . 43.95 -161.8 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 119.144 -0.455 . . . . 0.0 111.325 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.62 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER 15.51 -77.01 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.62 ' CD ' ' HB3' ' A' ' 17' ' ' ARG . 10.1 Cg_endo -50.34 -42.48 47.67 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.594 2.863 . . . . 0.0 113.509 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.35 -63.97 1.11 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.419 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.5 m -54.82 -31.75 59.59 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.579 ' HB3' HG22 ' A' ' 80' ' ' VAL . 27.7 mtm -64.93 -51.85 59.6 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.692 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.67 ' HG ' HG11 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -56.65 -36.98 70.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.082 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.62 -60.59 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -66.47 -51.17 59.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.399 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.528 HG22 ' HE2' ' A' ' 29' ' ' PHE . 70.7 m -51.93 -60.24 3.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.275 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.9 -48.24 81.35 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.949 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.0 t -58.56 -28.79 65.85 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.542 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -66.13 -49.8 66.21 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.671 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 14.1 m-85 -64.62 -40.94 96.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.998 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.43 -9.44 1.4 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.434 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.0 p -66.72 154.7 40.02 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.64 140.64 46.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.916 HD13 HD22 ' A' ' 44' ' ' LEU . 5.1 tt -146.96 114.1 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.181 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.648 ' HG2' ' HB2' ' A' ' 64' ' ' TYR . 17.9 pm0 -104.35 128.86 52.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.456 0.646 . . . . 0.0 110.37 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.741 HD12 HD12 ' A' ' 44' ' ' LEU . 5.8 tt -113.97 121.94 45.43 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.733 ' HG3' ' HA ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -100.56 177.83 4.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 125.733 1.896 . . . . 0.0 111.494 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.498 ' CD1' HD11 ' A' ' 53' ' ' LEU . 12.2 t80 -128.02 162.83 25.91 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.868 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -55.43 -12.49 1.11 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.531 179.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -155.7 46.92 0.51 Allowed Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.41 -177.68 1.05 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.757 0.313 . . . . 0.0 110.919 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.733 ' HA ' ' HG3' ' A' ' 36' ' ' GLU . 4.9 tmtm? -159.05 122.79 3.84 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 m -152.24 -174.75 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.025 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 45' ' ' LYS . 7.6 t30 -84.11 145.09 28.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.916 HD22 HD13 ' A' ' 33' ' ' ILE . 1.3 tt -67.66 58.55 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HB2' ' HA3' ' A' ' 49' ' ' GLY . 4.5 mtpm? -69.31 -49.44 55.78 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.658 ' HA ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER 73.78 -54.1 0.68 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.352 -178.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.18 -25.58 13.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.289 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.594 ' HA ' ' CG ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -169.78 -39.02 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -178.053 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 45' ' ' LYS . . . -48.68 -56.03 10.32 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.139 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.739 HG12 HD22 ' A' ' 35' ' ' LEU . 32.0 m -68.57 -50.25 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.594 ' CG ' ' HA ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -60.22 -40.95 91.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.3 p -58.43 -48.39 80.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.941 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.573 HD23 ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -66.09 -34.56 78.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.921 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.79 126.22 3.08 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.975 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.524 HG23 ' HA ' ' A' ' 51' ' ' MET . 2.9 t -129.13 84.16 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.571 0.224 . . . . 0.0 110.953 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.47 176.86 48.44 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 4.7 tttm -71.95 131.08 42.46 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.603 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 85.07 12.06 0.26 Allowed 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.671 0.607 . . . . 0.0 110.467 -178.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.97 121.59 12.2 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.321 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 2.8 tt0 -93.9 143.39 26.38 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.608 HD12 HD11 ' A' ' 63' ' ' ILE . 19.2 pt -146.14 172.82 3.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.49 ' C ' HD12 ' A' ' 63' ' ' ILE . 4.4 m -148.13 109.47 4.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.858 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.782 ' CG2' HD11 ' A' ' 33' ' ' ILE . 1.3 mp -96.16 142.04 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.707 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.648 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 84.0 m-85 -132.24 116.21 16.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.784 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.8 127.78 48.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.023 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -133.25 103.95 6.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.005 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.56 -155.53 26.54 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.765 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.2 p -69.18 -61.09 1.94 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 117.282 0.541 . . . . 0.0 111.659 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 29' ' ' PHE . 1.9 m-20 -92.2 37.92 0.99 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.544 0.211 . . . . 0.0 111.252 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.03 -22.45 66.98 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.35 -55.07 3.96 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.29 -34.6 66.62 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.461 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . . . -50.28 -58.88 4.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.24 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.623 HG12 ' CD ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -43.48 -51.02 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 123.218 0.324 . . . . 0.0 111.872 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -54.71 -68.7 0.16 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.83 71.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.454 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 73' ' ' ALA . 13.1 mm -62.09 -38.64 81.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.652 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -57.31 -57.68 11.56 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.269 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -44.16 -41.94 6.04 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.576 0.547 . . . . 0.0 110.288 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.67 HG11 ' HG ' ' A' ' 22' ' ' LEU . 3.8 t -62.91 -63.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.67 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.24 -26.52 68.42 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.066 0.46 . . . . 0.0 110.763 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 78' ' ' THR . 6.7 t -65.08 -33.59 76.4 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.976 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.752 ' O ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -60.19 -49.29 78.22 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.488 179.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 2.7 pt-20 -63.76 -28.12 69.66 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.312 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.753 ' HA2' HG22 ' A' ' 8' ' ' ILE . . . -65.42 -19.97 67.17 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.361 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.758 HD12 ' HG2' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -70.74 -46.01 63.79 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.594 ' N ' ' HG ' ' A' ' 86' ' ' LEU . 7.5 m 48.97 -80.22 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.628 0.771 . . . . 0.0 113.077 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.758 ' HG2' HD12 ' A' ' 86' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.881 -1.057 . . . . 0.0 112.218 -179.476 . . . . . . . . 2 2 . 1 stop_ save_